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I . Enantioselective Copper(I)-Catalysed Borylative Aldol Cyclisations of Enone Diones 
Asymmetric conjugate addition of bis(pinacolato)diboron followed by aldol cyclisation of 
enone diones under the action of a chiral copper catalyst has been developed.[1] This 
enantioselective process, using a chiral bisphosphine as ligand, allows the formation of 
bicyclic alcohols with four contiguous stereocentres in high diastero- and enantioselectivity. 
This catalytic system has been applied to the parallel kinetic resolution of a racemic β-
ketoamide. Further functionalization of the bicyclic alcohols synthesised was also possible.a  
 
 
II. Iridium-Catalysed Arylative Cyclization of Alkynones by 1,4-Iridium Migration 
A domino addition of arylboronic acids and cyclisation of alkynones via an undescribed 
iridium 1-4-migration process has been developed.[2] A range of tricyclic compounds using a 
variety of arylboronic acids have been synthesised in good yields and high 
diasteroselectivity. The use of chiral bisphosphine ligand together with an iridium salt allows 
the formation of enantioenriched compounds in moderate yield.  
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1.1. Domino Reactions 
One of the main challenges in modern organic chemistry is the use of more environmentally 
friendly reactions. Traditional organic chemistry does not usually follow the principles of 
Green chemistry,[3] which can be used as guidelines for the development of more sustainable 
processes. A common way to synthesise complex organic compounds is to form one 
molecular bond at a time. This multistep approach often requires work-up and purification at 
each stage and can produce a large amount of waste. It also increases the length of the 
synthesis and, therefore, increases the energy required for the process.  
Domino reactions can be viewed as a green approach to complex molecule synthesis. A 
domino reaction, defined by Professor Lutz F. Tietze as a “Transformation of two or more 
bond-forming reactions under identical reaction conditions, in which the latter 
transformations take place at the functionalities obtained in the former-bond forming 
reactions” would reduce the amount of waste by decreasing the number of steps in a 
synthesis, and, therefore the number of individual work-ups and purifications.[4] In this 
manner, the transformation would be closer to the definition of a green or sustainable process 
making it more environmentally friendly. 
Domino reactions have been intensively studied in the last few decades.[5] This type of 
process has been utilised to form numerous complex natural products using multiple 
strategies;[6] from cationic catalysts[7] to enzymatic transformations.[8] However, recently, 
special interest has been shown towards the use of transition metals in order to perform 
domino reactions.[9]  
Several transition metals have been shown to facilitate domino processes but rhodium[10], 
palladium[11] and ruthenium[12] stand out among the rest. More recently, copper has also been 
utilised to perform these transformations.[13] Other non-precious metals such as cobalt, nickel 
and iron have also been utilised in domino reactions, but their use is less common.[14] 
A good example of a palladium-catalysed domino reaction was reported by Carretero in 
2001 where the process is initiated by a Mizoroki-Heck reaction.[15] After aryl palladation of 
the α-β-unsaturated sulfone 1, palladium can undergo β-hydride elimination to form the syn-
 
alkene 2. However, palladium is also capable of forming a five-membered palladacycle 5 
through a C-H activation process. This palladacycle 5 can react with a second equivalent of 
phenyl iodide in a Suzuki-Miyaura-type reaction forming a new C-C bond. At this point 
palladium could, again undergo β-hydride elimination, but instead undergoes a second C-H 
activation as before to give 7. Finally, a seven-membered palladacycle 9 is formed, which, 
after reductive elimination give almost exclusively the tricyclic compound 3 (Scheme 1).  
 
 
Scheme 1: Palladium domino arylation/cyclisation process 
 
More recently,  Zhu published the synthesis of fused oxindoles by a domino process from 
anilides of type 10 using palladium catalysis.[16] After oxidative addition and 
carbopalladation of 10 to give 12, a five-membered ring palladacycle 13 is formed via C-H 
activation. This palladium species 13 then activates the aromatic methyl group to form a 
 
seven-membered ring palladacycle 15, which, after reductive elimination, gave tricyclic 
compound 11 (Scheme 2).  
 
Scheme 2: Palladium domino intramolecular arylation/cyclisation process 
 
The rhodium-catalysed asymmetric hydroarylation of alkenes has been well established in 
the last few years by several groups. Krische and co-workers used this methodology to 
perform an asymmetric domino arylation-cyclisation process.[17] Applying standard 
rhodium-catalysed hydroarylation conditions with (S)-BINAP (L01) as ligand, Krische’s 
group achieved very high levels of both diastereo- and enantiocontrol in the 
desymmetrisation of enone-diones 16 (Scheme 3).  
 
 
Scheme 3: Rhodium domino arylation/aldol cyclisation process 
 
A more recent example of a domino reaction involving an arylative process catalysed by 
rhodium was published in 2013 by the Lin group. They applied rhodium-catalysed 
hydroarylation conditions to symmetric cyclohexadienone-containing 1,6-dienynes 20.[18] 
Using (R)-BINAP (L02) as ligand, the initial arylation occurs exclusively on the alkyne (no 
hydroarylation of the alkenes was observed). The alkenylrhodium species formed 22 then 
adds on to the α-β-unsaturated ketone to form cis-hydrobenzofurans 21 in a highly diastereo- 
and enantioselective manner (Scheme 4).  
 
Scheme 4: Rhodium domino arylation/Michael addition process 
 
As mentioned previously, copper-catalysed domino processes have been developed recently 
as an alternative to more expensive precious transition-metal catalysed transformations. An 
example of such a transformation was reported by Ito et al. in 2013. Applying copper 
catalysis, Ito’s group performed a borylative exo-cyclization of alkenyl halides (24) with 
bis(pinacolato) diboron and Xantphos (L03) as ligand.[19] One of the main challenges of this 
process was the control of the chemoselectivity. With alkenyl bromides or chlorides in the 
presence of Xantphos (L03), the borylation occurred exclusively on the alkene without any 
traces of the simple boryl substitution product 26. Mechanistically, the copper-Xantphos 
catalyst performs the borylation on the unactivated alkene forming alkyl-copper species 30. 
This species 30 forms an ate complex 31 by coordination with the base present to then, after 
sequential oxidative addition and reductive elimination, give the desired cyclic compound 25 
(Scheme 5).  
 
 
Scheme 5: Copper domino borylation/cyclisation process 
 
Another example of borylative domino reaction using copper was published by Lin in 2013. 
In this case, an asymmetric borylative cyclization of cyclohexadione-containing 1,6-enynes 
was reported. Similarly as Ito (Scheme 6), Lin’s group applied borylation conditions with a 
chiral phosphoramidite ligand (L04) to achieve the formation of oxygen-containing 
bicycles.[20] The catalytic system proposed is capable of differentiating between the 
unsaturated ketone and the alkyne. The conjugate borylation of the alkene is supressed by the 
substituents on the cyclohexadione and the borylation of the alkyne is facilitated through 
coordination of the copper-boron species to the oxygen of the propargyl ether unit (34). After 
the borylation, asymmetric conjugate addition to the α,β-unsaturated ketone takes place to 




As mentioned previously, other metals have been shown to carry out domino processes. 
Although there is very little in the literature on domino reactions using iridium as a catalyst, 
it is worth mentioning the work done by Zhao’s group in 2014 towards the synthesis of allyl 
carbamates via a multicomponent domino process catalysed by iridium (Scheme 7).[21] In the 
presence of CO2 and an amine, allyl chlorides 36 react to form allyl carbamates 37 under 
iridium catalysis using a phosphoramidite ligand. 
 




1.2. Desymmetrisation Reactions of 1,3-Diones 
Enantioselective desymmetrisation is a very powerful tool to generate chiral compounds with 
more than one stereocentre in a single step. Examples of this type of chemistry have been 
extensively reported in the last few decades. Many different strategies have been applied to a 
wide range of symmetric compounds; from ring-opening of aziridines,[22] to acylation of 
symmetric diols[23] or olefin metathesis[24] (Scheme 8).  
 






A very useful type of substrate for desymmetrisation processes are 1,3-dione containing 
compounds. The diketone moiety can promote a number of different types of reaction. For 
instance, Mikami et al. applied the well stablished copper-catalysed conjugate addition of 
organozinc-reagents to α,β-unsaturated ketones to synthesise five-membered ring 
compounds containing all-carbon quaternary centres.[25] The alkylation of cyclic pentadiones 
50 using a phosphoramidite ligand (L06) gave the desired product with high levels of 
enantiocontrol and, in most cases, a single diastereoisomer (Scheme 9).  
 
Scheme 9: Copper catalysed conjugate addition for the desymmetrisation of 1,3-diones 
 
Another example of the desymmetrisation of 1,3-diones was reported by Chiu in 2012 where 
a reductive aldol cyclisation of enethioate derivatives 55 using copper-bisphosphine complex 
was reported.[26]  Ph3SiH and copper acetate in the presence of a Taniaphos ligand perform a 
conjugate reduction of the electron deficient alkene of substrates of type 55. Then the enolate 
formed during the reduction is intramolecularly trapped by the pendent 1,3-dione to give 
bicycle 56 as a single diasteroisomer and with high levels of enantioselectivity (Scheme 10).  
 
Scheme 10: Copper domino reductive aldol cyclisation 
 
 
More recently, Mukherjee published the desymmetrisation of cyclopentene-1,3-diones 59 via 
an organocatalysed nucleophilic addition of deconjugated butenolides 58.[27] The 
organocatalyst of choice for this transformation was an amino thiourea L08. A combination 
of (S)-tert-leucine and (1R, 2R)-diaminocyclohexane with a 3,5-bis(trifluoromethyl)benzyl 
group on the amide nitrogen L08  proved to be superior. The addition of different 
deconjugated butenolides to a range of cyclopentene-1,3-diones 59 gave the desired products 
with high d.r. and enantiomeric excess (Scheme 11).  
 
Scheme 11:  Organocatalyzed desymmetrisation of 1,3-diones 
  
 
2. Introduction to Enantioselective 
Copper(I)-Catalysed Borylative Aldol 
Cyclisations of Enone Diones 
 
2.1. Copper-Catalysed Asymmetric Conjugate 
Addition 
In the past few decades conjugate addition reactions, in particular, those catalysed by 
transition metals have been one of the most useful tools in organic chemistry to create 
molecular complexity.  
Palladium,[28] rhodium[28b] and nickel[29] have been applied in enantioselective conjugate 
additions  (ECA) but lately, due to its low cost and toxicity and its capability to perform 
addition of alkyl nucleophiles[30], copper has been the metal of focus of many groups for 
developing ECAs. Chiral-copper complexes can be easily transmetalated with various 
organometallic reagents and then add in 1,4- or 1,6-fashion to various electron-deficient 
alkenes. 
The first report on copper-catalysed ECA was published by Lippard in 1988. Using a N,N'-
disubstituted aminotroponeimine lithium species 77 as a ligand exchange compound 
(aminotropenimine structures are known to act as chelating agents for copper),[31] 
CuBr·Me2S and n-BuLi the addition of two Grignard reagents occurred with low 
enantiocontrol (Scheme 12).[32] 
 
Scheme	  12:	  First	  copper	  catalysed	  conjugated	  addition	  of	  enones 
 
 
A catalytic cycle was proposed where, after coordination of the copper salt with the chiral 
ligand the transmetalation step occurs to form a chiral copper alkyl complex 80. This 
complex then adds to cyclohexenone giving exclusively the 1,4-adduct plus some 
homocoupling product (Scheme 13).[32]  
 
Scheme	  13:	  Copper	  catalysed	  conjugate	  addition	  catalytic	  cycle 
 
After Lippard’s success, several groups investigated this chemistry applying different ligands 
and achieving better enantiocontrol for the 1,4-addition of Grignard reagents to enones.[33] 
However, it was not until Feringa using bisphosphine ligands for the process that the catalyst 
loading could be decreased to levels below 10% while still maintaining high 
enantioselectivity.[34] 
Although classic bisphosphine ligands such as BINAP, Trost ligands or DuPhos proved to be 
inferior to the nitrogen or sulphur-based ligands used previously; Feringa and co-workers 
found that ferrocenyl-based bisphosphine ligands delivered high levels of enantiocontrol in 
copper-catalysed ECA of Grignard reagents.[34] From all the ferrocenyl-based ligands 
screened by Feringa’s group, Taniaphos (L07) appeared to be the most adequate for the 
conjugate addition of a range of alkyl Grignard reagents to cyclohexanone, cycloheptanone 
and dihydropyranones (Scheme 14).  
 
 
Scheme	  14:	  Copper	  catalysed	  conjugate	  addition	  of	  Grignard	  reagents 
 
Further studies by Feringa showed that acyclic α-β unsaturated esters and thioesters also 
undergo conjugate addition using similar conditions. However, SL-J001-1 Josiphos (L09)  
proved to be superior for these substrates (Scheme 15).[35] 
 
Scheme	  15	  Copper	  catalysed	  conjugate	  addition	  of	  Grignard	  reagents 
 
 
Although excellent results were obtained by several groups using Grignard reagents for the 
conjugate addition, in some cases the chemoselectivity was still low and significant amounts 
of 1,2-adduct were observed.  
The other main organometallic reagent used in copper-catalysed ECA is organozinc 
compounds. Alexakis’s group in 1993, while investigating the use of organolithium reagents 
for the conjugate addition of cyclohexanone using a new family of trivalent phosphorus 
ligands L10, observed that diethyl zinc also produced the desired product with an 
encouraging 32% enantiomeric excess and 70% yield (Scheme 16).[36] 
 
Scheme	  16	  :	  Copper	  catalysed	  conjugate	  addition	  of	  organozinc	  reagents	  
 
In 1996, Feringa et al. developed further this chemistry applying a phosphoramidite ligand 
L11.[37] The 1,4-addition of diethyl zinc to a range of enones was reported by Feringa with 
high enantioselectivity, not observing any traces of the 1,2-addition product and achieving 
levels of enantioselectivity similar or higher to those with Grignard reagents (Scheme 17). 
 
Scheme	  17:	  Copper	  catalysed	  conjugate	  addition	  of	  organozinc	  reagents 
 
 
Other groups have also used copper to catalyse the ECA of organozincs to electrondeficient 
alkene.[30] For instance, Alexakis and co-workers reported the use of copper 
thiophenecarboxylate and a phosphoramidite ligand L12 for the asymmetric addition of 
diethyl zinc to enones and nitro-olefins (Scheme 18).[38] 
 
Scheme	  18:	  Copper	  catalysed	  conjugate	  addition	  of	  organozinc	  reagents 
 
Besides organozinc reagents and Grignard reagents, copper also catalyses conjugate 
additions of organoaluminium reagents to olefins. ECA of β-disubstituted-alkenes with the 
organometallic reagents described before was unsuccessful, probably due to steric effects.  In 
2003 the Alexakis group addressed this challenge using alkylaluminium reagents. The 
conjugate addition of these compounds to enones was reported by several groups[39] with 
moderate enantioselectivity using a variety of ligands. However, it was only the conditions 
developed by Alexakis, using copper thiophenecarboxylate and a phosphoramidite ligand, 
that were capable of performing the addition of trimethyl aluminium to β-disubstituted 
cyclohexanones (Scheme 19).[40]   
 
 
Scheme	  19:	  Copper	  catalysed	  conjugate	  addition	  of	  organoaluminium	  reagents	  
 
More recently, using similar conditions but with (R)-BINAP as a ligand, Alexakis has also 
reported the addition of organoaluminium reagents to β,γ-unsaturated α-ketoamides with 
high yields (Scheme 20).[41] 
 
Scheme	  20:	  Copper	  catalysed	  conjugate	  addition	  of	  organoaluminium	  reagents	  
 
Nowadays the use of copper to catalyse conjugate addition reactions of organometallic 
reagents is a common tool to create complex molecules. Moreover several groups have 
 
developed a variety of chiral ligands which, in combination with copper salts, led to high 
levels of enantiocontrol in asymmetric conjugate addition reactions. In the last decade the 
use of copper catalyst has been applied in the conjugate addition of boron reagents to alkenes 
















2.2 Copper-Catalysed Asymmetric Conjugate 
Borylation 
As described on the previous chapter, copper performs conjugate addition processes through 
transmetalation with organometallic reagents. The conjugate borylation of olefinic system 
has been a field of significant study in the last decade, via the transmetalation with boron 
reagents.  
Organoboron compounds play an important role in modern-day organic chemistry. 
Hydroboration-oxidation of olefins to obtain alcohols, nucleophilic allylation of aldehydes or 
palladium-catalysed cross-coupling chemistry using arylboronic acids to form C-C bonds are 
just some of the various reactions which involve organoboron compounds. Organoboron 
compounds can be synthesised via a range of methods. For example, though the reaction of a 
boron ester and the corresponding Grignard reagent (Scheme 21, Method A); haloboration of 
terminal alkynes with boron tribromide (Scheme 21, Method B) and; hydroboration of 
alkynes or alkenes (Scheme 21, Method C).[42] 
 
Scheme 21: Synthesis of organoboron reagents 
 
Recently, a new alternative to the well stablished rhodium-catalysed hydroboration of 
alkenes for the synthesis of alkyl boron compounds has been developed; namely, the 
metal-catalysed boron conjugate addition to activated double bonds.[43] 
 
2.2.1. Metal-Catalysed Boron Addition to Double Bonds 
The boron addition to double bonds has been performed racemically using different 
transition metals as catalysts. In 1995, Baker and Marder reported the first mono- and 
diboronation of alkenes using a rhodium complex and bis(catecholato)diboron. Three 
borylated products were observed 121, 122 and 123, being the hydroboration structure 122 
the main product (Scheme 22).[44] 
 
Scheme 22: Rhodium catalysed boron addition of alkenes 
 
A few years later, Miyaura et al. published a diboron addition to double-bonds using a 
platinum catalyst and B2(pin)2. This procedure could be applied to a range of different 
unsaturated molecules in good yields (Scheme 23).[45] 
 
Scheme 23: Platinum catalysed diboration of alkenes 
 
Shortly after this report by Miyaura, Rice et al. were able to perform the first mono-boronate 
addition to alkenes using a platinum catalyst. Rice observed a complete conversion of the 
 
vinyl ketone to the boron enol ester which, after aqueous work up, afforded the mono-
boronate species in quantitative yield (Scheme 24).[46]  
 
Scheme 24: Platinum catalysed boration of alkenes 
 
2.2.2. Copper-Catalysed Racemic Conjugate Boron 
Addition to Activated Olefins 
The copper-catalysed conjugate addition of boron species to activated double bonds has been 
studied extensively over the last decade. In 2000, Miyaura et al. reported the first 
copper-mediated mono-boration of a variety of activated alkenes using a stoichiometric 
quantity of copper(I) chloride, B2(pin)2 and potassium acetate in DMF with moderate yields. 
Acyclic and cyclic enones, α,β-unsaturated nitriles and esters were all effective substrates 
(Scheme 25).[47]  
 
Scheme 25: Copper catalysed conjugate boration of activated alkenes 
 
Mechanistically, Miyaura proposed the transmetalation of the copper (I) salt with the 
B2(pin)2 to give boron-copper species 138. This newly created boron species 138 would then 
attack the double bond to form copper enolate 140 which after aqueous work up would give 
the observed product 141 (Scheme 26). 
 
 
Scheme 26: Mechanism of the copper catalysed conjugate boration of activated alkenes 
 
A few months after this report by Miyaura, Hosomi and co-workers reported the first 
catalytic copper boration of activated alkenes. The use of a phosphine ligand was essential 
for the process, not observing the desired product in absence of ligand. The catalytic system 
was successfully applied to cyclic and non-cyclic enones (Scheme 27).[48] 
 








2.2.3. Copper-Catalysed Asymmetric Conjugate Boron 
Addition to Activated Double Bonds 
The major challenge for transition-metal-catalysed conjugate boration was to compete with 
the high enantio- and regioselectivity of the complementary rhodium-catalysed 
hydroboration.[43c] Even though rhodium and platinum can be used to perform conjugate 
boration reactions, most of the effort in this area has been invested in the use of copper(I) 
salts in combination with phosphorus or nitrogen-based chiral ligands. Although there have 
been reports recently of boron addition to unactivated double-bonds (See Chapter 2.1.2.4.), 
most additions are to activated olefins, i.e. those conjugated to electron-withdrawing groups 
such as esters, ketones and nitriles. 
Most of the studies on asymmetric conjugate boration in the past ten years have been carried 
out with α,β-unsaturated esters or ketones, but the first report of this type of reaction was on 
an α,β-unsaturated nitrile. In 2006 Yun and co-workers reported a catalytic non-asymmetric 
system for the conjugate addition of B2(pin)2 to a broad scope of activated double bonds such 
as α,β-unsaturated esters, ketones, phosphonates or nitriles (Scheme 28).[49]  
 
Scheme 28: Copper catalysed conjugate boration of activated alkenes 
 
The proposed catalytic cycle (Scheme 29) indicates the formation of the phosphine-ligated 
copper species 150 and its conjugate addition to the double bond to form a copper enolate 
152. The copper enolate 152 is hydrolysed with methanol to give the boron compound 154 




Scheme 29: Catalytic cycle of the copper catalysed conjugate boration of activated alkenes 
 
Since the transition state of the proposed mechanism involved the conjugation of the copper 
complex with the double bond, it was proposed that the use of a chiral phosphine might lead 
to an enantioselective process. Accordingly, using SL-J001-1 Josiphos, Yun achieved the 
asymmetric addition of bis(pinacolato)diboron to cinnamonitrile (155).[49] The product was 
isolated in 84% yield and with 82% enantiomeric excess after the oxidation of the borylated 
intermediate 156  to the alcohol 157 (Scheme 30). 
 
Scheme	  30:	  Copper catalysed asymmetric conjugate boration of activated alkenes	  
 
2.2.3.1. Asymmetric Conjugate Boration of α,β-Unsaturated 
Esters 
 
The copper-phosphine ligand system developed by Yun for asymmetric boration of α,β-
unsaturated nitriles was applied two years later to a range of different α,β-unsaturated 
carboxylic esters and nitriles (Scheme 31).[50] 
 
Scheme 31: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
As shown, the reactivity and stereoselectivity of the addition to ester substrates decreased 
slightly with respect to that observed for the nitrile substrates, which might imply that the 
strength of the electron-withdrawing group effect is a key factor for such reactions. Although 
the electron-withdrawing effect of the nitrile vs ester substrates was important in terms of 
yields and stereoselectivity, no real effect was observed when different esters were used. 
After screening a range of chiral phosphine ligands SL-J001-1 Josiphos provided the highest 
reactivity and stereoselectivity, with yields over 90% and enatioselectivities of 80 to 95% 
(Scheme 31). 
Chiral phosphine ligands are not the only class of ligand to have been used for the boron 
conjugate addition to activated double bonds. In 2009, Fernandez and co-workers reported 
 
the use of phosphorous-nitrogen ligands for the conjugate addition of bis(pinacolato)diboron 
to α,β-unsaturated esters.[51] The yield of the process was improved but the stereocontrol that 
the phosphorus-nitrogen ligands provided was decreased compared with Yun’s conditions 
using SL-J001-1 Josiphos (Scheme 32). 
 
Scheme 32: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
For the past two decades, N-heterocyclic carbene (NHC) ligands have been successfully 
utilised in transition-metal-catalysed asymmetric transformations.[52] The first attempt to use 
these type of ligands in the conjugate boration of activated olefins was reported by 
Fernandez et al. in 2009.[53] Although the yield and stereocontrol achieved was lower than 
using phosphine ligands, good conversions and moderate enantiomeric excesses were still 
achieved using different NHC ligands. The boronates obtained were transformed into esters 
167, 168, or 169 , via oxidation and acylation, to aid analysis (Scheme 33).  
 
Scheme 33: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
In 2010, Hoveyda and co-workers confirmed the capacity of NHC ligands to induce high 
stereocontrol in copper-catalysed conjugate boration reactions. Substituted α,β-unsaturated 
esters and thioesters underwent boration with moderate to high yields and very high 
enantioselectivity (Scheme 34).[54] 
 
Scheme 34: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
To increase the enantiocontrol of the catalytic system, the temperature was decreased to −78 
°C. Additionally, to ensure the hydrolysis of the boron enolate at −78 °C, an acidic methanol 
solution needed to be added. Control experiments, without acidic methanol, indicated that if 
the reactions were not properly quenched at −78 °C, adventitious conjugate addition of the 
remaining bis(pinacolato)diboron could occur as the mixture is allowed to warm to r.t., 
leading to lower enantiomeric purity of the product. The robustness of the catalytic system 
was demonstrated by the application of the optimum conditions to a range of substrates. 
Transformations with substrates bearing an ortho-bromo group on the aromatic ring (178), 
proceeded to afford the desired boronate with very good conversions and enantioselectivity. 
However, ortho-methyl (181) and para-methoxy (179) substituted aromatic alkenes were 
less reactive and gave lower enantioselectivity (Scheme 35).  
 
 
Scheme 35: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
Stereocontrol could be further improved by using thioester substrates rather than carboxylic 
esters (Scheme 36).  
 
Scheme 36: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
Hoveyda demonstrated the utility of these organoboron compounds by generating esters and 
ketones through silver-mediated and palladium-catalysed procedures respectively from the 
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Scheme 37: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
The use of methanol had been assumed to be necessary for good conversions and faster 
reaction rates in the copper-catalysed conjugate boration of olefins. However Hoveyda 
demonstrated that for the copper-NHC system, the alcohol additive was not necessary to 
perform the reaction successfully isolating boron enolate 191 in good yields (Scheme 38).[54] 
 
Scheme 38: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
Even though copper catalysis is very efficient for the conjugate boration of alkenes, other 
metals have been utilised to perform this type of reaction. In 2009 the groups of 
Nishiyama[55] and Fernández[56] reported the conjugate addition of boron to α,β-unsaturated 
carboxylic esters using rhodium and nickel catalysts, respectively. Thus, new type of 
rhodium complexes designed by Nishiyama et al. could perform the conjugate addition of 




Scheme 39: Rhodium catalysed asymmetric conjugate boration of activated alkenes 
 
Nishiyama proposed a catalytic cycle through the formation of a rhodium enolate 199, which 
undergoes an exchange reaction with B2(pin)2 to form the boron enolate 200 that is then  
hydrolysed to obtain the desired product. 
 













Fernández explored the use nickel and palladium to perform the asymmetric conjugate 
addition of B2(pin)2 to α,β-unsaturated esters.[56] Both palladium and nickel seemed to be 
efficient transition-metals for catalysing the conjugate boration of activated olefins. 
However, the scope of the reaction was relatively narrow and only variations of the ester part 
were tested (Scheme 41 and Scheme 42). 
 
Scheme 41: Nickel catalysed asymmetric conjugate boration of activated alkenes 
 







2.2.3.2. Asymmetric Conjugate Boration of α,β-Unsaturated 
Ketones 
 
In parallel to the studies with α,β-unsaturated esters, detailed in the previous sections, several 
groups have been working on the analogous conjugate addition to α,β-unsaturated ketones. 
Yun et al. reported the first boron conjugate addition to acyclic enones in 2009.[57] The same 
catalytic system used for α,β-unsaturated esters (Scheme 31) was successfully applied to a 
range of enones. As occurred in the boration of α,β-unsaturated ester, the addition to α,β-
unsaturated ketone requires the presence of an alcohol additive for the reaction to proceed at 
a satisfactory rate (Scheme 43).  
 
Scheme	  43:	  Copper catalysed asymmetric conjugate boration of activated alkenes 
 
Yun explained this addition with a similar catalytic cycle to that reported for α,β-unsaturated 
esters where at the end of the cycle the copper enolate is protonated with methanol to form a 
copper-alkoxide species. When the reaction was conducted using deuterated methanol, the 
reaction proceeds with deuterium incorporated at the α-position in accordance with the 
proposed mechanism (See Chapter 2.1.2.3 Scheme 29). 
The acceleration caused by the addition of methanol can be explained by the facile formation 
of the copper methoxide species followed by the fast boration of the copper methoxide with 
bis(pinacolato)diboron to regenerate the active species. This proposition was supported by 
DFT calculations reported by Marder, Lin and co-workers in their mechanistic studies of the 
diboration of aldehydes. It was proposed that the energy barrier in the σ-bond metathesis 
 
between a Cu-O bond and a B-B bond (1.4 kcal/mol) is much lower than the same process 
between a Cu-C bond and a B-B bond (15.6 kcal/mol). Therefore a process without alcohol, 
which implies the direct transmetalation of the copper enolate with the boron species, is in 
some cases slower (Scheme 45).[58] 
 
Scheme 44: Mechanistic studies on copper ECA processes  
 
Although phosphorus-nitrogen ligands did not provide excellent results for the boron 
conjugate addition to α,β-unsaturated esters (See Chapter 2.1.2.3.1. Scheme 32), in 2009 
Shibasaki and co-workers reported a phosphorus-nitrogen ligand copper catalytic system that 
performed the conjugate boration of substituted cyclic enones in high yields and 
stereocontrol.[59] 
Attempts to perform the conjugate boration of enone 214 showed that Yun’s conditions were 
not appropriate. After screening a variety of conditions the optimum system was found to be 
a combination of CuPF6(CH3CN)4 and  lithium tert-butoxide in DMSO; the addition of 
methanol was not required and also not recommended owing to a 10% decrease in yield for 
most of the substrates when methanol was added (Scheme 46). 
 
 
Scheme 45: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
However, despite this success, chiral phosphorous-nitrogen ligands did not provide good 
yields or stereocontrol when acyclic α,β-unsaturated ketones were employed as substrates. 
Shibasaki et al. overcame this issue by changing the ligand to a secondary diamine. Different 
chiral secondary diamine ligands were screened with the best results obtained with the 
diphenyl-substituted diamine L20. This Cu-diamine system was applied to a wide range of 
substituted acyclic enone with high yields and enantioselectivity (Scheme 47).[60] 
 
Scheme 46: Copper catalysed asymmetric conjugate boration of activated alkenes 
 
The copper-catalysed conjugate borations described so far were assumed to be-water 
sensitive as anhydrous conditions are usually employed, but in 2012 Kobayashi reported the 
addition of B2(pin)2 to α,β-unsaturated carbonyl compounds in water (Scheme 48). 
Copper(II) hydroxide in the presence of 2,2’-bipyridine ligand L21 and AcOH as additive in 
 
water gave excellent yield and enantiomeric excess in the boration of α-β-unsaturated 
ketones, amides and carboxylates (Scheme 48).[61] 
 
Scheme	  47:	  Copper catalysed asymmetric conjugate boration of activated alkenes 
 
The conjugate borylation of activated olefinic systems was recently extended by Lam and 
co-workers towards the asymmetric synthesis of allylboronates via a 1,6-boration of dienes 
catalysed by copper. A combination of CuF(PPh3)·2MeOH and SL-J001-1 Josiphos in the 
presence of i-PrOH as a proton source gave the 1,6- rather than the 1,4-addition with high 
yields and enantioselectivity (Scheme 49).[62]  
 





2.2.4. Boron Addition to Weakly-Activated Double Bonds 
Hydroboration is still the most effective strategy for forming a C-B bond from a simple non 
activated double bond. To date, Hoveyda’s group is the only one to report the addition of 
B2(pin)2 to a non-activated double bond using a copper(I) salt and an NHC ligand (Scheme 
50).[63]  
 
Scheme 49: Copper catalysed asymmetric conjugate boration of weakly activated alkenes 
 
Phosphine ligands were also evaluated but resulted in much lower conversions.  As observed 
in many conjugate borations, the addition of methanol seemed to be crucial. Even if a 
stoichiometric quantity of NHC-Cu complex was added after 10 minutes, the conversion was 
less than 20%. However, if methanol was added after 10 minutes, complete conversion was 
obtained. When deuterated methanol was added to the system the addition of deuterium 
alpha to the C-B bond was observed. This fact could imply that the mechanism will go 
through the protonation of a C-Cu bond, as described previously in the conjugate boration of 
activated double bonds (Scheme 50). 
 
Scheme	  50:	  Deuterated	  experiments	  on	  copper	  borylation	  
 
2.2.5. Organocatalytic Conjugate Boron Addition to Double 
Bonds 
The latest studies in the conjugate boration of activated olefins showed that this reaction can 
also be performed in the absence of a transition-metal catalyst. In 2010, Hoveyda reported 
the first metal-free (non-asymmetric) conjugate boration of enones promoted by NHCs.[64] As 
shown in Scheme 51, organocatalyst L23 promoted the addition of B2(pin)2 to a variety of 
enone substrates with high yield and in the absence of an alcohol additive.  
 
Scheme 51: NHC catalysed conjugate boration of enones 
 
Hoveyda proposed a mechanism where the B2(pin)2 undergoes a nucleophilic attack from the 
NHC to polarise the B-B bond. This polarised B-B species 253 would then be able to attack 
the enone to form a boron enolate 256, which, after an aqueous work-up, would be 
hydrolysed to the desired boron species 136 (Scheme 52). 
 
Scheme 52: Proposed mechanism for NHC borylation of enones 
 
Shortly after Hoveyda developed the organocatalytic NHC-catalysed system, Fernández 
reported a similar catalytic system using chiral phosphine ligands. This approach was applied 
to cyclic and acyclic enones and α,β-unsaturated esters with moderate to high conversions 
and enantiomeric excess’s. A combination of caesium carbonate and Josiphos-type ligand 
L23 in the presence of methanol were the optimal conditions for performing this transition 
metal-free conjugate boration (Scheme 53).[65] 
 
Scheme 53: Phosphine catalysed conjugate boration of activated alkenes 
 
Fernández et al. proposed where the nucleophilic attack of a phosphine ligand 258 to the 
B2(pin)2 promotes the conjugate addition to the alkene 151 and the formation of the boron 
enolate 260 which after protonation forms the desired compound 154 (Scheme 54). 
 
Scheme 54: Proposed mechanim for the phosphine catalysed borylation of activated alkenes 	  
 
2.3. Domino Conjugate Boration/Electrophilic Trapping 
As described previously, the accepted mechanism for the conjugate boration of olefins 
involves the formation of a copper- or boron-enolate, which is then protonated using 
methanol or another proton source to generate the product (See Chapter 2.1.2.3. Scheme 29). 
In 2009, Shibasaki and Hoveyda both reported the electrophilic trapping of the enolate, 
formed after the boration of an activated alkene, with benzaldehyde.[59, 64] Hoveyda et al.  
were able to perform this type of reaction in a transition metal-free fashion using a achiral 
NHC ligand. The aldol product 276, was obtained as a single diastereoisomer (Scheme 55).  
 
Scheme	  55:	  Diastereoselective	  domino	  copper	  boration/aldol	  addition 
 
Before our work, Shibasaki et al. reported the first and only example of an asymmetric 
boration and enolate trapping of activated alkenes. Using a phosphorous-nitrogen ligand 
(L19) in the presence of lithium tert-butoxide, the boration of 2-phenyl-2-cyclohexen-1-one 
(214) and the trapping of the resultant enolate using benzaldehyde was achieved with 91% 
enantiomeric excess and a 6.5:1 diastereomeric ratio (Scheme 56). 
 
Scheme 56: Enantioselective domino copper boration/aldol addition 
 
 
A more extensive study on this type of chemistry was reported by Riant’s group in 2012. 
Conjugate borylation of α-β-unsaturated esters and amides followed by enolate trapping with 
a range of aldehydes was performed using a combination of copper(I) chloride and racemic 
BINAP. Although it is a high yielding process, there was no control of the enantioselectivity 
and poor diastereomeric ratios were obtained (Scheme 57).[66] 
 
Scheme	  57:	  Racemic	  intermolecular	  conjugate	  domino	  boration/aldol	  addition 
 
The mechanism proposed by Riant follows the accepted mechanism reported by Yun 
(Chapter 2.1.2.3, Scheme 29). After boration of the acrylate the enolate formed 283 is 
trapped by the aldehyde to form a copper alkoxide 284. The intermediate undergoes σ-bond 
metathesis with the B2(pin)2 to regenerate the active catalyst and formed, after hydrolysis, 
the desired alcohol (Scheme 58). 
 
Scheme	  58:	  Proposed	  mechanism	  for	  the	  conjugate	  domino	  boration/aldol	  addition 
 
 
The conjugate boration of activated alkenes catalysed by copper has been well explored by 
several groups. Moreover the application of this reaction in domino process has been applied 
to the synthesis of complex molecules. It has been proposed the formation of a copper 
enolate during the borylation process. These copper enolate is usually protonated but it can 
also be trapped with a nucleophile in a domino process to formed more complex structures. 
Although the borylation of activated alkenes have been developed the trapping of the enolate 
formed during the process has not been well stablished. In the literature only poor diastereo 
and /or enantioselective process have been published. Other areas that could be investigated 
is the used of functional groups to activate the alkene other than carbonyl or nitrile groups.   
 
3. Copper Catalysed Conjugate Boration–
Aldol Cyclisation Domino Process  
 
3.1. Aims and Objectives 
As described in Chapter 2.1.2.3 (Scheme 29), the formation of an enolate intermediate in the 
conjugate boration of activated olefins has been reported by several research groups during 
the past decade.  This enolate is usually protonated with a proton source, methanol in most 
cases, to obtain the desired boronate. As demonstrated in Chapter 2.1.3., prior to the 
beginning of this research project, there had only been two reports of the trapping of an 
enolate formed in a conjugated boration reaction (Schemes 55 and 56).[59, 64] Additionally, 
during the course of the project, Riant’s group published a racemic intermolecular conjugate 
boration/enolate trapping process (Chapter 2.1.3., Scheme 57).[67] Therefore an opportunity 
existed to develop a range of asymmetric intramolecular domino conjugate boration-
electrophilic trapping reactions to generate complex products with multiple stereocentres, 
hopefully, with good control over both the relative and absolute stereochemistry. 
This project aimed to apply the well-established conjugate boration of activated olefins to 
substrates which allowed for an intramolecular electrophilic enolate trapping to form a 




Scheme 59: Proposed domino borylation/aldol cyclisation process 
 
It was hoped that, with the judicious choice of conditions and the appropriate use of a chiral 
ligand, the conjugate boration–cyclisation would be achieved in good yield and with high 
levels of both diastereo- and enantiocontrol. Once optimum reaction conditions were 
developed, this methodology was applied to a range of different substrates to illustrate the 
 
scope and discover the limitations of this type of chemistry. Finally, to demonstrate the 
utility of the conjugate boration–cyclisation process, a range of different transformations 
would be carried out with the B-C bond, i.e. oxidation to alcohol,27 Suzuki-Miyaura 
coupling28 or amination.29 
 
3.2. Conjugate Boration–Domino Trapping 
Process Screening 
The first attempt to perform this type of chemistry was carried out recently within the Lam 
group.  Asymmetric boration and enolate cyclisation of enone 288 would afford the aldol-
type product 289 via the mechanism proposed in Scheme 61. However, the chemistry did not 
proceed to give the boration-cyclisation product. In fact, when diketo-enone 288 was treated 
with NiBr2/PCy3, a Michael addition took place to form bicyclo[3.2.1]octane 290  in 52% 
yield (Scheme 60).b 
 
Scheme 60: First attempts on the boration/aldol cyclisation process 
 
It was not until a CuCl/P(OEt)3 catalytic system was applied, that success was achieved 
(Scheme 61). The use of the phosphite ligand was crucial to obtain the cyclised product. Full 
conversion of the enone 291 was observed after 18 h at r.t. However, not only the desired 
                                                      
b Reaction performed by Darryl Low 
 
cyclised product 292 was formed, 60% conversion of the non-cyclised product 293 was also 
observed (Scheme 61).c 
 
Scheme 61: Copper catalysed racemic boration/aldol cyclisation process 
 
The screening studies commenced with commercially available phosphine ligands in an 














                                                      
c Reaction performed by Dr Alan R. Burns 
 
Fortunately SL-J00-1 Josiphos ligand (L09) gave excellent results in combination with 
CuCl, B2(pin)2, NaOt-Bu as base and MeOH as additive in THF, delivering product 292 in 
high conversion an acceptable ratio of cyclised product and very good diastereo- and 
enantiocontrol (Table 1, Entry 2). Other bisphosphine ligands proved to be inferior in every 
aspect (Table 1, Entries 3-6).d  
Table 1:  Ligand Screening 
 




1 P(OEt)3 95% 40:60 >95:5 - 
2 L02 62% 48:52 >95:5 70% 
3 L19 74% 32:68 >95:5 10% 





5 L09 >95% 87:13 >95:5 93% 






I) Determined by 1H NMR analysis of the crude reaction mixture 
(disappearance of a signal of 1H, m at 6.85-6.89 Hz and appearance of a 
signal of 1H, d at 3.59 Hz)  
II) Determined by chiral HPLC 
                                                      
d Screening performed by Dr Alan R. Burns 
 
As it could have been expected the absence of a proton source in the reaction mixture 
increased the proportion of cyclised product. However, surprisingly, the enantioselectivity of 
the process was diminished (Table 2, Entry 2). Different strategies to promote the formation 
of the cyclic product were applied. The first attempt was the dilution of the reaction which 
increased the stereocontrol as well as the amount of uncyclised product (Table 2, Entry 3). 
The second strategy was to use a different proton source: when a bulkier alcohol as t-BuOH 
was added the ratio of cyclisation increased while the stereocontrol was preserved (Table 2, 
Entry 4). i-PrOH was marginally more efficient (Table 2, Entry 5). Therefore, it was these 
conditions that were used to study the scope of the process (Table 2).e 








1 MeOH 0.1 >95% 87:13 >95:5 90% 
2 None 0.1 >62% 93:7 >95:5 85% 
3 MeOH 0.05 >95% 72:28 >95:5 95% 
4 t-BuOH 0.05 >95% 83:17 >95:5 94% 
5 i-PrOH  0.05 >95% 84:16 >95:5 94% 
 
I) Determined by 1H NMR analysis of the crude reaction mixture (Table 1) 
II) Determined by Chiral HPLC 
 
The catalytic cycle proposed for this process is in accordance with the mechanism described 
by Yun’s group in their conjugate boration studies.[49] A copper salt transmetalates with 
B2(pin)2 to form copper-boron species 150. This species 150 then attacks the α-β unsaturated 
                                                      
e Screening performed by Dr Alan R. Burns 
 
ketone to form copper enolate 294. In this particular case, enolate 294 it is trapped by the 
tether ketone instead of protonation by the alcohol additive forming copper alkoxide 
intermediate 295. Finally the alcohol regenerates the active copper species and protonates the 
intermediate to form the observed alcohol 292 (Scheme 62). 
 
Scheme 62: Catalytic cycle for the boration/aldol cyclisation process 
 
With these optimised conditions in hand, the chemistry was applied to a range of enone 
diones. To synthesise the required substrates, two different routes were developed.  
 
3.3. Substrate Synthesis 
To enable the generation of a broad range of substrates to study the scope of the domino 
process, it was proposed to modify three parts of the enone starting material. The three parts 
to be modified were: i) the size and nature of the ring of the 1,3-diketone compound; ii) the 
length of the chain between the diketone ring and the alkene and; iii) the substituents in the 
aromatic ring adjacent to the α,β-unsaturated ketone (Figure 1).[68] 
 
 
Figure	  1:	  Proposed	  modification	  on	  dione	  substrate 
 
Two routes were applied to achieve the modifications proposed. The first route involved a 
Wittig olefination of aldehydes 296 with ylides 297, and the second was a cross-metathesis 
of alkenes 299 with α,β-unsaturated ketones 300, which were synthesised from the 
corresponding ylide and formaldehyde.[69] 
 
Scheme 63: Substrate synthesis 
 
3.3.1. Ylide Synthesis 
The ylides required for both routes were, on the whole, prepared from the corresponding 
α-bromoketone. These α-bromoketones were either commercially available or prepared from 
the ketone by bromination using copper(II) bromide. Thus, ylides 297 were prepared in 
overall yields of 78-90% for the two steps (Scheme 66).[70] 
 
 
Scheme	  64:	  Ylide	  synthesis	  
a) Bromine in a HBr/AcOH solution instead of CuBr2 in CH2Cl2. 
b) Synthesised by Darryl Low. 
 
One particular ylide was synthesised in a different fashion. An ylide containing an alkyl 
ketone was required to test the effect of having an alkyl chain next to the α,β-unsaturated 
ketone rather than an aromatic group. An ylide containing a methyl or an ethyl ketone could 
have been used for that purpose but the lack of a chromophore in the final cyclised product 
would make enantiomeric excess analysis through chiral HPLC more difficult. After 
surveying the literature, ylide 312 was targeted for synthesis as it has an alkyl chain next to 




To synthesise this molecule, a Negishi coupling was first attempted.[72] Thus, organozinc 314 
was prepared and reacted with chloroacetyl chloride under Pd(0)-catalysis (Scheme 65). 
 
Unfortunately, the corresponding chloroketone 316 was not detected observing a unseparable 
complex mixtures. 
 
Scheme 65: Attempted ylide synthesis 
 
Therefore, a second strategy to synthesise ylide 312 was sought. Accordingly, using a 
method from Stevens and Ellis, ylide 318 was deprotonated with n-BuLi and reacted with 
benzyl bromide 317.[71a] However, again the desired ylide was not detected observing mainly 
starting benzyl bromide (Scheme 66).  
 
Scheme 66: Attempted ylide synthesis 
 
The last strategy attempted to synthesise ylide 312 was to react hydrocinnamoyl chloride 319 
with methyltriphenylphosphonium bromide 320 in presence of n-BuLi.[73] As in the previous 
attempt, the base should deprotonate the methyl group of the phosphonium salt and then 
attack the acyl chloride. Nevertheless, the ylide was, unfortunately, not obtained 
(Scheme 67). 
 






Given these setbacks, it was proposed to synthesise a different ylide. Ylide 322 was a 
structure already described in the literature and also had the properties required; i.e. alkyl 
chain plus chromophore. To synthesise ylide 322, methyl ylide 318 was deprotonated using 
n-BuLi to then attack the halide 321 to form the desired ylide 322. Pleasingly, this reaction 
was successful and delivered ylide 322 in a moderate 45% yield (Scheme 68).[74] 
 
Scheme 68: Alkyl ylide synthesis 
 
3.3.2. Wittig Olefination Route 
 
Scheme 69: Substrate synthesis 
 
The double bond position was thought to be the ideal disconnection to synthesise substrates 
of type 298 through a Wittig reaction of aldehydes of type 296 with the corresponding ylides 
297. This type of substrate would result in products which would give a six-membered ring 
after the boration-cyclisation process was performed. 
To synthesise the aldehyde precursor, the corresponding cyclic diketone (2-methyl-1,3-
cyclopentanedione 323 or 2-methyl-1,3-cyclohexanedione 326) was treated with acrolein in 
water to perform a Michael addition. Diketone 326 was completely insoluble in water and 
very low yields were achieved when the Michael addition was performed in water, therefore 
the solvent was changed to t-BuOH (Scheme 70).[69b] 
 
 
Scheme 70: Aldehyde precursors sysnthesis 
 
For cyclohexadione 326, simple evaporation of the reaction solvent provided a quantitative 
yield of aldehyde 327. For cyclopentadione 323, a filtration through a pad of silica was 
required to deliver pure aldehyde 327, also in quantitative yield. 
The next step of the route was to form the α,β-unsaturated ketone through a Wittig 
olefination with ylides 297, which gave the final products with yields between 46 and 88% 
after purification via flash column chromatography on silica gel (Scheme 71 and 
Scheme 72). 
 




Scheme 72: Substrate synthesis 
a) Substrate synthesised by Dr Alan R. Burns 
 
 
Using the previously described route, two more substrates were synthesised modifying the 
substitution between the diketone and also the nature of the electrophilic part. The methyl 
substituent was modified for an ethyl and a allyl group. To achieve the corresponding 
aldehyde, 2-ethyl-1.3-cyclopentadione was reacted with acrolein in water. After 
concentrating under vacuum, the aldehyde was isolated and reacted with ylide 309 to obtain 
the corresponding α-β-unsaturated ketone 343. To synthesise the allyl-substituted substrate 
346, 1,3-cyclohexadione 344 was first reacted with allyl bromide in the presence of Triton B 
in water. Once allyl diketone 345 was obtained, the previously described route yielded 
product 346  (Scheme 73).[75] 
 
 
Scheme 73: Substrate synthesis 
a) Product synthesised by Darryl Low. 
 
Additionally, racemic cyclic β-ketoamide 351 was prepared to study if our system would be 
capable of performing a parallel kinetic resolution. The condensation of N-methylaniline 348 
and diethyl methyl malonate 347 at 220 °C gave β-ketoamide 349, which was then subjected 
to the Michael addition with acrolein and Wittig reaction with ylide 311 to result in dione 
351 (Scheme 74).[76] 
 
Scheme 74: Substrate synthesis 
 
3.3.3. Cross-Metathesis Route 
The second strategy to modify the enone substrate was to apply a cross-metathesis reaction 
to reduce the length of the linker between the olefin and the ketone. 
Therefore, using the Hoveyda-Grubbs 2nd generation catalyst, the reaction between alkene 
352 and α-β-unsaturated ketones 300 gave the desired enones 353 in moderate yields. The 
α,β-unsaturated ketones were obtained after a Wittig reaction of the corresponding ylide and 
formaldehyde (Scheme 75 and 76).[77]  
 
Scheme	  75:	  Precursor	  synthesis 
 
Scheme 76: Substrate synthesis 





3.4. Scope of the process 
The substrates synthesised through the routes shown on chapter 2.2.3. were used to 
investigate the scope of the borylation aldol cyclisation process.  
Following the previously optimised conditions for the reaction of enone 291, substitutions on 
the benzene ring were well tolerated. Substrates with both electron-donating and electron-
withdrawing substituents performed well under the optimised conditions to give the desired 
cyclised products in high yields and high enantioselectivities as a single diastereoisomer. We 
also observed that the reaction is not limited to aromatic α,β-unsaturated ketones. The 
copper-catalysed process achieved the synthesis of product 358, which contains an ester 
group as the activating group for the double-bond, and also product 359, where an alkyl 
chain was placed next to the α,β-unsaturated ketone with high stereocontrol (Scheme 77). 
 
Scheme 77: Copper catalysed boration/aldol cyclisation 
 
 
Ortho substitution in the aromatic ketone proved to be more challenging. Substrate 
containing a ortho-bromophenyl ketone gave poor diastereoselectivity (almost 1:1) and 
mediocre enantioselectivity especially in the case of the newly observed diastereoisomer 
(68% enantiomeric excess) (Table 3, Entry 1). In the case of meta-substitution, the 
diastereoselectivity was improved to almost 4:1 in favour of the new diastereoisomer 
observed in the previous experiments and the enantioselectivity was still high for both 
isomers (Table 3, Entry 2). Surprisingly, when a strong electronwithdrawing group was 
introduced in the aromatic ketone the diastereomeric ratio was inverted to the new 
diastereoisomer observed (3:2) although the enantiocontrol was still high (Table 3, Entry 3). 
 
Table	  3:	  Electron-­‐Poor	  Aromatic	  Ketones	  
 
Entry Substrate d.r.I Yield eeII 
1 Ar = 2-BrCC6H5 55:45 42% (48%)III 68% (83%)IV 
2 Ar = 3-F3CC6H5 23:77 60% (15%)III 83% (89%)IV 
3 Ar = 4-O2NC6H5 59:41 29% (49%)III 86% (87%)IV 
I) Determined by 1H NMR analysis of the crude reaction mixture (Signal of the 
CHCOAr in each diastereoisomer) 
II) Determined by Chiral HPLC 
III) Yield of new diastereoisomer 
IV) ee of new diastereoisomer 
 
Pyridyl and ortho-methoxide substituted substrates 335 and 329 did not produce the desired 
cyclic products 384 and 385. A complex mixture was recovered upon work-up in the case of 
pyridyl substituted dione 385 and mainly the non-cyclic product 386 was observed in the 
crude of the reaction of the ortho-methoxy substituted substrate 329 (Scheme 78 and 79). 
 
 
Scheme	  78:	  Attempted	  substrate 
 
Scheme	  79:	  Attempted	  substrate	  
 
The length between the diketone and the alkene as well, as the ring size of the cyclic 
1,3-diketone was also studied. In these cases the use of t-BuOH as additive instead of i-PrOH 
gave a marginal increase in the overall yields. 
When the size of the cyclic dione was reduced from cyclohexadione to cyclopentadione, an 
increase on the overall yield of the process was achieved. In the case of simple phenyl ketone 
product 387 a significant 20% increase of yield was obtained as well as a slight increase in 
the enantiocontrol. Both electron-rich and electron-poor aromatic ketones 390 and 388 gave 
a better yield maintaining the enantiomeric excess. We also observed that this process 
tolerates substitutions other than a methyl group at the 2-position for cyclopentadione 
substrates. Ethyl-substituted alcohol 389 was obtained in both good yields and enantiomeric 
excess. As well as for most of the cyclohexadione products, only one diastereoisomer was 
observed with the same relative stereochemistry (Scheme 80).  
 
 
Scheme 80: Copper catalysed boration/aldol cyclisation 
a) Product synthesised by Dr Alan R. Burns. 
 
The diastereocontrol was clearly diminished when a cyclopentane was formed during the 
aldol cyclisation, but high levels of enantioselectivity were still achieved (Scheme 81). 
 
Scheme 81: Copper catalysed boration/aldol cyclisation 
a) Product synthesised by Dr Alan R. Burns. 
b) ee of minor diastereoisomer. 
 
3.5. Parallel Kinetic Resolution 
Parallel kinetic resolution is a well-established tool to separate a mixture of enantiomers 
thanks to the different reaction rates in a chemical or enzymatic reaction of each 
enantiomer.[78] In order to test the capacity of this methodology to separate a mixture of 
enantiomers, a parallel kinetic resolution study was performed. A racemic substrate 
containing a cyclic β-ketoamide 351 was subjected to the optimised conditions using i-PrOH 
as additive. As a result, a mixture of diastereomer of tricycles 393 and 394 and uncyclised 
products 395 and 396 was obtained with high enantioselectivity. This indicates that the 
parallel kinetic resolution of racemic cyclic β-ketoamide 351 was not achieved effectively. A 
reaction performed with triethyl phosphite gave similar diastereomeric ratios, which might 
indicate that the diastereoselectivity of the process is controlled by the substrate rather than 
by the chiral copper complex. (Scheme 82) 
 
Scheme 82 
a) Product synthesised by Dr Alan R. Burns. 
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394 + 395: 42% yield, 83:17 d.r.
91% ee (86% ee)
396 + 397: 41% yield, 73:27 d.r.





3.6. C-B Bond Transformations 
A series of well-known procedures to modify boron-carbon bonds were applied to para-
chloro substituted aromatic ketone 356. To be able to try the transformations proposed and to 
prove that the developed methodology was scalable, 1.4 g of 334 was subjected to the 
borylation-cyclisation process obtaining similar yield and stereocontrol as in the small-scale 
reaction (Scheme 83). 
 
Scheme 83: Gram scale copper catalysed boration/aldol cyclisation process 
 
Oxidation of the B-C bond using NaOH/H2O2 did not produce the expected alcohol. 
Therefore, Marsden’s conditions for the oxidation of organoboron compounds using NaBO3 
were applied and alcohol 398 was obtained in a 86% yield without damaging the 
enantiomeric excess (Scheme 84).[79]  
 
Scheme	  84:	  Further	  transformations,	  oxidation 
 
In order to perform further transformations, the corresponding trifluoroborate salt 399 was 
synthesised using Aggarwal’s conditions.[80] It was proposed to use Suzuki-Miyaura coupling 
conditions in order to further fuctionalise the products synthesised. Unfortunately coupling 





















with bromobenzene using various conditions was not achieved. Either only starting salt 399 
or a complex mixture of products was observed (Scheme 85).[81] 
 
Scheme	  85:	  Further	  transformations,	  palladium	  catalysed	  Suzuki	  coupling 
 
Another transformation studied was the amination of the C-B bond. However, when salt 399 
was subjected to Matesson’s conditions[82]  for the amination of BF3K salts, a complex 
mixture of products was observed and the expected amine 401 was not isolated (Scheme 86).  
 































































1.6 equiv. benzyl azide
1,2-DCE,0 ºC -> r.t.X
 
3.7. Proposed Conformations to Explain the 
Diasterochemical Outcomes 
The methodology developed for the conjugate boration-cyclisation of enone gives only two 
diastereoisomers (in the case of cyclohexadione substrates). In order to propose the most 
plausible transition state different diastereomeric conformations were studied. Cis-decalin 
292, isolated in most of the cases, comes from an aldol cyclisation process. Assuming the 
formation of a copper-enolate after the borylation of the double bond, one could expect the 
formation of either a Z-enolate or an E-enolate. To achieve the desired diasteroselectivity in 
the case of a Z-enolate, a chair-like transition state 402 would be required. In the case of an 
E-enolate, it would go through a twist-boat transition state 403. It was proposed that the 
observed product 292 comes from the chair-like transition state 402 due to a series of factors 
(Scheme 87): 
a) The formation of a Z-enolate is generally more favourable, in the case of a copper-
enolate intermediate, than an E-enolate.[83] 
b) Generally, chair-like transition states have lower energy barriers than twist-boat 
transition states. 
c) In the case of transition state 402, the B(pin) and phenyl enolate substituents are in 
pseudo-equatorial positions. For twist-boat transition state 403, both of these 
substituents are pseudo-axial incurring energy penalties due to 1,3-diaxial 
interactions making this transition state less favourable.  
 
Scheme 87: Proposed diasteromeric conformations 
 
A different diastereoisomer 383 was observed when electron-poor aromatic ketone substrates 
were subjected to the domino process. Assuming the same premises as before, a chair-like 
transition state 404 from an E-enolate and a twist-boat transition state 405 from a Z-enolate 
402 403
 
were proposed. Following the same rational as previously, it is not straightforward to state 
which of the transition states is more favourable (Scheme 88): 
a) On the one hand, the chair-like transition state 404 has a low energy conformation 
but it comes from an E-enolate, which, as mentioned before, is less favourable for 
copper enolates.  
b) On the other hand the twist-boat transition state 405 is a high energy conformation; 
however, it comes from a Z-enolate which is preferable in the formation of copper 
enolates (Scheme 90).  
 
Scheme 88: Proposed diasteromeric conformations 
 
Further studies would be required to have a clearer picture of the process and to be able to 
confirm which of the transition states proposed for both diastereoisomers is the more 












3.8. Conclusions  
A new copper-catalysed system for the domino conjugate boration-cyclisation of enones has 
been developed achieving yields between 55 and >95%. 16 new byciclic structures were 
obtained with four contiguous stereocentres with both high diastereo- and enantioselectivity 
(up to 95:5 dr and >98 % ee). This new system has proven to be robust enough to be applied 
to a broad range of enone-dione substrates with different electronic properties on the 
aromatic part. The catalytic system was demonstrated to be moderately effective for the 
parallel kinetic resolution of a racemic β-ketoamide. Further transformations were performed 
to demonstrate the utility of the cyclised products. Although the system was applied to a 
wide range of substrates this methodology can still be applied to other structures. 
Modifications on the electrophilic part used to trap the enolate part aswell as modification on 
the functional group to activate the alkene can be investigated. This methodology works well 
for this intramolecular process, another challenge still present is the borylation and enolate 
trapping with an external electrophile. Examples of such a process have been shown in the 







4. Introduction to the Iridium-Catalysed 
Arylative Cyclisation of Alkynones by 1,4-
Iridium Migration 
 
As described in chapter 1.1., transition metal-catalysed domino reactions are a powerful tool 
for the synthesis of complex molecules. One mode of reactivity for metals used to carry out 
domino reactions is a 1,4-metal migration.[84] One the most common 1,4-metal shifts occurs 
between an alkenyl-metal 413 an aryl-metal species 416. This transformation is usually 
described as an oxidative insertion to form a metallacyle 415 and then reductive elimination. 
This mechanism fuctionalises a relative inert C-H bond creating a new carbon-metal bond 
which can undergo subsequent reactions (Scheme 89).[85]  
 
Scheme	  89:	  1,4-­‐Migration	  proprosed	  mechanism	  
 
The metals of choice for this type of transformation have been mainly palladium and 
rhodium but cobalt, nickel, platinum and very recently iridium have also shown the to 





4.1. 1,4-Palladium Migration 
The first 1,4-palladium migration process was described by Dyker et al. in while 
investigating a palladium catalysed C-H activation.[86] In the presence of Pd(OAc)2 the 
formation of benzofuran 418 from aryl iodide 417 was observed (Scheme 90).[87]  
 
Scheme	  90:	  Palladium	  catalysed	  1,4-­‐migration	  process	  
 
The mechanism proposed for the formation of benzofuran 418 starts with oxidative insertion 
of palladium into the aryl iodide to give arylpalladium(II) species 419. C-H activation of the 
methoxy group by oxidative insertion forms palladacycle 420. This palladacycle 420, upon 
reductive elimination, could perform a 1-4-migration to give alkylpalladium species 421. 
Finally Pd intermediate 421 would cyclise on to the reactive double bond to give benzofuran 
418. (Scheme 91). 
 
Scheme	  91:	  Mechanism	  proposed	  for	  the	  Palladium	  catalysed	  1,4-­‐migration	  process	  
 
Since this early report by Dyker, many groups have used palladium-catalysed 1,4-migration 
as a step in a domino process toward the synthesis of complex structures.[84a] 
 
4.1.1. Palladium-Catalysed Arylation of Alkynes/1,4-
Migration Domino Processes 
One of the methodologies where 1,4-palladium migration has been applied is the arylation of 
alkynes. Dyker’s group reported a palladium-catalysed cascade alkyne arylation/C-H 
 
activation reaction to form polycyclic structures (Scheme 92). It was observed that, in the 
presence of Pd(OAc)2, 4-iodoanisole reacted with diphenyl acetylene 423 to give 9,10-
diphenylphananthrene structures 424, 425, 426 and 427 with poor regioselectivity.[86c, 86e] 
 
Scheme	  92:	  Palladium	  catalysed	  arylation/C-­‐H	  activation	  process 
 
By changing the reaction conditions, the outcome of the process was altered.  By adding 
PPh3, and changing the base and the ammonium salt to NaOAc and n-Bu4NCl respectively, 
Larock’s group synthesised fluorene structures such as 428 in moderate yields from diphenyl 
acetylene and substituted aryliodides via a 1,4-palladium migration (Scheme 93).[88] 
 
Scheme	  93:	  Palladium	  catalysed	  arylation/1,4-­‐migration	  process	  
 
Larock proposed that the mechanism begins with the arylation of the triple bond to form 
alkenyl-palladium intermediate 434 which undergoes C-H insertion to give metallacycle 435. 
 
Reductive elimination would form arylpalladium species 436 which undergoes C-H 
activation to give palladacycle 437. Finally two consecutive reductive eliminations yield the 
observed fluorene 430 and regenerate the palladium catalyst (Scheme 95). 
 
Scheme	  94:	  Mechanism	  for	  the	  palladium	  catalysed	  arylation/1,4-­‐migration	  process	  
 
Since this first article, Larock became a key player in this field, publishing several papers on 
alkyne arylation/1,4-migration domino processes. One example is the synthesis of complex 
carbazoles 440 through reacting diaryl amines 438 and disubstituted alkynes 439 in the 
presence of a palladium catalyst (Scheme 96).[89]  
 
Scheme	  95:	  Palladium	  catalysed	  arylation/1,4-­‐migration	  process	  
 
It was suggested that after oxidative insertion to form Pd(II) species 440 carbopalladation 
with an alkyne would give alkenyl Pd(II) intermediate 442. C-H insertion gives palladacycle 
443 which, after reductive elimination, gives species 444. The 6-membered ring intermediate 
445 is formed through a second C-H insertion. Finally, reductive elimination gives the 
observed carbazole 446 (Scheme 97). 
 
 
Scheme	  96:	  Mechanism	  for	  the	  palladium	  catalysed	  arylation/1,4-­‐migration	  process	  
 
The ability of palladium to perform consecutive migration was also described by Larock et 
al. When a tert-butylmethylacetylene 448 reacts with an electron-poor aryl halide 447 in the 
presence of a Pd(0) catalyst three different alkene esters 449, 450 and 451 are formed 
(Scheme 98).[90] 
 
Scheme	  97:	  Palladium	  catalysed	  arylation/1,4-­‐migration	  process	  
 
Larock suggested that the three products 449, 450 and 451 came from the reaction of a 
pivalate anion with a π-allyl palladium species 458. The mechanism proposed starts with the 
arylation of alkyne 448 which then leads to a first palladium 1,4-migration to form 
arylpalladium species 455. A second 1,4-migration via the C-H activation of the methyl 
group gives alkylpalladium 457 through palladacycle 456. This intermediate 457 rapidly 
 
isomerizes to π-allylpalladium species 458 which reacts with the pivalate anion to give each 
of the isolated products 449, 450 and 451 (Scheme 99). 
 
Scheme	  98:	  Mechanism	  for	  the	  palladium	  catalysed	  arylation/1,4-­‐migration	  process 
 
4.1.2. Palladium 1,4-Migration/Alkene Arylation Domino 
Processes 
As described previously, the 1,4-migration of palladium can take place after the arylation of 
an alkyne. However, this palladium shift can also occur after the oxidative insertion of 
palladium with an aryl halide. Both Larock and Gallagher independently reported this 
process with the oxidative insertion/1,4-palladium migration of ortho-iodobiaryls 482 
followed by addition to ethyl acrylate (Scheme 99 and 100 respectively).[91] 
Larock’s conditions, using dppm (L85) as ligand, gave diaryl substituted alkenes in good 
yields. The regioselectivity was poorly controlled in the case of the methyl and methoxide 
substituted diaryls, with the formation of both 1,4-migration (483 and 485) and Heck 
products (484 and 486) in an almost 1:1 ratio. In the case of a benzofuran derivative, the 1,4-
migration product 487 was isolated exclusively (Scheme 99). 
 
 
Scheme	  99:	  :	  Palladium	  catalysed	  1,4-­‐migration/arylation	  process 
 
In the case of Gallagher’s conditions, inferior regioselectivity towards the 1,4-migration 
product was achieved. The palladium catalyst system applied to aryl-pyridyl substituted 
structures and ethyl acrylate gave complete consumption of the starting materials. However, 
the main product isolated was always the expected Heck product 490, 492 and 494 
(Scheme 100). 
 
Scheme	  100:	  Palladium	  catalysed	  1,4-­‐migration/arylation	  process	  
 
Both authors proposed a similar mechanism (Scheme 101). Oxidative insertion of Pd(0) to 
the biaryl substrate gives intermediate 497. This aryl Pd(II) species 497 is in equilibrium 
with aryl Pd(II) species 499 via a 1,4-migration process.  It was proposed that the 
 
equilibrium between the two aryl-palladium species 497 and 499 determines the ratio 
between the Heck and the 1,4-product 500 and 501 respectively.  
 
Scheme	  101:	  Mechanism	  proposed	  for	  the	  palladium	  catalysed	  1,4-­‐migration/arylation 
  
4.1.3. Palladium 1,4-Migration/Cyclisation 
As described in the previous section, palladium can undergo 1,4-migration after the 
oxidative insertion with an aryl halide. After the 1,4-migration the palladium species created 
503 could undergo intramolecular insertion with an appropriate tether, which would open an 
opportunity to synthesise complex cyclic structures 504 in one single step (Scheme 102). 
 
Scheme	  102:	  Proposed	  mechanism	  for	  the	  1,4-­‐migration/cyclisation	  process	  
 
Larock’s group investigated such a palladium catalysed cyclisation process. They reported 
the synthesis of multiple polycyclic structures using a 1,4-palladium migration via C-H 
activation of aryl groups (Scheme 103). Applying the conditions already described in chapter 
3.1.1.2. (Scheme 99), various polycycles were synthesised in good yields (Scheme 103).[92] 
 
 
Scheme	  103:	  Palladium	  catalysed	  1,4-­‐migration/cyclisation	  process	  
 
Larock suggested the reaction proceeded by initial oxidative addition of Pd(0) with  
aryliodide to give species 511 (Scheme 104). 1,4-Palladium migration occurs giving indole-
palladium species 512. Arylation to the pendant alkyne gives alkene palladium intermediate 
513. Finally a C-H activation would form palladacycle 514, which after reductive 
elimination gives the observed product 515. 
 
 
Scheme	  104:	  Mechanism	  proposed	  for	  the	  Palladium	  catalysed	  1,4-­‐migration/cyclisation	  
 
More recently, Zhu’s group reported a nice example of a 1,4-palladium migration/cyclisation 
process towards the synthesis of fused oxindoles. Using PCy3·HBF4 as ligand and through a 
series of 1,4-palladium migrations and cyclometallations, complex oxindoles were isolated 
in very good yields (Scheme 105 and Chapter 1.1 Scheme 2).[16] 
 





4.1.4.  Other Domino Processes Involving Palladium 1,4-
Migration 
Many other reactions can be triggered by 1,4-palladium migration. For instance, Larock 
reported an acyl C-H activation via 1,4-migration of palladium to form carbamates and 
esters.[93] It was observed that in the presence of a palladium catalyst, formamide 521 reacts 
with n-BuOH to form carbamate 522.[93] Larock proposed that, after palladium oxidative 
addition to formamide 521 to give aryl-palladium species 523, acyl C-H insertion would 
form palladacycle 524 Finally, reductive elimination would give Pd(II) intermediate 525 
which will be trapped by the alcohol to give carbamate 522 (Scheme 106). 
 
Scheme	  106:	  Palladium	  catalysed	  C-­‐H	  activation	  via	  	  1,4-­‐migration 
 
In 2005, Buchwald reported a domino 1,4-migration/Suzuki-Miyaura coupling of 2,4,6-tri-
tert-butylbromobenzene 526 with boronic acids (Scheme 107).[94] The mechanism 
proposed is as follows: after oxidative insertion of the Pd(0) to form aryl-palladium species 
528, C-H oxidative insertion followed by reductive elimination gives palladacycle 529. 
Then, selective protonation of the less hindered sp3 C-Pd bond in palladacycle 529 forms 
alkyl-palladium species 530. Transmetalation with the boronic acid give intermediate 531 
which, upon reductive elimination, forms the isolated structure 527. 
 
 
Scheme	  107:	  Palladium	  catalysed	  1,4-­‐migration/Suzuki	  coupling	  process 
 
Similarly, Buchwald and co-workers reported a catalytic intermolecular amination of 2,4,6-
tri-tert-butylbromobenzene via 1,4-palladium shift (Scheme 108).[95] They observed the 
formation of amine 532 when aryl bromide 526 was subjected to palladium catalysis in the 
presence of aniline. As described in Scheme 107, tert-butyl substituted phenyl rings under 
palladium catalysis form alkyl-palladium species 530 via oxidative insertion/1,4-migration. 
This species can then react with aniline to form the desired amine 532.    
 
Scheme	  108:	  Palladium	  catalysed	  1,4-­‐migration/amination	  process	  
 
4.2. 1,4-Rhodium Migration 
The first report of a 1,4-rhodium migration was by Miura and co-workers in 2000. The 
reaction between arylboronic acids and norbornene was reported.[96] However, instead of 
observing the expected arylative product 547, they isolated a range of multi-alkylated phenyl 
rings 544, 545 and 546. (Scheme 109).  
    
Scheme	  109:	  Rhodium	  catalysed	  1,4-­‐migration/arylation	  process 
 
Miura suggested that the formation of these multialkylated products came from a sequence 
of 1,4-rhodium migrations. It was proposed that norbornene 463 was first arylated to give 
alkylrhodium species 549, then a first C-H activation event takes place to form rhodium 
metallacycle 550. Reductive elimination then gives a new arylrhodium species 551, ready to 
perform a second arylation to a second norbornene molecule. This process occurred up to 
three times to give tetrasubstituted structure 546 (Scheme 110). 
 
Scheme	  110:	  Mechanism	  proposed	  for	  the	  Rhodium	  catalysed	  1,4-­‐migration/arylation	  	  
 
 
Miura’s group found that if acetic anhydride was present in the reaction, the 1,4-migration 
was prevented, and gave disubstituted norbornane 555. It was suggested that oxidative 
addition of rhodium species 549 (Scheme 110) to acetic anhydride would form Rh(III) 
intermediate 554 which was unable to undergo 1,4-migration (Scheme 111).[97] 
 
Scheme	  111:	  Rhodium	  1,4-­‐migration	  process	  
 
Independently, Hayashi’s group also reported a rhodium 1,4-migration process during the 
investigation into the addition of aryl boron species to alkynes. It was observed that if a 
deuterated phenyl boronic acid was added to alkyne 556, alkene 557 was isolated with >93% 
of deuterium exchange. Hayashi proposed that after arylation to form alkenylrhodium 
species 558, a 1,4-migration takes place. The new arylrhodium intermediate 559 formed 
would then be hydrolysed to form the observed product 557 (Scheme 112).[98]   
 
Scheme	  112:	  Deuterium	  experiments	  on	  Rh	  1,4-­‐migration	  process 
 
The formation of substituted indene 561 from 3-hexyne and triphenylboroxine 560 under 
rhodium catalysis, also supported the 1,4-migration event proposed. Hayashi suggested the 
arylation of 3-hexyne to give alkenylrhodium species 562. Then 1,4-migration gives 
arylrhodium intermediate 563. This intermediate 563 would then attack another alkyne to 
form structure 564. Then intramolecular carborhodation followed by reductive elimination 
gives intermediate 565. Finally, β-hydride elimination followed by isomerisation of the 
double-bond forms the observed indene 561 (Scheme 113). 
 
Scheme	  113:	  Rhodium	  catalysed	  domino	  arylation/1,4-­‐migration/cyclisation	  process 
 
These seminal papers by Miura and Hayashi opened an alternative to palladium 
1,4-migration. Since these reports, many other groups have used 1,4-rhodium migration in 
their methodology leading to a field which is now as developed as that of palladium 
1,4-migration. 
 
4.2.1. Rhodium Catalysed Arylation of Alkynes/1,4-
Migration Domino Processes 
As described for palladium in the previous chapter, rhodium-catalysed arylation of alkynes  
generates alkenylrhodium species capable of performing 1,4-migration. Murakami’s group 
described this process when NaBPh4 was added to symmetrical alkynes 566. Murakami 
suggested that after arylation to give alkenylrhodium species 568, a 1,4-migration took place 
 
forming arylrhodium intermediate 589. Addition of the organorhodium to the pendant ester 
gave the observed tetralone 567 (Scheme 114).[85] 
 
Scheme	  114:	  Rhodium	  catalysed	  domino	  arylation/1,4-­‐migration/cyclisation	  process 
 
Similarly, Hayashi’s group described the addition of arylzinc reagent to alkynyl-ketones 569 
to give racemic β,β-disubstitued indanones 570. Hayashi proposed that arylation of alkynone 
569 would give alkenylrhodium species 571. 1,4-Rhodium migration forms arylrhodium 
species 572 which undergoes intramolecular 1,4-addition to the α-β-unsaturated ketone to 
give the observed indanones 570 in moderate yields (Scheme 115).[99] 
 
Scheme	  115:	  Rhodium	  catalysed	  domino	  arylation/1,4-­‐migration/cyclisation	  process	  
 
Following this investigation towards the synthesis of disubstituted indanones via rhodium 
catalysed arylative cyclisation, Hayashi and co-workers reported an asymmetric version of 
the reaction using rhodium ligated with (R)-Segphos (L32). The reaction of arylboronates, 
gave indanones of type 575 in high yields and enantiomeric excesses (Scheme 116).[100] 
 
Scheme	  116:	  Rhodium	  catalysed	  domino	  arylation/1,4-­‐migration/cyclisation	  process	  
 
Applying similar conditions, Hayashi also reported the asymmetric synthesis of 
spirocarbocycles.[101] Using a rhodium catalyst ligated with chiral diene L33, a range of 
sodium tetraarylborates were reacted with alkyne 579 to give spyrocycles of type 580 in 
good yields and enantiomeric excesses (Scheme 121).  
 
Scheme	  117:	  Rhodium	  catalysed	  domino	  arylation/1,4-­‐migration/cyclisation	  process	  
 
4.2.2. Rhodium 1,4-Migration/Cyclisation Processes 
The 1,4-rhodium migration has also been applied to the formation of polycycles via 
intramolecular addition. Hayashi applied this to the synthesis of indanones.[102] It was 
observed that α-arylpropargyl alcohol 593 reacted in the presence of a rhodium catalyst to 
give indanone 594 in good yield (Scheme 118).  
 
Scheme	  118:	  Rhodium	  catalysed	  1,4-­‐migration/cyclisation	  process	  
 
Hayashi suggested that after rhodium insertion to the O-H bond of the alcohol, β-hydride 
elimination gives ketone 599. Hydrorhodation forms alkenylrhodium species 600, which 
could undergo 1,4-rhodium migration to give arylrhodium intermediate 601. Intramolecular 
1,4-addition of arylrhodium 601 to the α,β-unsaturated ketone and hydrolysis of the rhodium 
enolate 602 then gives the observed indanone 603 (Scheme 119). 
 
Scheme	  119:	  Mechanism	  proposed	  for	  the	  Rhodium	  catalysed	  1,4-­‐migration/cyclisation	  
 
An analogous reaction of symmetrical bis(alkynyl) carbinols 604 was also reported by 
Hayashi.[103] In this case the key step of the process is a β-carbon elimination to give 
intermediate 606. This intermediate would undergo alkynylrhodation to form 
alkenylrhodium species 607. This species would then follow the mechanism proposed 
previously by Hayashi (Scheme 119) to form the observed indanones (Scheme 120).  
 
Scheme	  120:	  Rhodium	  catalysed	  1,4-­‐migration/cyclisation	  process	  
 
Similarly, Cramer and Murakami reacted aryl-substituted cyclobutanol 608 and 610 with a 
rhodium catalyst and observed the formation of indanols 609 and 610 (Scheme 121).[104] A 
wide range of ligands were applied by both groups achieving the best results when a 
Josiphos type L33 and (R)-difluorophos L34  were applied respectively. 
 
Scheme	  121:	  Rhodium	  catalysed	  1,4-­‐migration/cyclisation	  process	  
 
Both Cramer and Murakami suggested similar mechanisms. The reaction mechanism is 
initiated by the formation of rhodium-alkoxide 613 from alcohol 612. Ring opening of the 
cyclobutane through β-carbon-elimination of the alkoxide 613 gives alkylrhodium species 
614. 1,4-Rhodium migration gives arylrhodium species 615 which undergoes intramolecular 
addition to the carbonyl group to give the observed indanol 617 (Scheme 122).  
 
Scheme	  122:	  Mechanism	  proposed	  for	  the	  Rhodium	  catalysed	  1,4-­‐migration/cyclisation	  
 
More recently Takahashi reported the arylation/1,4-migration/cyclisation of (3-
arylcyclobutylidene)acetates 618 by rhodium-catalysis to form spiro-ketone 619 
(Scheme 123).[105]  
 
Scheme	  123:	  Rhodium	  catalysed	  1,4-­‐migration/cyclisation	  process	  
 
Interesting, in this process two 1,4-migration processes are needed to form the observed 
tetracyclic structure 619. Takahashi proposed that, after arylation of the double bond to form 
alkylrhodium species 620, ring opening of the cyclobutane through a β-carbon elimination 
gives β-phenethylrhodium intermediate 621. 1,4-Migration then occurs to give arylrhodium 
species 622, which undergoes intramolecular conjugate addition to form alkylrhodium 
intermediate 623. A second 1,4-rhodium migration from the alkyl to the aryl ring gives 
 
arylrhodium species 624. This then undergoes 1,2-addition to the ester to give spiro-ketone 
619 (Scheme 124). 
 
Scheme	  124:	  Mechanism	  proposed	  for	  the	  Rhodium	  catalysed	  1,4-­‐migration/cyclisation	  
 
4.2.3. Recent Developments in Domino Processes Involving 
Rhodium 1,4-Migrations 
The use of rhodium to carry out 1,4-migration transformations is still a topic of great interest. 
Recently many groups have reported new reactions where rhodium performs domino 
processes, including 1,4-migrations, to synthesise complex structures. 
In 2012 Hayashi and Kantchev reported a domino 1,4-migration/1,4-addition of 
diphenylethenylboronic acid to enones.[106] It was proposed that, after transmetallation of 
rhodium with boronic acid 635, a 1,4-rhodium migration occurred to give arylrhodium 




Scheme	  125:	  Rhodium	  catalysed	  1,4-­‐migration/arylation	  process 
 
By replacing the norbornadiene ligand with a chiral diene L35 the asymmetric tandem 1,4-
migration/1,4-addition of cis-2-arylethenylboronic acids 635 to both cyclic and acyclic 
enones in good yield and high enantiomeric excesses was achieved (Scheme 126).[107]  
 
Scheme	  126:	  Asymmetric	  Rhodium	  catalysed	  1,4-­‐migration/arylation	  process 
 
Kantchev performed DFT calculations for the above process and proposed an oxidative 
insertion/reductive elimination mechanism was in operation. The formation of an unstable 
Rh(III) 643 species as an intermediate between the alkenylrhodium 637 and the arylrhodium 
species 638 was suggested (Scheme 127). 
 
 
Scheme	  127:	  RhIII	  intermediate	  proposed	  for	  the	  the	  1,4-­‐migration	  process 
 
Recent investigations by Kantchev and Su reported the formation of a similar intermediate in 
the C-H activation by domino 1,2-addition/1,4-rhodium migration of phenyl boronic acid to 
norbornene (Scheme 128).[108] The DFT calculations supported that the transition between 
alkylrhodium 549 and arylrhodium 551 occurred via a Rh(III) species 550. It was also 
suggested that the higher barrier energy of the protonolysis of alkylrhodium 549 (20.9 kCal 
mol-1) compared to the protonolysis of arylrhodium 551 (16.7 kCal mol-1) drives the 
equilibrium toward the formation of arylrhodium species 551. 
 
Scheme	  128:	  Mechanism	  proposed	  for	  the	  Rh	  catalysed	  1,4-­‐migration	  process 
 
Another recent example of 1,4-rhodium migration was described by Nozaki’s group in 2014. 
They reported the polymerization of 3,3-diarylcyclopropenes 644 through a rhodium 
catalysed continuous arylation-1,4-migration process. The use of different boronic acids as 
initiators and a variety of ligands such as cod, (rac)-BINAP or nbd allowed the synthesis of 
polymers from 900 to 7900 g/mol (Scheme 129).[109] 
 
 
Scheme	  129:	  Polimer	  synthesis	  via	  Rhodium	  1,4-­‐migration	  
 
The proposed mechanism starts with the arylation of cyclopropene 646 to give alkylrhodium 
intermediate 647. 1,4-Rhodium migration from the alkyl to the aryl position gives 
arylrhodium 648, which undergoes arylation to another cyclopropene substrate 646. 
Sequential 1,4-rhodium migration and arylation then gives different polymers depending on 
the ligand and the initiator used (Scheme 130). 
 
Scheme	  130:	  Mechanism	  proposed	  for	  the	  Rh	  catalysed	  synthesis	  of	  polimers 
 
Very recently, the Lam group demonstrated two new process involving a rhodium 1,4-
migration. In 2012, the enantioselective rhodium-catalysed allylation of imines was 
reported.[110] During these investigations, when allyltrifluoroborate salt 652 was used in the 
reaction, the formation of sulfonamide 653 as well as the expected allylation product 654 
was observed. Using a diene ligand L36 the synthesis of various cyclic sulfonamides in good 
yields and high enantiomeric excesses was achieved (Scheme 131).[111] 
 
 
Scheme	  131:	  Rhodium	  catalysed	  allylation	  of	  imines	  via	  1,4-­‐migration 
 
It was proposed that first the allyltrifluroborate 652 transmetalates with rhodium to give 
allylrhodium species 653. Then a reversible 1,4-migration process takes places to give 
allylrhodium species 654. Finally, reaction of this allylrhodium species 654 with imine 651 
would give sulfonamide 653 (Scheme 132). 
 
Scheme	  132:	  Mechanism	  proposed	  for	  the	  Rh	  catalysed	  allylation	  of	  iminies	  
 
In 2014, Lam reported in a second paper on the topic of rhodium 1,4-migration processes. 
Through the investigation of the C-H activation/oxidative annulation of 2-aryl cyclic 1,3-
dicarbonyl compounds 657 with enyne 658, the formation of tricyclic compound 659 was 
observed.[112] It was suggested that nucleophilic arylrhodium(III) species 660, formed via C-
H activation, gives intermediate 661 via migratory insertion into enyne 658. Then, 
protonolysis gives alkenylrhodium species 662 that undergoes a sp2-sp3 1,4-migration to 
 
form allyl-rhodium 663. Isomerisation to form electrophilic π-allylrhodium species 664 
followed by nucleophilic attack of the enol gives the observed product 659 (Scheme 133).  
 
Scheme	  133:	  Rhodium	  catalysed	  C-­‐H	  activation/1,4-­‐migration	  process	  
 
4.3. 1,4-Migration Catalysed by Other Transition Metals 
As shown previously in chapter 3.1. and 3.2, rhodium and palladium are very effective 
catalysts for 1,4-migration processes. Other metals such as cobalt, nickel, platinum or 
iridium have also been shown to undergo 1,4-migration. 
Cobalt has been used by Yoshikai to perform the addition of arylzinc reagents to alkynes 
(Scheme 134).[113] Similar to Hayashi’s rhodium arylation/1,4-migration (Chapter 3.2., 
 
Scheme 117), Yoshikai reported that, when reacting a deuterated phenylzinc reagent 665 
with alkyne 664 under cobalt catalysis, alkene 666 was isolated with exclusive deuterium 
incorporation at the olefinic position. This suggested that, after arylation to form alkenyl-
cobalt species 667, 1,4-migration gives arylcobalt species 668, which upon aqueous work up 
gives alkene 666.[113a] 
 
Scheme	  134:	  Cobalt	  catalysed	  domino	  arylation/1,4-­‐migration	  process 
 
Yoshikai used these conditions, introducing an electrophile to trap the nucleophilic 
arylcobalt species 668 (created after the 1,4-migration process Scheme 134) to give a range 
of disubstitued aryl compounds 669 (Scheme 135). 
 
Scheme	  135:	  Cobalt	  catalysed	  domino	  arylation/1,4-­‐migration	  process	  
 
 
Yoshikai and co-workers observed that if the electrophile used to trap the arylcobalt species 
668 (Scheme 134) was sulphur in the presence of CuI, benzothiophenes 675-679 were 
isolated (Scheme 136). Using this one-pot method, a wide range of substituted 
benzothiophenes were synthesised in moderate yields.[113b]  
 
Scheme	  136:	  Cobalt	  catalysed	  domino	  arylation/1,4-­‐migration	  process	  
 
Other metals have been described to undergo a 1,4-shift, but no synthetic applications have 
been developed using those metals. Sharp’s group reported the 1,4-migration of a platinum 
complex through the reaction of Pt(PEt3)4 with 9-bromodibenz[a,c]anthracene 680. After 
initial oxidative addition to form Pt(II) species 682 1,4-migration occurred to give 681 which 
was isolated and characterised (Scheme 137).[114] 
 
Scheme	  137:	  Platinum	  catalysed	  1,4-­‐migration	  process	  
 
In 2007, Johnson reported the 1,4-migration of nickel through heating biarylyl complex 684. 
It was suggested that the isomerisation between complex 684 and complex 686 occurred 
through the formation of intermediate 685, which involves the 1,4-migration of nickel 
between aryl positions (Scheme 138).[115] 
 
Scheme	  138:	  Nickel	  catalysed	  1,4-­‐migration	  process	  
 
More recently, in 2014, iridium 1,4-migration was reported but not applied in any synthetic 
methodology. Ishii et al. observed that in the presence of diphenyl acetylene 723, Ir(III) 
complex 687 reacted to give a mixture of two different species (Observed by 31P NMR); 
alkenyliridium complex 688 and an aryliridium complex 689 (Scheme 139). After arylation 
of the alkyne to give alkenyliridium species 688, it was suggested that aryliridium species 
689 would presumably be formed by a 1,4-iridium migration process.[116] 
 
Scheme	  139:	  Iridium	  catalysed	  1,4-­‐migration	  process 
 
Transition metal-catalysed 1,4-migrations has been widely applied into domino processes to 
synthesised complex structures. Rh and Pd are usually the metals of choice to catalyse this 
process. Other metals have been reported to undergo 1,4-migration but only cobalt has 
shown synthetic applications.  
 
5. Arylative Cyclisation Via a 1,4-Iridium 
Migration 
 
5.1. Aims and Objectives 
In chapter 3.1 the versatility of transition metals to catalysed domino arylation-cyclisation 
processes involving a 1,4-shift of the catalyst was reviewed.  
With our previous experience in the desymmetrisation of diones,[1] it was suggested that a 
process similar to Hayashi’s Rhodium-catalysed asymmetric synthesis of spirocarbocycles 
(Chapter 3.1.2., Scheme 117) could be investigated. In this case the electrophile would be a 
symmetrical diketone 692 instead of a prochiral α-β unsaturated ketone 690 (Scheme 140). 
 
Scheme 140: Proposed arylation/1,4-migration/aldol cyclisation process 
 
The aim was to design a substrate where we could carry out the process, identify a metal to 






5.2. Arylation-Cyclisation of Alkynyl-Diones 
Due to our success in the desymmetrisation of 1,3-cyclopentadiones and 1,3-
cyclohexadiones in previous projects,[1] symmetric alkyndiones 694 were proposed as 
possible substrate for our investigations. These particular substrates would have the two 
motifs needed for our proposed arylation-cyclisation process; an alkyne that can be arylated, 




The mechanism proposed for the synthesise of polycyclic alcohol 695 was to first perform an 
aryl metallation of alkyne 694 to give intermediate 696. 1,4-metal migration from the alkenyl 
position to and aryl position would give species 697. Finally, intramolecular addition by the 
aryl-metal to the ketone, followed by protonation, would afford polycyclic alcohol 695. In 
this manner, with the adequate metal complex, we would be able to functionalise a remote C-
H bond via a 1,4-migration process. (Scheme 141). 
 
Scheme 141: Mechanism for the proposed arylation/1,4-migration/aldol cyclisation process 
 
 
This C-H activation would lead to the formation of complex polycyclic alcohols 695, 
hopefully, with high levels of diastero and enantioselectivity.  
 
5.3. Identifying a Metal Catalyst 
As described in Chapter 3.1.2, Rh(I) complexes are capable of perform arylation of alkynes 
as well as 1,4-migration processes. Taking Hayashi’s synthesis of chiral spirocarbocycles 
through arylative-cyclisation as inspiration (Chapter 3.1.2., Scheme 117).[101] It was proposed 
to use Rh(I) catalysts as a starting point for our investigations. 
Four different alkynes 694 were subjected to react with sodium tetraphenyl borate in the 
presence of [Rh(cod)Cl]2 and water in THF. After 16 hours at 65 °C the alkyne was 
completely consumed and two new products were detected 695 and 698. For each of the 
alkynes the desired cyclised product 695 was isolated in moderate yield and as a single 
diastereoisomer, as determined by 1H NMR spectroscopy of the crude reaction mixture. A 
second product 698 was also isolated with a lower yield. The remainder of the mass balance 
was a complex mixture (Table 4). 
Table 4: Rhodium arylative-cyclisation 
 
Entry n Ar Yield of 695 Yield of 698 
1 1 4-MeOC6H4 38% 11% 
2 1 phenyl 42% 12% 
3 2 4-MeOC6H4 40% 9% 
4 2 phenyl 39% 10% 
 
The second product isolated 698 was presumably formed by a process already described by 
Murakami et al. in 2005. They reported a rhodium-catalysed reaction of alkyndione with aryl 
boronic acids to give a ring expansion product 700 (Scheme 142). Murakami suggested that 
 
cis-arylation of alkyne 699 gives alkenylrhodium 701. Then intramolecular nucleophilic 
addition to the ketone would give cyclobutane 702. Hydrolysis of 702 gives alcohol 703 
which forms the observed product 700 after retro-aldol reaction.[117]  
 
Scheme	  142:	  Rhodium	  catalysed	  1,4-­‐migration	  process 
 
In the case of the alkynes studied the 8- and 9-membered ring cycles isolated 698 were 
formed by initial arylation of the alkyne 694 with the opposite regioselectivity compared to 
tricycle 695, to give intermediate 705. After the arylation, nucleophilic attack by the 
alkenylrhodium species 705 on to the pendant ketone forms cyclobutane 706. Then after 




Scheme	  143:	  Mechanism	  proposed	  for	  the	  ring	  opening	  product	  observed	  
 
In search of a metal that would perform the arylation more selectively and with higher yields 
other metals known to undergo transmetalation with organometallic reagents were also 
studied. 
As described in Chapter 3.1., palladium was the first metal reported to undergo 1,4-
migratory insertion processes. Therefore a variety of PdII and Pd0 pre-catalysts were trialled 
using either aryl-boronic acids or aryl-halides as the aryl source. However, no productive 
reaction was observed, with either starting material alkynone 694 returned or a complex 
mixture recovered.f  
Platinum hydroarylation of alkynes has not been reported in the literature, however platinum 
does undergo transmetalation with Grignard reagents and arylboronic acids,[118] in addition 
platinum has been reported to undergo 1,4-migration (Chapter 3.1.3, Scheme 137).[114] It was 
proposed then that the arylplatinum species formed could be capable of perform the 
arylation-1,4-migration process expected in our investigation. Therefore different platinum 
catalyst system with both Grignard reagents and arylboronic acids were tried. Unfortunately 
either the starting alkyne 709 or very complexes mixtures were observed (Scheme 144). 
                                                      
f Screening performed by Dr Benjamin M. Partridge 
 
 
Scheme 144: Metal screening for the proposed 1,4-migration process 
 
As described in Chapter 3.1.3 (Scheme 134) cobalt has also been reported to perform 
domino arylation-1,4-migration processes. Both Yoshikai’s conditions for the addition of 
arylzinc reagents to alkynes and Chien Hong’s hydroarylation of alkynes with organoboronic 
acids were tested on alkynone 709. In both cases neither the desired product 710 nor the ring 
expansion side product 698 were isolated. Only the starting alkyne 709 or complex mixtures 
were observed (Scheme 145).[113a, 119] 
 







Other metals that had not been reported to undergo 1,4-migration were tried without success 
until iridium complex [Ir(cod)Cl]2 was applied. The transmetalation of iridium complexes 
with arylboronic for the arylation of alkenes has been reported.[120] However, to the best of 
our knowledge, the 1,4-Iridium migration was not reported before our investigations. Despite 
this, to our delight, the arylative process using [Ir(cod)Cl]2 and NaBPh4 gave a 10% 
conversion to tricycle 712 with no ring expansion product 713 observed (Scheme 146).  
 
Scheme 146: Metal screening for the proposed 1,4-migration process 
 
Different solvents and temperature were screened to try to increase the yield of tricycle 712. 
THF at 120 °C in a sealed vial gave the highest conversion of alcohol 712 (Table 5, Entry 6). 
It was also found that the use of polar protic solvents such as MeOH and i-PrOH seemed to 
inhibit the reaction (Table 5, entries 3 and 4).  
Table 5: Solvent and temperature screening
 
Entry Solvent T (°C) ConversionI 
1 Ether 40 17% 
2 CH2Cl2 40 24% 
3 MeOH 60 0% 
4 i-PrOH 80 0% 
5 THF 65 37% 
6 THF 120 60% 
7 Toluene 120 44% 
 
I) Determined by 1H NMR analysis of the crude reaction mixture, (disappearance 
of a signal of 3H, s at 1.19 Hz and appearance of a signal of 3H, s at 1.01 Hz)  
 
Next, the effect of the amount of water in the reaction was studied. It was observed that 1.2 
equivalents of water was the optimum amount for the arylative process (Table 6, Entry 2). 
2.0 equivalent of H2O led to a reduced conversion of 37%, and a water free reaction also 
gave a lower conversion 46% (Table 6). 
Table 6: Water amount screening 
 
Entry Equiv. of H2O ConversionI 
1 2.0 37% 
2 1.2 56% 
3 0 46% 
 
I) Determined by 1H NMR analysis of the crude reaction mixture (See Table 5) 
 
The use of additives to try to make the ketone more prone to nucleophilic attack was also 
studied. Different Lewis acids gave similar conversions as without additive but more 
reproducible results (The reaction sometimes gave lower conversions in absence of metal 
additive) (Table 7). 
Table 7: Lewis acid additive screening
 
Entry Lewis acid ConversionI (65 °C) ConversionI (120 °C) 
1 AgOTf 50% 97% 
2 NaBF4 50% 89% 
3 YbOTf 48% 87% 
 
I) Determined by 1H NMR analysis of the crude reaction mixture (See Table 5) 
 
 
Complete conversion of the starting alkyne 711 was achieved using AgOTf as an additive 
and at higher temperature (Table 7, Entry 1). However, upon scale up the desire product 712 
was isolated in only 31% yield. A second side product was also observed with a very low Rf 
(The product was isolated but not fully characterised at that point) (Scheme 147). 
 
Scheme 147: Optimised conditions for the Iridium 1,4-migration process using NaBPh4 
 
5.4. Replacing NaBPh4 for PhB(OH)2  
NaBPh4 is commercially available, however other sodium tetraaryl borate reagents are 
difficult to find and if they are found they are usually much more expensive. Beside that it 
was proposed to use arylboronic acids from a sustainable point of view. The atom economy 
of the domino process using NaBPh4 is only 55%, very low compared with to an almost 90% 
obtained for the same process using PhB(OH)2.[121] 
Early studies exchanging NaBPh4 for PhB(OH)2 were not too promising only detecting 
traces of the desired product detected. However, when a base was added to the reaction 
mixture both the conversion and the NMR yield were improved. From all the bases studied 
KF seemed to be more appropriate for the desired process giving a 63% yield despite 
incomplete conversion of starting alkynone 711 (Table 8).g 
 
 
                                                      
g Screening performed by Dr Benjamin M. Partridge 
 
Table 8: Base screening 
 
 
Entry Base ConversionI NMR yieldII 
1 - 5% 5% 
2 K2CO3 100% 62% 
3 K3PO4 93% 62% 
4 CsF 100% 64% 
5 KF 89% 63% 
 
I) Determined by 1H NMR analysis of the crude reaction mixture (See Table 5) 
II) Determined by 1H NMR analysis of the crude reaction mixture using 
1,3,5-trimethoxybenzene as internal standard (Comparing 3H peak at 1.01 from 
desired product and 3H peak at 6.10 Hz from 1,3,5-trimethoxybenzene). 
 
Further screening investigated the reaction solvent, additive, and temperature. It was found 
that the reaction of alkyne 711 with phenylboronic acid in the presence of t-BuOH instead of 
H2O in toluene at 65 °C gave a 79% NMR yield. It needs to be mentioned that the loading of 
iridium dimer was decreased to 1.5 mol% without diminishing the yield obtained from when 
2.3 mol% of the catalyst was applied. Once the reaction was scaled up to 0.3 mmol, the 
desired cyclised product 712 was isolated in 72% yield together with an unknown side 
product 714. The structure of this new product was elucidated via NMR spectroscopy and 
X-ray crystallography (Scheme 148).h 
                                                      
h Optimisation performed by Dr Benjamin M. Partridge 
 
 
Scheme 148: Optimised conditions for the Iridium 1,4-migration process using PhB(OH)2 
 
The mechanism for the formation of the side product was proposed to start with the arylation 
of the alkyne 711 to give intermediate 715. 1,4-iridium migration to the aryl position gave 
716. This intermediate 716 does not react intramolecularly, instead attacks a second 
molecule of starting alkyne 711 to form structure 717. Finally a second 1,4-migration  
followed by cyclisation of the aryl iridium onto the ketone would give structure 713 
(Scheme 149). 
 
Scheme 149: Mechanism proposed for the formation of the observed side product 
 
The formation of side product 714 rise from two factors; the arylation with opposite 
regioselectivity compare to desired product 712 and the intermolecular addition of 
intermediate 716 to a second starting alkyne 711 (Scheme 153). It was proposed that the 
intermolecular step could be supressed by the dilution of the reaction mixture. In this manner 
less starting alkyne would be “wasted” in the formation of side product 714 and therefore a 
higher yielding process would be achieved. As predicted, when the concentration was 
 
decreased from 0.2 to 0.04 the ratio 711:714 was increased. However, the increase in the 
yield of 711 was negligible (Table 9, Entry 2). Surprisingly, in an experiment at a higher 
concentration the ratio 711:714 was also increased compare to the experiment a 0.2 M. Even 
though a slightly higher yield was achieved when the concentration was increased, the 
optimum condition were established at 0.2 M due to a solubility problems with some of the 
others substrates (Table 9).     
Table	  9:	  Concentration	  screening	  
 
Entry Concentration Yield of 712 Yield of 714 Ratio 712:714 
1 0.2 M 72% 27% 2.7 
2 0.04 M 74% 15% 4.9 
3 0.4 M 79% 17% 4.6 
 
The optimised conditions using phenyl boronic acids were applied using [Rh(cod)Cl]2 
instead of [Ir(cod)Cl]2 in order to find out if Ir was still a better catalyst than rhodium under 
this conditions. The desired alcohol 712 was isolated in a lower 41% yield, along with 17% 
of dione 713. Although adduct  was not observed with Rh; 18% yield of hydroarylation 
product 719 was reported (Scheme 150). 
 




5.5. Substrate Synthesis 
With conditions for the arylative cyclisation process developed, investigation of the scope of 
the reaction to find the limitations of this particular process began. For this purpose, a broad 
range of substrates were synthesised.  
A simple route to access symmetric and asymmetric, cyclic and acyclic alkynones was 
developed. Propargylation of commercially available 2-methyl-1,3-cyclopentadione 720 or 
2-methyl-1,3-cyclohexadione 723 gave terminal alkynes 721 and 724. Subsequent 
Sonogashira coupling with an aryl halide led to the formation of different cyclic 1,3 
diketones 722 and 725. This was designed so we could study the effect of the electronics and 
the sterics of the aromatic substituent. Both electronwithdrawing and electrondonating 
groups were introduced on para as well as modifications on meta and ortho position 
(Scheme 151 and Figure 4). [122] 
Changes in the conditions of the Sonogashira reaction were applied in some cases in order to 
increase the yield of the process (See Chapter 4.2 for more details).  
 





I) Substrates synthesised by Dr Benjamin M. Partridge 
 
The electrophilic diketone was also modified. Terminal alkyne 736 was synthesised in two 
steps from dimethyl phthalate, through reaction with methyl propionate 741 and propargyl 
bromide 742. Commercially available 2-phenyl-1,3-indandione 738 was reacted with 
propargyl bromide 742 affording alkyne 739. The corresponding terminal alkynes 736 and 
739 were subjected to Sonogashira coupling with phenyl iodide to give 737 and 740 in good 
yields (Scheme 152).i[123] 
                                                      
i Substrates synthesised by Dr Benjamin M. Partdrige 
 
 
Scheme 152: Substrate synthesis 
 
Racemic β-keto esters 745 and 748 were also synthesised to explore the scope of the 
dielectrophilic part.  Propargylation of 2-cyclopentanonecarboxylic acid ethyl ester 743 gave 
terminal alkyne 744 which under Sonogashira coupling conditions with PhI gave 745. 
Similarly methyl acetoacetate 746 was reacted with propargyl bromide 742 to give alkyne 
747 and then Sonogashira coupling with bromobenzene gave acyclic β-keto ester 748 
(Scheme 153). [124]  
 
 
Scheme 153: Substrate synthesis 
 
 
Another acyclic substrate was synthesised following the same procedure as for the racemic 
β-ketoester 748. Diethyl malonate 759 was treated with propargyl bromide in the presence of 
NaH affording alkyne 760, Sonogashira coupling of alkyne 761 with bromobenzene gave in 
good yield (Scheme 154). 
 
Scheme 154: Substrate synthesis 
 
To study further the electrophilic part of the substrate, racemic β-ketoamide 763 was 
synthesised. Amide 349 (Chapter 2.2.3, Scheme 64) was reacted with propargyl bromide to 
give alkyne 762. Finally coupling of alkyne 762 with chlorobenzene gave β-ketoamide 763 
in moderate yield (Scheme 155). 
 
Scheme 155: Substrate synthesis 
 
5.6. Scope of the Reaction 
The conditions obtained from the screening on alkynone 711 were applied to the different 
substrates synthesised. 
Cyclopentadiones containing different substitutions on the aromatic ring where first studied 
(Scheme 160). When a strong electron withdrawing groups such as NO2 was introduced at 
the para-position, the yield of tricycle 780 increased compare to product 766 with no 
substitution in the aromatic ring. Following this pattern, an electrodonating para-OMe 
 
substituent gave a lower yield of tricycle 767. Substitution at the 3-position of the aromatic 
ring was also tolerated; meta-methyl substituted product 769 was obtained in good yield. 
When a ortho-nitrile group was introduced on the phenyl ring, a higher iridium catalyst 
loading was used to obtain an acceptable yield of tricycle 770 (Scheme 156).  
 
Scheme 156: Scope of the Ir catalysed 1,4-migration process 
I) Product synthesised by Dr Benjamin M. Partridge 
II) Yield using 2.5 mol% of [Ir(cod)Cl]2  
 
According to these results, the arylation towards the formation of the desired cyclic product 
is favoured with electron-poor aromatic alkynes. The phenyl ring is a moderate EWG which 
polarises the alkyne leaving a partial negative charge on the carbon next to the aromatic 
group and a partial positive charge on the other carbon 782. Therefore, the arylation takes 
place preferably with the regioselectivity to give alcohol 695 (See Chapter 3.2.2 Scheme 
141). When a EWG is placed on the aromatic ring, this effect is increased making more 
favourable the arylation towards the desired alcohol 695. In the case of electron-rich 
aromatic alkynes, the aryl ring still pulls electrons from the alkyne but, due to the EDG, less 
effectively. Therefore, the arylation towards the formation of alcohol 767 (62% yield) is less 
 
favoured than with more electron-poor aryl-alkynes 712 (72% yield) or 780 (82% yield) 
(Scheme 156 and 157). 
 
Scheme	  157:	  Polarisation	  of	  the	  triple	  bond	  by	  the	  aromatic	  ring 
 
Further experiments demonstrated that the aryl substituent is needed for the process to take 
place. Neither a terminal alkyne 721 nor methyl substituted 786 reacted with PhB(OH)2 with 
only starting alkynes recovered from the reactions (Scheme 158).  
 
Scheme	  158:	  Scope	  of	  the	  1,4-­‐migration	  process	  
 
Tricycle 785 is presumably not formed due to deprotonation of the terminal alkyne by KF 
and complexation with iridium to form an unreactive alkynyl-iridium species 789. In the 
case of the less electrophilic methyl-substituted substrate 786, due to sterics the arylation 
presumably occurs on the less hindered carbon to give intermediate 790. This alkyliridium 
species 790 could undergo 1,4-migration but the corresponding aryliridium 791 is set up to 
perform the cyclisation process to the formation of a less favourable 7-membered ring. Since 




alkyliridium intermediates 791, are not reactive enough to perform any other reaction 
consuming the iridium catalyst (Scheme 159). 
 
Scheme	  159:	  Proposed	  rationale	  for	  the	  unreactivity	  of	  certain	  substrates	  
 
Similarly to the cyclopentadione substrates, cyclohexadiones 792 performed well in the 
arylative cyclisation reaction. The same electronic pattern was observed in this case 
achieving the highest yield in the case of electron poor 4-chloro substituted polycyclic 
alcohol 796 and the lowest yield for para-methoxide substituted tricycle 795 (Scheme 160). 
 
Scheme	  160:	  Scope	  of	  the	  1,4-­‐migration	  process	  
 
Modifications on the electrophilic part of the starting alkyne were also tolerated. An 
indane-1,3-dione derivative with a methyl substituent between the ketones 799 performed 
 
well with a 67% yield. When a bulkier substituent was introduced between the ketones of the 
indane-1,3-dione a higher catalyst loading was again needed to afford the desired product 
with modest yield (800). The β-ketoamide proved to be a valid substrate for the reaction 
performing the arylative cyclisation on to the more reactive carbonyl in high yield (801) 
(Scheme 161).  
 
Scheme 161: Scope	  of	  the	  1,4-­‐migration	  process 
a) Product synthesised by Dr Benjamin M. Partridge 
 
The two β-keto ester substrates synthesised 743 and 746 showed to be more challenging. 
Ketone 743 needed sequential additions of a solution of iridium catalyst to afford the desired 
tricycle 802 with acceptable yields. Acetoacetate derivative 746 proved to be even more 
challenging. Higher catalyst loadings and temperatures, different solvents and the use of 
NaBPh4 instead of PhB(OH)2 were tried but only gave either very complex mixtures or 
mainly starting materials. Similarly, malonate derivate 759 did not perform the arylative-
cyclisation process, and only starting alkyne 759 was recovered (Scheme 162). 
 
 
Scheme	  162:	  Scope	  of	  the	  1,4-­‐migration	  process 
 
The scope of the boronic acid was also studied. The use of both electron-rich and 
electron-poor arylboronic acids was tolerated. Both para-methoxy and meta-methyl 
substituted aryl boronic acids gave good yields and in the case of the meta-substituted 
boronic acid only one regioisomer 808 was observed (presumably due to sterics in the 1,4-
iridium migration process). Para and meta electronwithdrawing substituents in the 
arylboronic acid proved to be more challenging needing a higher catalyst loading to perform 
the reaction (Scheme 163).j 
                                                      





Scheme 163: Scope	  of	  the	  1,4-­‐migration	  process	  using	  different	  boronic	  acids 
 
Even increasing the catalyst loading in the case of the 4-substitued carboxylate boronic acid 
the reaction does not go to completion and a 41% yield of the starting alkyne was recovered 
with a 39% of product 811. In the case of 2-napthyl boronic acid an increase of the catalyst 
loading together with a higher temperature was needed. With tetracycle 822 formed in good 
yield with complete conversion of the starting alkyne 701 (Scheme 164).k 
 
Scheme 164: Scope	  of	  the	  1,4-­‐migration	  process	  using	  different	  boronic	  acids 
                                                      
k Reactions performed by Dr Benjamin M. Partdrige 
 
The fact that electron-poor arylboronic acids are less reactive towards arylation-cyclisation is 
presumably due to the less favourable transmetalation of the boronic acid with the iridium 
complex.[120a] 
The reaction of pentadeuteriophenylboronic acid 813 gave tricyclic alcohol 814 in a 56% 
yield. Exclusive deuterium incorporation was observed on the alkene position by 1H NMR 
spectroscopy. This provides strong evidence that a 1,4-migration shift occurs during this 
process (Scheme 165).l 
 
Scheme 165: Deuterium experiments for the 1,4-migration process 
  
5.7. Asymmetric Variant 
Both rhodium and iridium were shown to perform the racemic arylation-cyclisation of 
alkynones using cod as ligand. Commercially available and synthesised chiral ligands were 
tried in order to achieve a high enantioenriched process.  
The reaction in the presence of both [Ir(coe)2Cl]2 and [Rh(C2H4)2Cl]2, using NaBPh4 as 
arylative agent, showed complete inactivity towards the arylative-cyclisation process 
(Scheme 166).  
                                                      
i Reactions performed by Dr Benjamin M. Partdrige 
 
 
Scheme 166: Testing the background reaction using Ir and Rh catalysts 
 
A range of catalysts were prepared (in situ) from these two complexes and a wide variety of 
chiral ligands. Various commercially available phosphine ligands were the first evaluated to 
see if they generated a suitable chiral catalyst for the arylative-cyclisation process.  
In the case of rhodium, the combination of [Rh(C2H4)2Cl]2 with (S)-Segphos L32 and 
(R)-DTBM-Segphos L37 showed similar levels of conversions to those achieved with 
[Rh(cod)Cl]2 but no enantioselectivity was induced in the reaction (Table 10 Entry 1). Lower 
conversion and still no enantiocontrol was observed with other commercially available 
phosphine ligands such as (R,S)-Josiphos L09 , (R)-BINAP L02 or (R)-Difluorophos  L34 
(Table 10). 
Table 10: Ligand screening with Rh 
 
Entry Ligand ConversionI eeII 
1 L32 45% 0% 
2 L37 35% 0% 
3 L09 20% 0% 
4 L02 15% 0% 
5 L34 0% Not measured 
 
I) Determined by 1HNMR analysis of the crude reaction mixture (See Table 5) 




At low loading, iridium catalyst showed no activity unless cycloctadiene was present in the 
complex. A wide range of phosphine, phosphoramidite and diene ligands were applied but 
only starting material was observed. Applying the optimised conditions using phenylboronic 
acid gave similar results to those observed with NaBPh4 when using either iridium or 
rhodium catalyst. 
It was proposed to run a few selected ligands with a higher catalyst loadings to examine if 
catalyst turnover was a problem. Reaction of alkynone 726 with phenylboronic acid in the 
presence of 20 mol% of iridium dimer and 40 mol% of (R)-BINAP L02 led to formation of 
tricyclic alcohol 768 in good enantioselectivity albeit with low conversion. The conversion 
increased when using (R)-Difluorophos as ligand maintaining the levels enantiocontrol. 
Surprisingly (R)-Segphos as ligand, that showed good conversion with rhodium, led to only 
low conversion of alkynone 726 under iridium catalysis. Other classes of ligands were also 
screened but the enantioselectivities achieved were much inferior to those showed with 






                                                      
m Screening performed by Dr Benjamin M. Partdrige 
 
Table 11: Ligand screening with Ir 
 
 
Entry X mol% Ligand ConversionI eeII 
1 20 L02 20% 93% 
2 15 L34 35% 95% 
3 15 L32 10% Not measured 
 
I) Determined by 1HNMR analysis of the crude reaction mixture (See Table 5) 
II) Determined by Chiral HPLC 
 
 
By increasing the temperature to 110 °C using Xylenes as the solvent and t-AmOH instead 
of t-BuOH, led to the formation of alcohol 768 in moderate yield and excellent enantiomeric 
excess, using only a 5 mol% of iridium dimer. While alcohol 768 is formed selectively (no 
other side products were isolated), catalyst decomposition presumably was the cause of the 
low yield as 56% of unreacted starting alkyne 726 was also recovered. This same conditions 
were applied to substrate 737 obtaining a 62% yield of tetracycle 799 with a 91% 
enantiomeric excess and recovering 35% of the starting alkyne (Scheme 167).n 
                                                      




Scheme	  167:	  Ir	  catalysed	  asymmetric	  1,4-­‐migration	  process 
 
5.8. Conclusions 
Rhodium has been used for the arylation of alkynes followed by 1,4-migration and 
intramolecular 1,4-conjugate addition of α-β-unsaturated ketone. When rhodium was applied 
to a arylation/1,4-migration/aldol cyclisation process showed to be unsuccessful. Instead a 
iridium-catalysed system achieve successfully the arylation/1,4-migration/aldol cyclisation 
domino process. Yields between 58 and 82% were obtained observing a single diastereomer 
in each case racemically. This first 1,4-iridium migration has been applied to a wide range of 
alkynones synthesising up to 20 complex polycyclic structures in a single step. An 
asymmetric variant has been developed and applied obtaining high levels of enantiocontrol 
and moderate yields. Further investigations would be needed to improve the enantioselective 
process to achieve better yields with a lower catalyst loading and applying it to a wider range 
of alkyndiones. Iridium catalysed asymmetric alyllation is a well-known procedure therefore 
the allylation of alkyndione substrate can also be explored. As described in previous chapters 
palladium and rhodium 1,4-migration process are well explored. Knowing that iridium also 
undergoes 1,4-migration, iridium catalyst can be investigated as an alternative for process 
when rhodium and/or palladium do not produced the desired products. 
  
 
6. Experimental Procedure 
 
All non-aqueous reactions were carried out under a nitrogen atmosphere in oven-dried 
apparatus. Anhydrous CH2Cl2, THF, Toluene and MeCN were dried and purified by passage 
through activated alumina columns using a solvent purification system from 
www.glasscontour.com.  Arylboronic acids were used as received unless the sample 
contained >10% boroxine as determined by 1H NMR analysis. In this case, the boronic acid 
was stirred in a mixture of Et2O and water for 30 minutes. The organic phase was separated, 
dried (Na2SO4), filtered, and concentrated in vacuo to give the corresponding boronic acid 
which was used without further purification.  ‘Petrol’ refers to that fraction of light 
petroleum ether boiling in the range 40-60 °C.  All other commercially available reagents 
were used as received. Thin layer chromatography (TLC) was performed on Merck DF-
Alufoilien 60F254 0.2 mm precoated plates. Product spots were visualized by UV light at 254 
nm, and subsequently developed using potassium permanganate or vanillin solution as 
appropriate. Flash column chromatography was carried out using silica gel (Fisher Scientific 
60 Å particle size 35-70 micron) employing the method of Still and co-workers.[125]  Melting 
points were recorded on a Gallenkamp melting point apparatus and are uncorrected. Infra-red 
spectra were recorded on a Jasco FT/IR-460 Plus, a Shimadzu IRAffinity-1 or a Nicolet 
Avatar 360 FT instrument as a thin film on sodium chloride plates or as a dilute solution in 
CHCl3. 1H NMR spectra were recorded on Bruker AVA500 (500 MHz) spectrometer or a 
Bruker AVA400 (400 MHz) spectrometer. Chemical shifts (δ) are quoted in parts per million 
(ppm) downfield of tetramethylsilane, using residual protonated solvent as internal standard 
(CHCl3 at 7.27 ppm). Abbreviations used in the description of resonances are: s (singlet), d 
(doublet), t (triplet), q, (quartet), app (apparent), br (broad), m (multiplet). Coupling 
constants (J) are quoted to the nearest 0.1 Hz. Proton-decoupled 13C NMR spectra were 
recorded on a Bruker AVA500 (125.8 MHz) spectrometer or a Bruker AVA400 (100.6 
MHz) spectrometer. Chemical shifts (δ) are quoted in parts per million (ppm) downfield of 
tetramethylsilane, using deuterated solvent as internal standard (CDCl3 at 77.0 ppm, CD3OD 
at 49.0 ppm). Assignments were made using the DEPT sequence with secondary pulses at 
90° and 135°. Proton-decoupled 19F NMR spectra were recorded on a Bruker AVA400 (376 
MHz) spectrometer. Chemical shifts (δ) are quoted in ppm downfield of CFCl3 (δ = 0 ppm), 
using fluorobenzene (C6H5F at –113.5 ppm) or trifluoroacetic acid (CF3CO2H at −76.55 
ppm), as internal standard. High resolution mass spectra were recorded using electrospray 
ionization (ESI) or electron impact (EI) techniques at the EPSRC National Mass 
 
Spectrometry Service Centre, Swansea University, at the School of Chemistry, University 
of Edinburgh or at the School of Chemistry, University of Nottingham. Optical rotations 
were performed on an Optical Activity POLAAR 20 polarimeter or on a Bellingham and 
Stanley ADP 400 polarimeter. X-Ray diffraction data were collected at 120 K on either an 
Agilent SuperNova diffractometer using Mo Kα radiation at 0.71 Å or on an Agilent 
GV1000 using CuKα radiation, and refined in SHELXTL by the cristalography teams at the 
University of Edinburgh and the University of Nottingham . Chiral HPLC analysis was 
performed on an Agilent Technologies 1260 Infinity instrument using CHIRALPAK® 4.6 × 
250 mm columns.  
 
6.1. Enantioselective Copper(I)-Catalysed 
Borylative Aldol Cyclisations of Enone Diones 
6.1.1. Diketone Precursors Synthesis 
3-(1-Methyl-2,5-dioxocyclopentyl)propionaldehyde (325) 
 
To a stirred solution of 2-methyl-1,3-cyclopentanedione (6.30 g, 50.0 mmol) in H2O (250 
mL) was added acrolein (5.01 mL, 75.0 mmol) in one portion and the resulting mixture was 
stirred at room temperature for 18 hours. The reaction mixture was then concentrated in 
vacuo and the residue was purified by column chromatography (50% EtOAc/CH2Cl2) to give 
the title compound 325 (7.01 g, 84%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 9.56 
(1H, t, J = 1.0 Hz, CH2O=CH), 2.71 (4H, s, O=CCH2CH2C=O), 2.38 (2H, dt, J = 7.2, 0.9 
Hz, CH2CH2O=CH), 1.81 (2H, t, J = 7.2 Hz, CH2CH2O=CH), 1.02 (3H, s, O=CCCH3); 13C 
NMR (125.8 MHz, CDCl3) δ 215.5 (C), 200.7 (2 x C), 55.0 (C), 38.3 (CH2), 34.7 (2 x CH2), 
25.9 (CH2), 19.3 (CH3). 





To a stirred solution of 2-methyl-1,3-cyclohexanedione (12.6 g, 100 mmol) in t-BuOH (500 
mL) was added acrolein (10.0 mL, 150 mmol) in one portion and the resulting mixture 
stirred at room temperature for 18 hours. The reaction mixture was then concentrated in 
vacuo to give the title compound 327 (17.05 g, 95%) as a yellow-brown oil. 1H NMR (500 
MHz, CDCl3) δ 9.63 (1H, t, J = 1.2 Hz, CH2O=CH), 2.56-2.61 (4H, m, 
O=CCH2CH2CH2C=O), 2.30 (2H, dt, J = 7.1, 0.9 Hz, CH2CH2O=CH), 2.05 (2H, dt, J = 7.1, 
0.9 Hz, CH2CH2O=CH), 1.96-1.88 (2H, m, O=CCH2CH2CH2C=O), 1.23 (3H, s, 
O=CCCH3); 13C NMR (125.8 MHz, CDCl3) δ 209.8 (2 x C), 201.0 (C), 64.3 (C), 39.3 (CH2), 
37.8 (2 x CH2), 27.1 (CH2), 21.6 (CH2), 17.5 (CH3). 
The data were in agreement with those reported in the literature.[69b] 
 
6.1.2. Ylide Synthesis 
Representative procedure A: Synthesis of ylides 
1-(4-Methoxyphenyl)-2-(triphenylphosphoranylidene)ethanone (304) 
 
To a stirred solution of triphenylphosphine (15.7 g, 60.0 mmol) in toluene (100 mL) was 
added a solution of 2-bromo-4-methoxycetophenone (9.20 g, 50.0 mmol) in toluene (100 
mL) and the resulting mixture was stirred for 5 h at 80 °C. After cooling to room 
temperature, the solid formed was filtered, washed with toluene (3 × 20 mL) and Et2O (20 
mL) and then dissolved in CH2Cl2 (50 mL). A solution of Na2CO3 (5.82 g, 55.0 mmol) in 
H2O (50 mL) was added to the CH2Cl2 solution and the resulting mixture was stirred for 18 h 
at room temperature. The organic layer was separated and the aqueous layer was extracted 
 
with CH2Cl2 (3 × 25 mL). The combined organic layers were dried (MgSO4), filtered and 
concentrated in vacuo to give the title compound 304 as a yellow solid Rf = 0.28 (90% 
EtOAc/hexane). 1H NMR (500 MHz, CDCl3) δ 7.94 (2H, d, J = 9.0 Hz, ArH), 7.75-7.70 
(6H, m, ArH), 7.56-7.54 (3H, m, ArH), 7.48-7.45 (6H, m, ArH), 6.87 (2H, d, J = 9.0 Hz, 
ArH), 4.36 (1H, s, Ph3P=CH), 3.83 (3H, s, OCH3) ; 13C NMR 184.4 (C, d, J = 3.5 Hz), 134.0 
(CH, d, J = 14.0 Hz), 133.1 (5 x CH, d, J = 9.4 Hz), 132.1 (C), 131.9 (3 x CH, d, J = 2.9 Hz, 
ArC), 128.8 (5 x CH, d, J = 12.6 Hz), 128.5 (2 x CH), 128.4 (2 x CH), 127.3 (3 x C, d, J = 
90.8 Hz), 55.2 (CH3), 49.4 (CH, d, J = 117.5 Hz). 
The data were in agreement with those reported in the literature.[126] 
 
1-(4-Nitrophenyl)-2-(triphenylphosphoranylidene)ethanone  (308) 
The title compound was prepared according to the Representative 
Procedure from 2-bromo-4-nitroacetophenone (12.1 g, 50.0 mmol) 
and triphenylphosphine (15.7 g, 60.0 mmol). Extraction with CH2Cl2 gave a bright yellow 
solid (18.2 g, 85%). Rf = 0.53 (90% EtOAc/hexane). 1H NMR (500 MHz, CDCl3) δ 8.20 
(2H, d, J = 10.2 Hz, ArH),  8.09 (2H, d, J = 10.2 Hz, ArH) 7.75-7.68 (6H, m, ArH), 7.63-
7.59 (3H, m, ArH), 7.54-7.47 (6H, m, ArH), 4.51 (1H, d, J = 23.0 Hz, Ph3P=CH); 13C NMR 
183.4 (C, d, J = 2.9 Hz), 133.1 (5 x CH, d, J = 10.1 Hz), 132.4 (3 x CH, d, J = 10.7 Hz), 
132.0 (C d, J = 3.2 Hz), 129.0 (5 x CH, d, J = 12.8 Hz), 127.7 (2 x CH), 126.1 (3 x C, d, J = 
92.8 Hz), 123.1 (2 x CH), 49.4 (CH, d, J = 117.5 Hz). 
The data were in agreement with those reported in the literature.[127] 
 
1-Phenyl-2-(triphenylphosphoranylidene)ethanone (309) The title 
compound was prepared according to the Representative Procedure from 
2-bromoacetophenone (19.7 g, 100 mmol) and triphenylphosphine (31.4 g, 
120 mmol). Extraction with CH2Cl2 gave a white solid (30.1 g, 80%). Rf = 0.53 (90% 
EtOAc/hexane). 1H NMR (500 MHz, CDCl3) δ 8.20 (2H, d, J = 10.2 Hz, ArH),  7.79 (2H, d, 
J = 10.2 Hz, ArH) 7.77-7.67 (6H, m, ArH), 7.63-7.59 (3H, m, ArH), 7.54-7.47 (8H, m, 
ArH), 4.45 (1H, d, J = 25.0 Hz, Ph3P=CH). 




The title compound was prepared according to the Representative 
Procedure from 2-bromo-2-methoxycetophenone (1.93 g, 10.5 mmol) and 
triphenylphosphine (3.14 g, 12.0 mmol). Extraction with CH2Cl2 gave a bright yellow solid 
(4.10 g, 95%). Rf = 0.25 (90% EtOAc/hexane). δ 7.88 (1H, dd, J = 6.9, 2.0 Hz, ArH), 7.81-
7.75 (6H, m, ArH), 7.59-7.54 (3H, m, ArH), 7.51-7.46 (6H, m, ArH),  7.29 (1H, dt, J = 8.1, 
1.8 Hz, ArH), 6.99-6.92 (2H, m, ArH), 4.62 (1H, d, J = 22.0 Hz, Ph3P=CH), 3.91 (3H, s, 
OCH3); 13C NMR (125.8 MHz, CDCl3) δ 183.9 (C, d, J = 2.8 Hz), 157.4 (CH), 133.2 (5 x 
CH, d, J = 8.5 Hz), 132.05 (CH, d, J = 10.1) , 131.9 (3 x CH, d, J = 2.8 Hz, ArC), 129.7 (C, 
d, J = 8.5 Hz), 128.8 (5 x CH, d, J = 12.3 Hz), 128.5 (2 x CH, d, J = 12.0 Hz), 127.3 (3 x C, 
d, J = 90.3 Hz, ArC), 120.3 (CH), 111.5 (CH), 55.9 (CH3), 55.2 (CH, d, J = 106.4 Hz).  




To a refluxing suspension of CuBr2 (3.30 g, 11.1 mmol) in EtOAc (7.50 mL) was added a 
solution of 3'-(trifluoromethyl)-acetophenone (1.12 g, 6.00 mmol) in CHCl3 (7.50 mL) the 
resulting mixture was stirred for 18 hours under reflux conditions. The solution was filtered 
and then washed with sat. NaHCO3 (aq.) (5 mL) and brine (5 mL). ). The organic layer was 
concentrated in vacuo and the residue was dissolved in toluene (50mL) and PPh3 (1.88 g, 
7.20 mmol) was added. The solution was heated at 80 °C for 14h. The solid formed during 
the reaction was filtered and washed with diethyl ether (3 x 10 ml) and disolved in 50 mL of 
CH2Cl2. A solution of Na2CO3 (1.20 g, 11.0 mmol) in H2O (25 mL) was added to the CH2Cl2 
solution and the resulting mixture was stirred for 18 h at room temperature. The organic 
layer was separated and the aqueous layer was extracted with CH2Cl2 (3 × 10 mL). The 
combined organic layers were dried (NaSO4), filtered and concentrated in vacuo to give the 
title compound 307 as a pale-orange solid (2.40 g, 85%). Rf = 0.48 (1:9 hexane/EtOAc); m.p. 
120-122 °C; IR 3071, 1620 (C=O), 1527, 1479, 1435, 1387, 1323, 1126, 718, 692 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 8.24 (1H, s, ArH), 8.15 (1H, d, J = 7.8 Hz, ArH) 7.75-7.66 (6H, 
 
m, ArH), 7.62-7.57 (3H, m, ArH), 7.55-7.45 (8H, m, ArH), 4.46 (1H, d, J = 23.0 Hz, 
Ph3P=CH); 13C NMR (125.8 MHz, CDCl3) δ 182.8 (C, d, J = 3.7 Hz), 141.9 (C, d, J = 14.4 
Hz), 133.1 (6 × CH, d, J =10.1 Hz), 132.2 (CH, d, J = 2.6 Hz), 132.0 (CH, d, J = 10.2 Hz), 
131.9 (CH, d, J = 2.6 Hz), 130.2 (CH), 128.9 (6 × CH, d, J = 12.0 Hz), 128.4 (CH, d, J = 
12.2 Hz), 128.1 (CH), 126.5 (3 × C, d, J = 91.9 Hz,), 124.8 (CH, dm, J = 91.9 Hz), 51.6 (CH, 
d, J = 106.3 Hz); 31P NMR (162 MHz, CDCl3) δ 29.1, 16.8; 19F NMR (376 MHz, CDCl3) δ: 




To a refluxing suspension of CuBr2 (9.91 g, 33.3 mmol) in EtOAc (10.0 mL) was added a 
solution of 2’-bromoacetophenone (3.58 g, 18.0 mmol) in CHCl3 (10.0 mL) the resulting 
mixture was stirred for 18 hours under reflux conditions. The solution was filtered and then 
washed with Sat. NaHCO3 (10 mL) and brine (10 mL). The organic layer was concentrated 
in vacuo and the residue was dissolved in toluene (100mL) and PPh3 (5.21 g, 20.0 mmol) 
was added. The solution was heated at 80 °C for 14h. The solid formed during the reaction 
was filtered and washed with diethyl ether (3 x 30 ml) and dissolved in 100 mL of CH2Cl2. A 
solution of Na2CO3 (2.64 g, 20.0 mmol) in H2O (100 mL) was added to the CH2Cl2 solution 
and the resulting mixture was stirred for 18 h at room temperature. The organic layer was 
separated and the aqueous layer was extracted with CH2Cl2 (3 × 25 mL). The combined 
organic layers were dried (NaSO4), filtered and concentrated in vacuo to give the title 
compound 306 as pale orange solid (4.53 g, 55%). Rf = 0.26 (90% EtOAc/hexane); 1H NMR 
(300 MHz, CDCl3) δ 7.80-7.75 (5H, m, ArH), 7.71-7.66 (2H, m, ArH) 7.61-7.47 (12H, m, 
ArH), 4.41 (1H, d, J = 25.2 Hz, Ph3P=CH). 






To a stirred solution of actetylpyridine (6.05 g, 50.0 mmol) in 30% HBr/HOAc (60 mL) was 
added dropwise Br2 (2.57 mL, 50 mmol) at 15 °C then the mixture was stirred at 40 °C for 
2 h. The mixture was cooled to r.t., diluted with Et2O (250 mL) and stirred for 30 min. The 
precipitate was filtered and washed Et2O (25 mL). The brown solid was then dissolved in 
Sat. NaHCO3 (50 mL) and extracted with CH2Cl2 (3 x 25 mL). The combined organic layers 
were dried (NaSO4), filtered and concentrated in vacuo. The residue was dissolved in 
toluene (100mL) and PPh3 (14.3 g, 55.0 mmol) was added. The solution was heated at 80 °C 
for 14 h. The solid formed during the reaction was filtered and washed with diethyl ether (3 
x 30 ml) and dissolved in 100 mL of CH2Cl2. A solution of Na2CO3 (2.64 g, 20.0 mmol) in 
H2O (100 mL) was added to the CH2Cl2 solution and the resulting mixture was stirred for 18 
h at room temperature. The organic layer was separated and the aqueous layer was extracted 
with CH2Cl2 (3 × 25 mL). The combined organic layers were dried (NaSO4), filtered and 
concentrated in vacuo to give the title compound 310 as an off-white gummy solid (13.9 g, 
73%). Rf = 0.18 (9/18/73 MeOH/EtOAc/petroleum ether); IR 2959, 2928, 1724 (C=O), 
1572, 1522, 1483, 1438, 1397, 1239, 1107 cm-1; 1H NMR (400 MHz, CDCl3) δ 8.59 (1H, d, 
J = 4.0 Hz, ArH), 8.15 (1H, d, J = 7.9 Hz, ArH), 7.80-7.70 (6H, m, ArH), 7.60-7.53 (3H, m, 
ArH), 7.52-7.45 (6H, m, ArH), 7.31-7.25 (2H, m, ArH), 4.32 (1H, d, J = 21.4 Hz, 
Ph3P=CH); 13C NMR (100.6 MHz, CDCl3) δ 196.5 (C, d, J = 5.7 Hz), 148.0 (CH), 141.1 (C) 
136.6 (CH), 133.3 (6 x CH, d, J = 10.2 Hz), 132.1 (3 x CH, d, J = 2.7 Hz), 128.9 (6 x CH, d, 
J = 12.3 Hz), 126.1 (3 x C, d, J = 91.5 Hz), 124.1 (CH), 120.6 (CH), 51.9 (CH, d, J = 110.9 
Hz); 31P NMR (162 MHz, CDCl3) δ 17.4; HRMS (ESI) Exact mass calculated for 





To a −78 °C suspension of 1-(triphenylphosphoranylidene)acetone (3.66 g. 11.50 mmol) in 
THF (100 mL) was added dropwise n-BuLi [1.6 M solution in hexane (7.90 mL, 12.65 
mmol)], the resulting mixture was stirred at −78 °C for 3 hours then benzyl chloromethyl 
ether (1.97 g, 12.6 mmol) was added. The reaction mixture was warmed to room temperature 
and stirred for 16 hours. The brown reaction mixture was then concentrated in vacuo and the 
residue was purified by column chromatography (95% EtOAc/MeOH) to afford the title 
compound  322  as a pearl white solid (2.19 g, 45% yield). Rf = 0.11 (90% EtOAc/hexane). 
1H NMR (500 MHz, CDCl3) δ 7.70-7.65 (5H, m, ArH),  7.58-7.54 (4H, m, ArH), 7.48-7.43 
(6H, m, ArH), 7.40-7.27 (6H, m, ArH), 4.59 (2H, s, O=CCH2O), 3.88 (2H, t, J = 7 Hz 
OCH2CH2), 2.69 (2H, t, J = 7 Hz OCH2CH2); 13C NMR (125.8 MHz, CDCl3) δ 190.5 (C, d, 
J = 2.9 Hz), 138.9 (CH), 133.0 (5 x CH, d, J =10.0 Hz, ArC), 132.0 (CH, d, J = 9.9 Hz), 
131.9 (3 x CH, d, J = 2.8 Hz), 128.7 (5 x CH, d, J = 12.0 Hz), 128.4 (CH, d, J = 11.6 Hz), 
128.1 (2 x CH), 127.5 (2 x CH) 127.2 (C), 127.0 (3 x C, d, J = 91.0 Hz), 72.8 (CH2), 68.4 
(CH2), 52.2 (CH, d, J = 112.3 Hz), 41.7 (CH2, d, J = 15.6 Hz). 
The data were in agreement with those reported in the literature.[77a] 
 
6.1.3. Enone-Dione Synthesis 




To a stirred solution of 3-(1-methyl-2,6-dioxocyclohexyl)propanal (2.22 g, 12.1 mmol) in 
CHCl3 (120 mL) was added 1-(4-chlorophenyl)-2-(triphenylphosphoranylidene)ethanone 
(5.59 g, 13.5 mmol) in one portion at room temperature and the resulting mixture was stirred 
under reflux for 4 h. The reaction mixture was then concentrated in vacuo to afford the crude 
residue. Purification of the residue by column chromatography (4:1 hexane/EtOAc) gave the 
title compound 334 (2.52 g, 65%) as a white solid. Rf = 0.33 (3:2 hexane/EtOAc); m.p. 96-98 
°C; IR 2955, 1724 (C=O), 1693 (C=O), 1667, 1615, 1588, 1402, 1305, 1092, 666 cm-1; 1H 
 
NMR (500 MHz, CDCl3) δ 7.86 (2H, d, J = 8.6 Hz, ArH), 7.45 (2H, d, J = 8.6 Hz, ArH), 
6.97 (1H, dt, J = 15.3, 6.8 Hz, CH2CH=), 6.82 (1H, dt, J = 15.3, 1.3 Hz, =CHC=O), 2.75-
2.63 (4H, m, CH2CH2CH2), 2.18-2.14 (2H, m, CH2CH=), 2.03-1.91 (4H, m, CH2CH2CH2, 
CH2CH2CH=), 1.32 (3H, s, CH3); 13C NMR (125.8 MHz, CDCl3) δ 209.9 (2 × C), 189.2 (C), 
148.5 (CH), 139.2 (C), 136.0 (C), 129.9 (2 × CH), 128.9 (2 × CH), 125.9 (CH), 64.9 (C), 
38.0 (2 × CH2), 33.9 (CH2), 28.2 (CH2), 21.7 (CH2), 17.5 (CH3); HRMS (ESI) Exact mass 
calcd for C18H20O3Cl [M+H]+: 319.1095, found: 319.1098.  
 
2-[(E)-5-(4-Methoxyphenyl)-5-oxopent-3-enyl]-2-
methylcyclohexane-1,3-dione (330). The title compound 
was prepared according to the Representative Procedure from 
3-(1-methyl-2,6-dioxocyclohexyl)propanal (2.00 g, 10.9 mmol) and 1-(4-methoxyphenyl)-2-
(triphenylphosphoranylidene)ethanone (4.96 g, 12.1 mmol). Purification by column 
chromatography (80:20 hexane/CH2Cl2) gave an orange solid (3.05 g, 88%). Rf = 0.44 (1:1 
hexane/EtOAc); m.p. 85-87 °C; IR 2967, 2922, 1721 (C=O), 1693 (C=O), 1663, 1614, 1599, 
1574, 1327, 1256, 1030, 1015, 812 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.93 (2H, d, J = 9.3 
Hz, ArH), 6.94 (2H, d, J = 9.3 Hz, ArH), 6.93-6.90 (1H, m, CH2CH=), 6.86 (1H, d, J =15.6 
Hz, CH2CH=CH), 3.87 (3H, s, OCH3), 2.70-2.67 (4H, m, CH2CH2CH2), 2.17-2.11 (2H, m, 
CH2CH2CH2), 2.04-1.93 (4H, m,  CH2CH2CH=), 1.31 (3H, s, CH3); 13C NMR (125.8 MHz, 
CDCl3) δ 209.9 (2 × C), 188.7 (C), 163.3 (C), 146.6 (CH), 130.8 (2 × CH), 130.5 (C), 126.1 
(CH), 113.7 (2 × CH), 64.9 (C), 55.4 (CH3), 37.9 (2 × CH2), 34.4 (CH2), 28.0 (CH2), 21.0 




yl)cyclohexane-1,3-dione (346). The title compound was prepared 
according to the Representative Procedure from 3-[2,6-dioxo-1-
(prop-2-en-1-yl)cyclohexyl]propanal (1.01 g, 5.50 mmol) and 1-
phenyl-2-(triphenylphosphoranylidene)ethanone (2.97 g, 7.80 mmol). Purification by column 
chromatography (4:1 hexane/EtOAc) gave a white solid (1.00 g. 60%). Rf = 0.35 (3:2 
hexane/EtOAc), m.p. 59-60 °C; IR (film) 2957, 2926, 1714 (C=O), 1688 (C=O), 1670, 1618, 
1444, 1290, 1221, 1022, 924, 772, 691 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.92-7.90 (2H, 











m, CH2CH2CH=), 6.83 (1H, dt, J = 15.8, 0.9 Hz, CH2CH=CH), 5.62-5.53 (1H, m, 
CH=CH2), 5.11-5.06 (2H, m, =CH2), 2.67-2.60 (4H, m, CH2CH2CH2), 2.52 (2H, d, J = 7.5 
Hz, CH2CH2CH2), 2.14-2.10 (2H, m, CH2CH=CH2), 2.07-1.99 (3H, m, CH2CH2CH=), 1.94-
1.85 (1H, m, CH2CH2CH=); 13C NMR (125.8 MHz, CDCl3) δ 209.9 (2 × C), 190.7 (C), 
147.9 (CH), 137.7 (C), 132.7 (CH), 131.8 (CH), 128.5 (4 × CH), 126.4 (CH), 119.7 (CH2), 
68.3 (C), 41.7 (CH2), 39.4 (2 × CH2), 32.9 (CH2), 28.2 (CH2), 16.9 (CH2); HRMS (ESI) 




To a stirred solution of 3-(1-methyl-2,6-dioxocyclohexyl)propanal (728 mg, 4.00 mmol) in 
toluene (20 mL) was added [4-(benzyloxy)-2-oxobutylidene]triphenylphosphorane (2.19 g, 
5.00 mmol) in one portion and the resulting mixture was stirred at 80 °C for 16 h. The 
mixture was concentrated in vacuo and the residue was purified by column chromatography 
(CH2Cl2) to give the title compound 336 as pale yellow oil (950 mg, 65%). Rf = 0.35 
(CH2Cl2); IR 2976, 2874, 1724 (C=O), 1694 (C=O), 1670, 1618, 1454, 1269, 1101, 912, 733 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.35-7.26 (5H, m, ArH), 6.78-6.71 (1H, m, 
CH2CH=CH), 6.08 (1H, dt, J = 16.0, 1.5 Hz, CH2CH=CH), 4.52 (2H, s, CH2Ph), 3.78 (2H, t, 
J = 6.6 Hz, OCH2CH2C=O), 2.84 (2H, t, J = 6.6 Hz, OCH2CH2C=O), 2.69-2.58 (4H, m, 
CH2CH2CH2), 2.09-2.02 (2H, m, CH2CH2CH2), 1.95-1.90 (4H, m, CH2CH2CH=), 1.29 (3H, 
s, CH3); 13C NMR (125.8 MHz, CDCl3) δ 209.9 (2 × C), 198.3 (C), 146.4 (CH), 138.1 (C) 
130.8 (CH), 128.3 (2 × CH), 127.7 (2 × CH), 127.6 (CH), 73.2 (CH2), 65.4 (CH2), 64.8 (C), 
40.0 (CH2), 37.9 (CH2), 33.8 (2 × CH2), 27.9 (CH2), 21.7 (CH3), 17.5 (CH2); HRMS (ESI) 
Exact mass calcd for C21H27O4 [M+H]+: 343.1904, found: 343.1908.  
 
2-[(E)-5-(2-Methoxyphenyl)-5-oxopent-3-enyl]-2-
methylcyclohexane-1,3-dione (361). The title compound was 
prepared according to the Representative Procedure from 3-(1-







(triphenylphosphoranylidene)ethanone (5.13 g, 12.5 mmol). Purification by column 
chromatography (4:1 hexane/EtOAc) gave a colorless oil (1.100 g, 75%). Rf  = 0.45 (1:1 
hexane/EtOAc); IR 2953, 2941, 1719 (C=O), 1694 (C=O), 1653, 1265, 1169, 1026, 739, 698 
cm-1; 1H NMR (500 MHz, CDCl3) δ 7.39-7.30 (5H, m, ArH), 6.91 (1H, dt, J = 15.7, 6.7 Hz, 
CH2CH=), 5.85 (1H, dt, J = 15.7, 1.5 Hz, CH2CH=CH), 5.17 (2H, s, CH2Ph), 2.72-2.58 (4H, 
m, CH2CH2CH2), 2.07-2.00 (2H, m, CH2CH2CH2), 1.98-1.87 (4H, m, CH2CH2CH=), 1.28 
(3H, s, CH3); 13C NMR (125.8 MHz, CDCl3) δ 209.8 (2 × C), 166.1 (C), 148.1 (CH), 136.0 
(C), 128.5 (2 × CH), 128.13 (CH), 128.12 (2 × CH), 121.6 (CH), 66.0 (CH2), 64.8 (C), 37.9 
(2 × CH2), 33.9 (CH2), 27.5 (CH2), 21.3 (CH3), 17.5 (CH2); HRMS (ESI) Exact mass calcd 
for C19H26NO4 [M+NH4]+: 332.1856, found 332.1859. 
 
2-[(E)-5-(4-Nitrophenyl)-5-oxopent-3-enyl]-2-
methylcyclohexane-1,3-dione (331). The title compound 
was prepared according to the Representative Procedure from 
3-(1-methyl-2,6-dioxocyclohexyl)propanal (2.00 g, 10.9 mmol) and 1-(4-nitrophenyl)-2-
(triphenylphosphoranylidene)ethanone (5.14 g, 12.1 mmol). Purification by column 
chromatography (95:5 CH2Cl2/EtOAc) gave an orange solid (1.64 g, 46%). Rf = 0.34 (1:1 
hexane/EtOAc); m.p. 119-121 °C; IR 3105, 3067, 2953, 2918, 1722 (C=O), 1689 (C=O), 
1672, 1622, 1520 (NO2), 1344 (NO2), 1217, 1026, 854, 696 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 8.32 (2H, d, J = 7.2 Hz, ArH), 8.04 (2H, d, J = 7.2 Hz, ArH), 7.05-6.98 (1H, m, 
CH2CH=), 6.82 (1H, dt, J = 15.2, 1.0 Hz CH2CH=CH), 2.78-2.72 (2H, m, CH2CH2CH2), 
2.68-2.62 (2H, m, CH2CH2CH2),  2.21-2.14 (2H, m, CH2CH2CH2), 2.07-1.99 (3H, m, 
CH2CH2CH=), 1.98-1.89 (1H, m, CH2CH2CH=), 1.33 (3H, s, CH3); 13C NMR (125.8 MHz, 
CDCl3) δ 209.9 (2 × C), 189.1 (C), 150.5 (CH), 150.0 (C), 142.6 (C), 129.4 (2 × CH), 125.9 
(CH), 123.7 (2 × CH), 64.8 (C), 38.0 (2 × CH2), 33.4 (CH2), 28.4 (CH2), 22.4 (CH3), 17.5 
(CH2); HRMS (ESI) Exact mass calcd for C18H19NO5 [M+H]+: 330.1336, found: 330.1337.  
 
2-[(E)-5-(3-Trifluoromethylphenyl)-5-oxopent-3-enyl]-2-
methylcyclohexane-1,3-dione (332). The title compound was 
prepared according to the Representative Procedure from 3-
(1-methyl-2,6-dioxocyclohexyl)propanal (546 mg, 3.00 mmol) and 1-(3-
trifluormethylphenyl)-2-(triphenylphosphoranylidene)ethanone (S2) (1.79 g, 4.00 mmol). 












mg, 70%). Rf  = 0.35 (3:2 hexane/EtOAc); m.p. 60-62 °C; IR 2963, 2940, 1726 (C=O), 1694 
(C=O), 1668, 1618, 1331, 1163, 1124, 1072, 804, 690 cm-1; 1H NMR (500 MHz, CDCl3) δ 
8.15 (1H, s, ArH), 8.08 (1H, d, J = 7.9 Hz, ArH), 7.82 (1H, d, J = 7.5 Hz, ArH), 7.62 (1H, t, 
J = 7.5 Hz, ArH), 7.05-6.89 (1H, m, CH2CH=CH), 6.85 (1H, dt, J = 15.9, 1.5 Hz, 
CH2CH=CH), 2.77-2.62 (4H, m, CH2CH2CH2), 2.19-2.16 (2H, m, CH2CH2CH2), 2.04-1.93 
(4H, m, CH2CH2CH=), 1.33 (3H, s, CH3); 13C NMR (125.8 MHz, CDCl3) δ 209.8 (2 × C), 
189.1 (C), 149.4 (CH), 138.2 (C), 131.7 (CH), 131.1 (C, q, 2JCF = 32.9 Hz), 129.2 (CH), 
129.1 (CH, q, 3JCF = 3.6 Hz), 125.7 (CH), 125.3 (CH, q, 3JCF = 3.8 Hz), 123.7 (C, q, 1JCF = 
272.6 Hz), 64.8 (C), 37.9 (2 × CH2), 33.7 (CH2), 28.2 (CH2), 21.8 (CH3), 17.5 (CH2); 19F 
NMR (376 MHz, CDCl3) δ −63.8 (3F, s); HRMS (EI) Exact mass calcd for C19H19O3F3 
[M]+: 352.1286, found: 352.1277.  
 
2-[(E)-5-(2-Bromophenyl)-5-oxopent-3-enyl]-2-
methylcyclohexane-1,3-dione (333). The title compound was 
prepared according to the Representative Procedure from 3-(1-
methyl-2,6-dioxocyclohexyl)propanal (335 mg, 1.80 mmol) and 1-(2-bromophenyl)-2-
(triphenylphosphoranylidene)ethanone (1.05 g, 2.30 mmol). Purification by column 
chromatography (80:20 hexane/EtOAc) gave a colorless oil (450 mg, 70%). Rf  = 0.40 
(CH2Cl2); IR 3056, 2963, 2936, 1724 (C=O), 1694 (C=O), 1657, 1618, 1427, 1300, 1024, 
766 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.60 (1H, d, J = 8.4 Hz, ArH), 7.38 (1H, t, J = 8.4 
Hz, ArH), 7.32-7.27 (2H, m, ArH), 6.60-6.54 (1H, m, CH2CH=), 6.40 (1H, d, J = 16.2 Hz, 
CH2CH=CH), 2.74-2.61 (4H, m, CH2CH2CH2), 2.14-2.09 (2H, m, CH2CH2CH2), 1.99-1.91 
(4H, m, CH2CH2CH=), 1.29 (3H, s, CH3); 13C NMR (125.8 MHz, CDCl3) δ 209.8 (2 × C), 
194.9 (C), 151.1 (CH), 140.7 (C), 133.2 (CH), 131.1 (CH), 130.5 (CH), 128.8 (CH), 127.1 
(CH), 119.2 (C), 64.7 (C), 37.9 (2 × CH2), 33.4 (CH2), 28.1 (CH2), 21.8 (CH3), 17.4 (CH2); 
HRMS (EI) Exact mass calcd for C18H19O379Br [M]+: 362.0512, found: 362.0508. 
 
 2-[(E)-5-(2-methoxyphenyl)-5-oxopent-3-en-1-yl]-2-
methylcyclohexane-1,3-dione (329). The title compound was 
prepared according to a modification of the Representative 
Procedure from 3-(1-methyl-2,6-dioxocyclohexyl)propanal (455 
mg, 2.50 mmol) and  1-(2-methoxyphenyl)-2-(triphenylphosphanylidene)ethan-1-one (1.23 






Purification by column chromatography (30 to 40% EtOAc/petroleum ether) gave a yellow 
oil (504 mg, 66%). Rf = 0.25 (40% EtOAc/petroleum ether); IR 2943, 2841, 1726 (C=O), 
1696 (C=O), 1662, 1617, 1599, 1376, 1286, 1025 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.42-
7.30 (2H, m, ArH), 6.94-6.85 (2H, m, ArH), 6.64 (1H, dt, J = 15.6, 6.3 Hz, CH2CH=), 6.56 
(1H, app d, J = 15.6 Hz, CH2CH=CH), 3.76 (3H, s, OCH3), 2.58 (4H, t, J = 6.9 Hz, 
CH2CH2CH2), 2.05-1.96 (2H, m, CH2CH=), 1.91-1.81 (4H, m, CH2CH2CH2 and 
CH2CH2CH=), 1.19 (3H, s, CCH3); 13C NMR (100.6 MHz, CDCl3) δ 209.7 (2 x C), 192.9 
(C), 157.5 (C), 146.5 (CH), 132.4 (CH), 130.8 (CH), 129.7 (CH), 128.6 (C), 120.2 (CH), 
111.3 (CH), 64.6 (C), 55.3 (CH3), 37.6 (2 x CH2), 34.0 (CH2), 27.6 (CH2), 20.7 (CH3), 17.2 




yl]cyclohexane-1,3-dione (335). The title compound was 
prepared according to the Representative Procedure from 3-(1-
methyl-2,6-dioxocyclohexyl)propanal (547 mg, 3.00 mmol) and 1-(pyridin-2-yl)-2-
(triphenylphosphanylidene)ethan-1-one (1.30 g, 3.41 mmol). Purification by column 
chromatography (20 to 40 to 50% EtOAc/petroleum ether) gave a grey solid (608 mg, 71%). 
Rf = 0.22 (40% EtOAc/petroleum ether); m.p. 73-74 °C (cyclohexane/EtOAc); IR 2931, 
1722, 1688 (C=O), 1675 (C=O), 1627, 1582, 1329, 1220, 1136, 1036, 996, 785, 744 cm−1; 
1H NMR (400 MHz, CDCl3) δ 8.70 (1H, ddd, J = 4.8, 1.7, 0.9 Hz, ArH), 8.11 (1H, dt, J = 
7.9, 1.0 Hz, ArH), 7.85 (1H, td, J = 7.7, 1.7 Hz, ArH), 7.57 (1H, dt, J = 15.7, 1.5 Hz, 
CH2CH=CH), 7.47 (1H, ddd, J = 7.6, 4.8, 1.2 Hz, ArH), 7.13 (1H, dt, J = 15.7, 6.7 Hz, 
CH2CH=), 2.69 (4H, app t, J = 6.6 Hz, CH2CH2CH2), 2.25-2.16 (2H, m, CH2CH=), 2.09-
2.02 (2H, m, CH2CH2CH=), 2.01-1.89 (2H, m, CH2CH2CH2), 1.31 (3H, s, CH3); 13C NMR 
(100.6 MHz, CDCl3) δ 209.9 (2 x C), 189.3 (C), 154.0 (C), 148.8 (CH), 148.0 (CH), 137.0 
(CH), 126.8 (CH), 125.0 (CH), 122.9 (CH), 65.0 (C), 38.0 (2 x CH2), 34.5 (CH2), 28.1 
(CH2), 20.5 (CH3), 17.6 (CH2); HRMS (ESI) Exact mass calculated for C17H19NNaO3 
[M+Na]+: 308.1257, found: 308.1245. 
 
2-[(E)-5-(4-Chlorophenyl)-5-oxopent-3-enyl]-2-
methylcyclopentane-1,3-dione (341). The title compound was 






methyl-2,5-dioxocyclopentyl)propanal (673 mg, 4.00 mmol) and 1-(4-chlorophenyl)-2-
(triphenylphosphoranylidene)ethanone (1.99 g, 4.80 mmol). Purification by column 
chromatography (7:3 Petroleum ether/EtOAc) gave a white solid (943 mg, 77%). Rf = 0.25 
(70:30 hexane/EtOAc); m.p. 76-78 °C; IR (film) 2924, 1723 (C=O), 1671 (C=O), 1621, 
1454, 1421, 1265, 1093, 739, 704 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.87-7.83 (2H, dm, J 
= 8.5 Hz, ArH), 7.46-7.43 (2H, dm, J = 8.5 Hz, ArH), 6.90 (1H, dt, J = 15.4, 1.5 Hz, 
CH2CH=), 6.79 (1H, d, J = 15.4 Hz, =CHC=O), 2.90-2.69 (4H, m, O=CCH2CH2C=O), 2.25-
2.20 (2H, m, CH2CH=), 1.89-1.86 (2H, m,  CH2CH2C=), 1.18 (3H, s, CH3); 13C NMR (125.8 
MHz, CDCl3) δ 215.8 (2 × C), 189.0 (C), 147.8 (CH), 139.3 (C), 135.9 (C), 129.9 (2 × CH), 
128.9 (2 × CH), 126.1 (CH), 56.1 (C), 35.0 (2 × CH2), 32.7 (CH2), 27.8 (CH2), 20.0 (CH3); 
HRMS (ESI) Exact mass calcd for C17H18O3Cl [M+H]+: 305.0939, found: 305.0942. 
 
2-[(E)-5-(4-Methoxyphenyl)-5-oxopent-3-enyl]-2-
methylcyclopentane-1,3-dione (340). The title compound 
was prepared according to the Representative Procedure from 
3-(1-methyl-2,5-dioxocyclopentyl)propanal (1.68 g, 10.0 mmol) and 1-(4-methoxyphenyl)-
2-(triphenylphosphoranylidene)ethanone (4.92 g, 12.0 mmol). Purification by column 
chromatography (4:1 CH2Cl2/hexane) gave an orange solid (2.75 g, 91%). Rf = 0.75 (1:1 
hexane/EtOAc); m.p. 88-90 °C; IR (film) 2931, 1719 (C=O), 1660 (C=O), 1587, 1417, 1338, 
1257, 1224, 1026, 974 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.92 (2H, d, J = 8.8 Hz, ArH), 
6.95 (2H, d, J = 8.8 Hz, ArH), 6.86-6.85 (2H, m, CH2CH=CH), 3.88 (3H, s, OCH3), 2.83-
2.74 (4H, m, O=CCH2CH2C=O), 2.22-2.20 (2H, m, CH2CH=), 1.90-1.87 (2H, m, 
CH2CH2CH=), 1.18 (3H, s, CCH3); 13C NMR (125.8 MHz, CDCl3) δ 215.9 (2 × C), 188.5 
(C), 163.4 (C) 146.1 (CH), 130.8 (2 × CH), 130.4 (C), 126.3 (CH), 113.8 (2 × CH), 56.1 (C), 
55.4 (CH3), 35.0 (2 × CH2), 33.0 (CH2), 27.8 (CH2), 19.8 (CH3); HRMS (EI) Exact mass 









A mixture of diethyl methylmalonate (4.70 mL, 27.6 mmol) and N-methylaniline (2.98 mL, 
27.6 mmol) was heated to 220 °C in a 50 mL round bottomed flask topped with a short path 
distillation head until EtOH stopped distilling over. The mixture solidified upon cooling to 
room temperature. The crude product was washed with H2O (50 mL) and CH2Cl2 (50 mL) 
and dried in vacuo to leave the title compound 349 as a yellow solid (3.12 g, 60%). Rf = 0.85 
(1:1 MeOH/EtOAc); 1H NMR (500 MHz, MeOD) δ 8.06 (1H, dd, J = 7.9, 1.9 Hz, ArH), 
7.64-7.60 (1H, m, ArH), 7.53 (1H, d, J = 8.0 Hz, ArH), 7.32-7.28 (1H, m, ArH), 3.73 (3H, s, 
NCH3), 2.15 (3H, s, CCH3). 




To a solution of 349 (2.50 g, 13.3 mmol) in t-BuOH (30 mL) at room temperature was added 
acrolein (1.34 mL, 19.9 mmol) and Et3N (2.21 mL, 15.9 mmol) in one portion and the 
resulting mixture was stirred for 18 h. The mixture was concentrated in vacuo to leave the 
title compound 808 as a colorless oil (3.02 g, 92%), which was used in the next step without 
further purification. Rf = 0.11 (7:3 hexane/EtOAc); IR 2976, 2941, 1721 (C=O), 1694 (C=O), 
1655 (C=O), 1603, 1471, 1375, 1348, 1098, 758 cm-1; 1H NMR (500 MHz, CDCl3) δ 9.69 
(1H, t, J = 1.2 Hz, CH=O), 8.01 (1H, dd, J = 7.7, 1.7 Hz, ArH), 7.66 (1H, td, J = 7.3, 1.8 Hz, 
ArH) 7.72-7.18 (2H, m, ArH), 3.48 (3H, s, NCH3), 2.42-2.29 (4H, m, CH2CH2), 1.49 (3H, s, 
CCH3); 13C NMR (125.8 MHz, CDCl3) δ 200.9 (CH), 196.7 (C), 173.0 (C), 143.0 (C), 136.2 
(CH), 128.2 (CH), 123.3 (CH), 120.0 (C), 114.8 (CH), 56.4 (C), 39.6 (CH2), 29.8 (CH3), 







The title compound was prepared according to the 
Representative Procedure from the aldehyde 808 (1.61 g, 
6.55 mmol) and 1-(4-chlorophenyl)-2-(triphenylphosphoranylidene)ethanone (3.26 g, 7.86 
mmol). Purification by column chromatography (4:1 hexane/EtOAc) gave a pale yellow oil 
(1.35 g, 54%). Rf = 0.26 (4:1 hexane/EtOAc); IR 2923, 1694 (C=O), 1659 (C=O), 1618, 
1601, 1587, 1472, 1348, 1092, 756 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.03 (1H, dd, J = 
7.9, 1.7 Hz, ArH), 7.75 (2H, dt, J = 8.7, 2.4 Hz, ArH), 7.62 (1H, ddd, J = 8.5, 7.4, 1.8 Hz 
ArH), 7.39 (2H, dt, J = 8.7, 2.4 Hz, ArH), 7.19 (1H, td, J = 7.7, 0.8 Hz, ArH), 7.13 (1H, d, J 
= 8.3 Hz, ArH), 6.92 (1H, dt, J = 15.4, 6.6 Hz, CH2CH=), 6.67 (1H, dt, J = 15.4, 1.3 Hz, 
=CHC=O), 3.46 (3H, s, NCH3), 2.30-2.21 (4H, m, CH2CH2), 1.49 (3H, s, CCH3); 13C NMR 
(125.8 MHz, CDCl3) δ 196.9 (C), 189.0 (C), 173.2 (C), 148.6 (CH), 143.1 (C), 139.0 (C), 
136.2 (CH), 136.0 (C), 129.8 (2 × CH), 128.8 (2 × CH), 128.1 (CH), 125.8 (CH), 123.2 
(CH), 120.0 (C), 114.8 (CH), 56.7 (C), 35.9 (CH2), 29.8 (CH3), 28.7 (CH2), 25.0 (CH3); 
HRMS (EI) Exact mass calcd for C22H20O3ClN [M]+: 381.1126, found: 381.1130. 
 
6.1.4. Copper-Catalysed Borylative Aldol Cyclisations 




A solution of CuCl (1.5 mg, 0.015 mmol), ligand L09 (11 mg, 0.017 mmol), B2(pin)2 (84 
mg, 0.33 mmol) and NaOt-Bu (2.2 mg, 0.023 mmol) in THF (4 mL) was stirred at room 
temperature for 30 min. A solution of enone 291 (85 mg, 0.30 mmol) in THF (2 mL) was 
added via cannula, followed by i-PrOH (46 µL, 0.60 mmol) and the resulting mixture was 
 
stirred at room temperature for 18 h. The reaction mixture was quenched with 50:50 10% 
HCl (aq.)/MeOH (0.2 mL) then neutralized with sat. NaHCO3 (aq.) (0.2 mL), diluted with 
H2O (15 mL) and extracted with CH2Cl2 (3 × 15 mL). The combined organic phases were 
dried (Na2SO4), filtered, and concentrated in vacuo. The resultant crude product was purified 
by column chromatography (9:1 hexane/EtOAc) to give the title compound 292 as a 
colorless glassy film (88 mg, 71%) as a >95:5 ratio of diastereomers. Rf = 0.25 (4:1 
hexane/EtOAc); [α] 20D +7.1 (c 0.70, CHCl3); IR 3456 (OH), 2930, 1705 (C=O), 1653 (C=O), 
1449, 1371, 1325, 1219, 1142, 1009, 851, 708 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.06 (2H, 
dd, J = 8.4, 1.1 Hz, ArH), 7.59 (1H, t, J = 7.4 Hz, ArH), 7.47 (2H, t, J = 7.8 Hz, ArH), 4.83 
(1H, s, OH), 3.59 (1H, d, J = 12.0 Hz, CHCOPh), 2.66-2.56 (1H, m, O=CCH2), 2.27 (1H, 
dd, J = 15.4, 5.3 Hz, O=CCH2), 2.14 (1H, ddd, J = 14.4, 14.3, 5.2 Hz, O=CCH2CH2CH2), 
2.06-1.99 (1H, m, C(CH3)CH2), 1.89-1.79 (1H, m, BCH), 1.71-1.47 (4H, m, 
O=CCH2CH2CH2, C(CH3)CH2, O=CCH2CH2), 1.39-1.31 (1H, m, BCHCH2), 1.30-1.19 (1H, 
m, BCHCH2), 1.23 (3H, s, C(CH3)CH2), 0.89 (6H, s, C(CH3)2), 0.86 (6H, s, C(CH3)2); 13C 
NMR (125.8 MHz, CDCl3) δ 213.9 (C), 207.5 (C), 137.4 (C), 133.8 (CH), 129.4 (CH), 128.4 
(CH), 83.2 (2 × C), 75.3 (C), 54.6 (C), 47.2 (CH), 36.4 (CH2), 32.3 (CH2), 29.6 (CH2), 24.4 
(CH3), 24.3 (CH2), 23.8 (CH3), 22.9 (CH3), 19.2 (CH2), tertiary carbon (CH) next to boron 
not observed due to quadrupolar coupling effects of 11B; HRMS (ESI) Exact mass calcd for 
C24H34O510B [M+H]+: 412.2530, found: 412.2538; Enantiomeric excess was determined by 
HPLC with a CHIRALPAK IA-3 column (95:5 hexane:i-PrOH, 2.0 mL/min, 254 nm, 25 




decahydronaphthalen-1-one (356). The title compound was prepared 
according to the Representative Procedure from enone 334 (96 mg, 0.30 
mmol). Purification by column chromatography (9:1 hexane/EtOAc) 
gave a white solid (97 mg, 74%) as a >95:5 ratio of diastereomers. Rf  0.25 (4:1 
hexane/EtOAc); m.p. 163-165 °C; [α] 20D  +17.3 (c 0.52, CHCl3); IR 3460 (OH), 2945, 1703 
(C=O), 1661 (C=O), 1585, 1371, 1219, 1143, 1091, 851 cm-1; 1H NMR (500 MHz, CDCl3) δ 
8.01 (2H, d, J = 8.5 Hz, ArH), 7.45 (2H, d, J = 8.5 Hz, ArH), 4.51 (1H, s, OH), 3.52 (1H, d, 
J = 12.0 Hz, CHCOAr), 2.65-2.57 (1H, m, O=CCH2), 2.27 (1H, dd, J = 15.5, 5.2 Hz,  








C(CH3)CH2), 1.85 (1H, ddd, J = 12.7, 12.6, 3.6 Hz, BCH), 1.69-1.55 (4H, m, C(CH3)CH2, 
O=CCH2CH2, BCHCH2), 1.53-1.40 (1H, m, O=CCH2CH2), 1.33-1.25 (1H, m, 
O=CCH2CH2CH2), 1.25 (3H, s, C(CH3)CH2), 0.95 (6H, s, C(CH3)2), 0.89 (6H, s, C(CH3)2); 
13C NMR (125.8 MHz, CDCl3) δ 213.8 (C), 206.4 (C), 140.3 (C) 136.0 (C), 130.8 (2 × CH), 
128.6 (2 × CH), 83.4 (2 × C), 75.3 (C), 54.6 (C), 47.4 (CH), 36.4 (CH2), 32.3 (CH2), 29.6 
(CH2), 24.41 (2 × CH3), 24.35 (2 × CH3), 23.7 (CH2), 22.9 (CH3), 19.3 (CH2), tertiary carbon 
(CH) next to boron not observed due to quadrupolar coupling effects of 11B; HRMS (ESI) 
Exact mass calcd for C24H33O510BCl [M+H]+: 446.2140, found: 446.2142; Enantiomeric 
excess was determined by HPLC with a CHIRALPAK IA-3 column (98:2 hexane:EtOH, 1.0 
mL/min, 254 nm, 25 °C); tr (major) = 9.5 min, tr (minor) = 11.2 min; 94% ee. 
Gram-scale experiment: A solution of CuCl (15.6 mg, 0.16 mmol), ligand L09 (111 mg, 
0.17 mmol), B2(pin)2 (879 mg, 3.45 mmol) and NaOt-Bu (22.7 mg, 0.24 mmol) in THF (40 
mL) was stirred at room temperature for 30 min. A solution of enone 334 (1.00 g, 3.15 
mmol) in THF (20 mL) was added via cannula, followed by i-PrOH (484 µL, 6.30 mmol) 
and the resulting mixture was stirred at room temperature for 18 h. The reaction mixture was 
quenched with 50:50 10% HCl (aq.)/MeOH (22 mL) then neutralized with sat. NaHCO3 
(aq.) (2 mL), diluted with H2O (80 mL) and extracted with CH2Cl2 (3 × 100 mL). The 
combined organic phases were dried (Na2SO4), filtered and concentrated in vacuo. 
Purification by column chromatography on (9:1 hexane/EtOAc) gave a white solid (1.06 g, 
77%) as a >95:5 ratio of diastereomers. Enantiomeric excess was determined by HPLC with 
a CHIRALPAK IA-3 column (98:2 hexane:EtOH, 1.0 mL/min, 254 nm, 25 °C); tr (major) = 




yl)-decahydronaphthalen-1-one (357). The title compound was 
prepared according to a slight modification of the Representative 
Procedure from enone 330 (94 mg, 0.30 mmol) and t-BuOH  (10 M in 
THF, 60 µL, 0.60 mmol) in place of i-PrOH. Purification by column chromatography (9:1 
hexane/EtOAc) gave a white solid (109 mg, 82%) as a >95:5 ratio of diastereomers. Rf = 
0.44 (3:2 hexane/EtOAc); m.p. 188-190 °C; [α] 20D  +16.4 (c 0.61, CHCl3); IR 3429 (OH), 
2980, 2930, 1738 (C=O), 1694 (C=O), 1454, 1371, 1323, 1142, 847, 741 cm-1; 1H NMR 








3.89 (3H, s, OCH3), 3.52 (1H, d, J = 12.0 Hz, CHCOAr), 2.67-2.56 (1H, m, O=CCH2), 2.28 
(1H, dd, J = 15.4, 5.2 Hz, O=CCH2CH2CH2), 2.14 (1H, td, J = 14.4, 5.1 Hz, O=CCH2), 2.05-
1.99 (1H, m, C(CH3)CH2), 1.88-1.79 (1H, m, BCH), 1.71-1.49 (5H, m, C(CH3)CH2, 
O=CCH2CH2, BCHCH2, O=CCH2CH2CH2), 1.41-1.36 (1H, m, BCHCH2), 1.24 (3H, s, 
C(CH3)CH2), 0.91 (6H, s, C(CH3)2), 0.88 (6H, s, C(CH3)2); 13C NMR (125.8 MHz, CDCl3) δ 
214.1 (C), 205.6 (C), 164.3 (C), 131.9 (CH), 130.4 (C), 113.5 (C), 83.2 (2 × C), 75.3 (C), 
55.6 (CH3), 54.6 (C), 46.7 (CH), 36.5 (CH2), 32.3 (CH2), 29.6 (CH2), 24.4 (2 × CH3), 24.3 (2 
× CH3), 23.8 (CH2), 22.9 (CH3), 19.4 (CH2), tertiary carbon (CH) next to boron not observed 
due to quadrupolar coupling effects of 11B; HRMS (ESI) Exact mass calcd for C25H36O610B 
[M+H]+: 442.2636, found: 442.2638; Enantiomeric excess was determined by HPLC with a 
CHIRALPAK IA-3 column (98:2 hexane:EtOH, 1.0 mL/min, 254 nm, 25 °C); tr (major) = 
14.7 min, tr (minor) = 16.4 min; >99% ee. 
 
(4aS,5S,6R,8aR)-5-Benzoyl-4a-hydroxy-8a-(prop-2-en-1-yl)-6-(4,4,5,5-
tetramethyl-1,3-dioxolan-2-yl)-decahydronaphthalen-1-one (360). The 
title compound was prepared according to the Representative Procedure 
from enone 346 (93 mg, 0.30 mmol). Purification by column 
chromatography (9:1 hexane/EtOAc) gave a pale yellow solid (92 mg, 
70%) as a >95:5 ratio of diastereomers. Rf = 0.59 (3:2 hexane/EtOAc); m.p. 115-120 °C; [α]
20
D  +3.8 (c 0.53, CHCl3); IR 3460 (OH), 2936, 1705 (C=O), 1657 (C=O), 1371, 1327, 1221, 
1140, 920, 849, 716 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.07 (2H, dd, J = 8.3, 1.1 Hz, ArH), 
7.56 (1H, t, J = 7.4 Hz, ArH), 7.46 (2H, t, J = 7.8 Hz, ArH), 5.52 (1H, ddt, J = 17.4, 10.0, 
7.4 Hz, CH=CH2), 5.09-4.99 (2H, m, =CH2), 4.67 (1H, br s, OH), 3.61 (1H, d, J = 12.0 Hz, 
CHCOPh), 2.70 (1H, dd, J = 14.4, 7.6 Hz, O=CCH2), 2.59-2.41 (2H, m, CH2CH=), 2.31 
(1H, dd, J = 15.0, 5.1 Hz, O=CCH2), 2.23-2.12 (2H, m, O=CCH2CH2CH2, CH2CH2CHB), 
1.84 (1H, td, J = 12.2, 3.8 Hz, BCH), 1.71-1.48 (4H, m, O=CCH2CH2CH2, CH2CH2CHB, 
O=CCH2CH2), 1.40-1.33 (1H, m, BCHCH2), 1.32-1.20 (1H, m, BCHCH2), 0.90 (6H, s, 
C(CH3)2), 0.86 (6H, s, C(CH3)2); 13C NMR (125.8 MHz, CDCl3) δ 212.2 (C). 207.4 (C), 
137.4 (C), 133.9 (CH), 132.7 (CH), 129.4 (2 × CH), 128.4 (2 × CH), 118.1 (CH2), 83.3 (2 × 
C), 75.7 (C), 58.2 (C), 47.3 (CH), 39.3 (CH2), 37.7 (CH2), 32.1 (CH2), 26.8 (CH2), 24.35 (2 × 
CH3), 24.32 (2 × CH3), 23.6 (CH2), 19.5 (CH2), tertiary carbon (CH) next to boron not 
observed due to quadrupolar coupling effects of 11B; HRMS (ESI) Exact mass calcd for 






HPLC with a CHIRALPAK IA-3 column (90:10 hexane:i-PrOH, 1.5 mL/min, 254 nm, 25 




(359). The title compound was prepared according to the Representative 
Procedure from enone 336 (103 mg, 0.30 mmol). Purification by column 
chromatography (9:1 hexane/EtOAc) gave a colorless film (73 mg, 52%) as a >95:5 ratio of 
diastereomers. Rf = 0.38 (3:2 hexane/EtOAc); [α]
20
D  +25.5 (c 0.47, CHCl3); IR  3442 (OH), 
2974, 2930, 1701 (C=O), 1373, 1319, 1144, 1092, 849, 735 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.34-7.23 (5H, m, ArH), 4.47 (1H, d, J = 11.2 Hz, CH2Ph), 4.41 (1H, d, J = 11.2 
Hz, CH2Ph), 3.99 (1H, ddd, J = 10.9, 8.8, 3.1 Hz, CH2OBn), 3.66 (1H, dt, J = 8.5, 4.1 Hz, 
CH2OBn), 3.32 (1H, ddd, J = 12.4, 8.8, 4.0 Hz, CH2CH2OBn), 3.28 (1H, d, J = 12.7 Hz, 
O=CCHCHB), 3.18 (1H, br s, OH), 2.49 (1H, td, J = 14.3, 6.9 Hz, O=CCH2CH2CH2), 2.39 
(1H, dt, J = 7.4, 3.5 Hz, CH2CH2OBn), 2.21 (1H, td, J = 14.1, 4.6 Hz, O=CCH2CH2CH2), 
2.15-2.08 (1H, m, O=CCH2CH2CH2), 1.91 (1H, td, J = 13.2, 4.3 Hz, C(CH3)CH2), 1.71-1.65 
(1H, m, BCHCH2), 1.64-1.56 (1H, m, BCH), 1.55-1.48 (1H, m, O=CCH2CH2CH2), 1.46-
1.34 (2H, m, BCHCH2, O=CCH2CH2CH2), 1.34-1.26 (2H, m, C(CH3)CH2, 
O=CCH2CH2CH2), 1.23 (3H, s, C(CH3)CH2), 1.19 (6H, s, C(CH3)2), 1.13 (6H, s, C(CH3)2); 
13C NMR (125.8 MHz, CDCl3) δ 215.0 (C), 214.9 (C), 136.8 (C), 128.6 (CH), 128.3 (CH), 
128.1 (CH), 83.3 (2 × C), 78.3 (C), 73.9 (CH2), 67.5 (CH2), 58.7 (CH), 55.0 (C), 44.8 (CH2), 
36.7 (CH2), 35.4 (CH2), 27.7 (CH2), 24.7 (2 × CH3), 24.3 (2 × CH3), 21.5 (CH2), 19.5 (CH2), 
14.4 (CH3), tertiary carbon (CH) next to boron not observed due to quadrupolar coupling 
effects of 11B; HRMS (ESI) Exact mass calcd for C27H40O610B [M+H]+: 470.2949, found: 
470.2940; Enantiomeric excess was determined by HPLC with a CHIRALPAK IA-3 column 
(90:10 hexane:i-PrOH, 1.5 mL/min, 254 nm, 25 °C); tr (major) = 7.5 min, tr (minor) = 10.0 




The title compound was prepared according to the Representative 
Procedure from enone 361 (94 mg, 0.30 mmol). Purification by column 












diastereomers. Rf = 0.86 (3:2 hexane/EtOAc); [α]
20
D  −25.5 (c 0.51, CHCl3); IR 3478 (OH), 
1730 (C=O), 1703 (C=O), 1454, 1379, 1321, 1142, 968, 847, 696 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.39-7.30 (5H, m, ArH), 5.26 (1H, d, J = 12.4 Hz, CH2Ph), 5.11 (1H, d, J = 12.4 
Hz, CH2Ph), 3.27 (1H, br s, OH), 2.99 (1H, d, J = 12.4 Hz, CHCO2Bn), 2.57 (1H, td, J = 
14.3, 6.7 Hz, O=CCH2), 2.31-2.22 (1H, m, O=CCH2), 2.04 (1H, qt, J = 13.7, 4.3 Hz, 
O=CCH2CH2), 1.94 (1H, ddd, J = 12.8, 12.6. 4.1 Hz, C(CH3)CH2), 1.82-1.74 (1H, m, 
O=CCH2CH2), 1.73-1.67 (1H, m C(CH3)CH2), 1.62-1.43 (3H, BCHCH2, BCH, 
O=CCH2CH2CH2), 1.40-1.34 (1H, m, BCHCH2), 1.23 (3H, s, C(CH3)CH2), 1.21-1.16 (1H, 
m, O=CCH2CH2CH2), 1.18 (6H, s, C(CH3)2), 1.13 (6H, s, C(CH3)2); 13C NMR (125.8 MHz, 
CDCl3) δ 214.4 (C), 174.3 (C), 135.2 (C), 128.6 (2 × CH), 128.5 (CH), 128.2 (2 × CH), 83.3 
(2 × C), 76.9 (C), 66.9 (CH2), 54.4 (C), 50.4 (CH), 36.8 (CH2), 35.1 (CH2), 28.6 (CH2), 24.7 
(2 × CH3), 24.3 (2 × CH3), 21.6 (CH2), 19.9 (CH2), 14.9 (CH3), tertiary carbon (CH) next to 
boron not observed due to quadrupolar coupling effects of 11B; HRMS (ESI) Exact mass 
calcd for C25H36O610B [M+H]+: 442.2636, found: 442.2637; Enantiomeric excess was 
determined by HPLC with a CHIRALPAK IA-3 column (90:10 hexane:i-PrOH, 1.2 mL/min, 




decahydronaphthalen-1-one (809a) and (4aS,5S,6R,8aS)-4a-
Hydroxy-8a-methyl-5-[(4-nitrophenyl)carbonyl]-6-(tetramethyl-
1,3,2-dioxaborolan-2-yl)-decahydronaphthalen-1-one (809b). The 
title compounds 809a and 809b were prepared according to the 
Representative Procedure from enone 351 (99 mg, 0.30 mmol). 
Purification by column chromatography (9:1 hexane/EtOAc) gave 
809a as a yellow solid (67 mg, 49%) and 809b as an off-white solid 
(40 mg, 29%). 
Data for 809a: Rf = 0.32 (3:2 hexane/EtOAc); m.p. 198-200 °C; [α]
20
D  +12.2 (c 0.49, 
CHCl3); IR 3460 (OH), 2949, 1705 (C=O), 1655 (C=O), 1447, 1371, 1327, 1221, 1142, 920, 
851 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.30-8.26 (2H, m, ArH), 8.14-8.10 (2H, m, ArH), 
4.03 (1H, d, J = 12.5 Hz, CHCOAr), 2.68 (1H, td, J = 14.4, 6.7 Hz, O=CCH2), 2.48 (1H, td, 
J = 14.4, 4.6 Hz, O=CCH2CH2CH2), 2.30-2.23 (1H, m, O=CCH2), 2.10 (1H, td, J = 13.2, 4.3 
Hz, C(CH3)CH2), 1.97-1.71 (4H, m, BCH, C(CH3)CH2, O=CCH2CH2), 1.62-1.42 (3H, m, 
 
BCHCH2, O=CCH2CH2CH2), 1.37 (3H, s, C(CH3)CH2), 1.10 (6H, s, C(CH3)2), 1.00 (6H, s, 
C(CH3)2); 13C NMR (125.8 MHz, CDCl3) δ 214.0 (C), 203.7 (C), 149.7 (C), 144.7 (C), 129.5 
(2 × CH), 123.4 (2 × CH), 83.6 (2 × C), 78.8 (C), 55.6 (C), 52.4 (CH), 36.6 (CH2), 35.6 
(CH2), 27.8 (CH2), 24.7 (2 × CH3), 24.2 (2 × CH3), 21.6 (CH2), 20.1 (CH2), 14.4 (CH3), 
tertiary carbon (CH) next to boron not observed due to quadrupolar coupling effects of 11B; 
HRMS (ESI) Exact mass calcd for C24H33O710BN [M+H]+: 457.2381, found: 457.2381; 
Enantiomeric excess was determined by HPLC with a CHIRALPAK IA-3 column (90:10 
hexane:i-PrOH, 1.5 mL/min, 254 nm, 25 °C); tr (major) = 7.2 min, tr (minor) = 21.1 min; 
86% ee. 
Data for 809b: Rf = 0.45 (3:2 hexane/EtOAc); m.p. 168-170 °C; [α]
20
D  −5.8 (c 0.52, CHCl3); 
IR 3418 (OH), 2974, 2929, 1734 (C=O), 1653 (C=O), 1449, 1371, 1325, 1225, 1142, 847 
cm-1; 1H NMR (500 MHz, CDCl3) δ 8.32 (2H, dd, J = 9.0, 2.0 Hz, ArH), 8.23 (2H, dd, J = 
9.0, 2.0 Hz, ArH), 4.01 (1H, br s, OH), 3.58 (1H, d, J = 12.0 Hz, CHCOAr), 2.61 (1H, ddd, 
J = 15.2, 13.9, 7.9 Hz, O=CCH2), 2.27 (1H, dd, J = 15.4, 5.3 Hz, O=CCH2), 2.17 (1H, dt, J = 
14.5, 5.0 Hz, O=CCH2CH2CH2), 2.09-2.01 (1H, m, C(CH3)CH2), 1.89 (1H, ddd, J = 12.6, 
12.4, 3.2 Hz, BCH), 1.75-1.54 (4H, m, C(CH3)CH2, O=CCH2CH2, BCHCH2), 1.46-1.31 
(1H, m, O=CCH2CH2), 1.29-1.19 (1H, m, O=CCH2CH2CH2), 1.24 (3H, s, C(CH3)CH2), 0.98 
(6H, s, C(CH3)2), 0.89 (6H, s, C(CH3)2); 13C NMR (125.8 MHz, CDCl3) δ 213.4 (C), 206.5 
(C),  150.5 (C), 142.4 (C), 130.2 (2 × CH),  123.5 (2 × CH), 83.6 (2 × C), 75.5 (C), 54.7 (C),  
48.4 (CH), 36.3 (CH2), 32.4 (CH2), 29.6 (CH2), 24.6 (2 × CH3), 24.3 (2 × CH3), 23.6 (CH2), 
22.9 (CH3), 19.2 (CH2), tertiary carbon (CH) next to boron not observed due to quadrupolar 
coupling effects of 11B;  HRMS (ESI) Exact mass calcd for C24H33O710BN [M+H]+: 
457.2381, found: 457.2380; Enantiomeric excess was determined by HPLC with a 
CHIRALPAK IA-3 column (90:10 hexane:i-PrOH, 1.5 mL/min, 254 nm, 25 °C); tr (major) = 




dioxaborolan-2-yl)-decahydronaphthalen-1-one (810a) and 
(4aS,5S,6R,8aS)-4a-Hydroxy-8a-methyl-5-[(3-
trifluoromethylphenyl)carbonyl]-6-(tetramethyl-1,3,2-
dioxaborolan-2-yl)-decahydronaphthalen-1-one (810b). The title 
compounds 810a and 810b were prepared according to the 
 
Representative Procedure from enone 332 (106 mg, 0.30 mmol). Purification by column 
chromatography (9:1 hexane/EtOAc) gave 810a as a colorless film (22 mg, 15%) and 810b 
as a colorless film (86 mg, 60%). 
Data for 810a: Rf = 0.29 (3:2 hexane/EtOAc); [α]
20
D  +2.0 (c 1.0, CHCl3); 
1H NMR (500 
MHz, CDCl3) δ 8.23 (1H, s, ArH), 8.18 (1H, d, J = 6.7 Hz, ArH), 7.78 (1H, d, J = 8.7 Hz, 
ArH), 7.59 (1H, t, J = 6.7 Hz, ArH), 4.04 (1H, d, J = 12.6 Hz, CHCOAr), 2.67 (1H, dt, J = 
14.2, 6.7 Hz, O=CCH2), 2.49 (1H, dt, J = 14.2, 5.1 Hz, O=CCH2CH2CH2), 2.27 (1H, td, J = 
14.7, 2.2 Hz, O=CCH2), 2.11 (1H, dt, J = 13.6, 4.6 Hz, C(CH3)CH2), 1.93-1.87 (1H, m, 
O=CCH2CH2), 1.85-1.77 (2H, m, O=CCH2CH2, BCHCH2), 1.62-1.53 (2H, m, BCHCH2, 
O=CCH2CH2CH2), 1.48-1.44 (1H, m, O=CCH2CH2CH2), 1.39 (3H, s, C(CH3)CH2), 1.09 
(6H, s, C(CH3)2), 0.99 (6H, s, C(CH3)2); 13C NMR (125.8 MHz, CDCl3) δ 214.2 (C), 203.6 
(C), 140.6 (C), 132.0 (CH), 130.7 (C, q, 2JCF = 33.5 Hz), 128.8 (CH), 128.7 (CH, q, 3JCF = 
3.4 Hz), 125.3 (CH, q, 3JCF = 3.5 Hz), 123.9 (C, q, 1JCF = 275.5 Hz), 83.6 (2 × C), 78.7 (C), 
55.5 (C), 51.9 (CH), 36.7 (CH2), 35.6 (CH2), 27.9 (CH2), 24.6 (2 × CH3), 24.1 (2 × CH2), 
21.7 (CH2), 20.1 (CH3), 14.4 (CH2), tertiary carbon (CH) next to boron not observed due to 
quadrupolar coupling effects of 11B; 19F NMR (376 MHz, CDCl3) δ −75.5 (3F, s); m/z (ESI) 
503 ([M+Na]+, 50), 481 ([M+H]+, 45); Enantiomeric excess was determined by HPLC with a 
CHIRALPAK IA-3 column (90:10 hexane:i-PrOH, 1.5 mL/min, 254 nm, 25 °C); tr (major) = 
4.3 min, tr (minor) = 8.0 min; 82% ee. 
Data for 810b: Rf = 0.49 (3:2 hexane/EtOAc); [α]
20
D  +5.9 (c 0.51, CHCl3); IR 3443 (OH), 
2976, 2936, 1705 (C=O), 1659 (C=O), 1371, 1323, 1211, 1167, 1142, 1072, 999, 851 cm-1; 
1H NMR (500 MHz, CDCl3) δ 8.32 (1H, s, ArH), 8.23 (1H, d, J = 7.9 Hz, ArH), 7.85 (1H, d, 
J = 7.8 Hz, ArH), 7.62 (1H, t, J = 7.8 Hz, ArH), 4.31 (1H, br s, OH), 3.58 (1H, d, J = 12.0 
Hz, CHCOAr), 2.61 (1H, ddd, J = 15.2, 13.9, 7.9 Hz, O=CCH2), 2.29 (1H, dd, J = 15.4, 5.3 
Hz, O=CCH2CH2CH2), 2.16 (1H, td, J = 14.5, 5.0 Hz, O=CCH2), 2.08-2.01 (1H, m, 
C(CH3)CH2), 1.87 (1H, ddd, J = 12.7, 12.5, 2.7 Hz, C(CH3)CH2), 1.72-1.54 (4H, m, BCH, 
O=CCH2CH2, BCHCH2, O=CCH2CH2CH2), 1.50-1.37 (1H, m, BCHCH2), 1.31-1.25 (1H, 
m, O=CCH2CH2), 1.24 (3H, s, C(CH3)CH2), 0.95 (6H, s, C(CH3)2), 0.86 (6H, s, C(CH3)2); 
13C NMR (125.8 MHz, CDCl3) δ 213.7 (C), 206.6 (C), 138.4 (C), 132.3 (CH), 131.1 (C, q, 
2JCF = 33.0 Hz), 129.9 (CH, q, 3JCF = 3.6 Hz), 129.0 (CH), 126.2 (CH, q, 3JCF = 3.7 Hz), 
123.6 (C, q, 1JCF 272.6 Hz), 83.4 (2 × C), 75.4 (C), 54.6 (C), 47.7 (CH), 36.3 (CH2), 32.4 
(CH2), 29.6 (CH2), 24.4 (2 × CH3), 24.2 (2 × CH2), 23.6 (CH2), 22.9 (CH3), 19.2 (CH2), 
tertiary carbon (CH) next to boron not observed due to quadrupolar coupling effects of 11B; 
 
19F NMR (376 MHz, CDCl3) δ −63.7 (3F, s); HRMS (EI) Exact mass calcd for 
C25H32O510BF3 [M]+: 480.2404, found: 480.2404; Enantiomeric excess was determined by 
HPLC with a CHIRALPAK IA-3 column (98:2 hexane:EtOH, 1.0 mL/min, 254 nm, 25 °C); 




decahydronaphthalen-1-one (811a)  and (4aS,5S,6R,8aS)-4a-Hydroxy-
8a-methyl-5-[(2-bromophenyl)carbonyl]-6-(tetramethyl-1,3,2-
dioxaborolan-2-yl)-decahydronaphthalen-1-one (811b). The title 
compounds 811a and 811b were prepared according to the Representative 
Procedure  from enone 333 (109 mg, 0.30 mmol). Purification by column 
chromatography (9:1 hexane/EtOAc) gave 811a as an off-white solid (70 
mg, 48%) and 811b as an off-white solid (62 mg, 42%). 
Data for 811a: Rf = 0.32 (3:2 hexane/EtOAc); m.p. 138-140 °C; [α]
20
D  +12.0 (c 0.50, 
CHCl3); IR 3493 (OH), 2978, 2934, 1699 (C=O), 1678 (C=O), 1377, 1325, 1219, 1142, 
1018, 849, 741 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.74 (1H, dd, J = 7.7, 1.6 Hz, ArH), 7.60 
(1H, dd, J = 8.0, 1.0 Hz, ArH), 7.38 (1H, td, J = 7.6, 1.1 Hz, ArH), 7.26 (1H, td, J = 7.8, 1.7 
Hz, ArH), 3.86 (1H, d, J = 12.3 Hz, CHCOAr), 2.67-2.57 (1H, m, O=CCH2), 2.43 (1H, ddd, 
J = 18.0, 10.0, 4.5 Hz, O=CCH2CH2CH2), 2.26 (1H, ddd, J = 6.0, 4.2, 2.3 Hz, O=CCH2), 
2.05 (1H, ddd, J = 13.3, 13.1, 4.1 Hz, C(CH3)CH2), 1.94-1.76 (5H, m, BCH, O=CCH2CH2, 
BCHCH2, O=CCH2CH2CH2, C(CH3)CH2), 1.53 (1H, ddd, J = 14.5, 14.1, 3.8 Hz, 
O=CCH2CH2), 1.41 (1H, ddd, J = 13.3, 3.9, 2.3 Hz, BCHCH2), 1.25 (3H, s, C(CH3)CH2), 
1.21 (6H, s, C(CH3)2), 1.13 (6H, s, C(CH3)2); 13C NMR (125.8 MHz, CDCl3) δ 214.2 (C), 
206.6 (C), 143.3 (C), 134.2 (CH), 131.3 (CH), 129.3 (CH), 127.1 (CH), 118.6 (C), 83.5 (2 × 
C), 78.9 (C), 56.5 (CH), 55.5 (C), 36.7 (CH2), 35.6 (CH2), 28.1 (CH2), 24.7 (CH3), 24.5 
(CH3), 21.7 (CH2), 19.9 (CH2), 14.4 (CH3), tertiary carbon (CH) next to boron not observed 
due to quadrupolar coupling effects of 11B; HRMS (ESI) Exact mass calcd for 
C24H33O510B79Br [M+H]+: 490.1635, found: 490.1634; Enantiomeric excess was determined 
by HPLC with a CHIRALPAK IA-3 column (90:10 hexane:i-PrOH, 1.5 mL/min, 254 nm, 25 
°C); tr (major) = 8.9 min, tr (minor) = 10.3 min; 68% ee 
 
Data for 811b: Rf = 0.39 (3:2 hexane/EtOAc); m.p. 117-120 °C; [α]
20
D  +2.0 (c 0.51, CHCl3); 
IR 3491 (OH), 2976, 2932, 1703 (C=O), 1661 (C=O), 1373, 1321, 1142, 1007, 851, 737 cm-
1; 1H NMR (500 MHz, CDCl3) δ 8.15 (1H, dd, J = 7.8, 1.6 Hz, ArH), 7.68 (1H, dd, J = 7.9, 
1.1 Hz, ArH), 7.41 (1H, ddd, J = 7.7, 7.6, 1.2 Hz, ArH), 7.33 (1H, ddd, J = 7.7, 7.5, 1.7 Hz, 
ArH), 3.45 (1H, d, J = 12.2 Hz, CHCOAr), 3.27 (1H, br s, OH), 2.55 (1H, ddd, J = 15.2, 
13.9, 7.9 Hz, O=CCH2), 2.17 (2H, m, J = 14.5, 14.4, 4.6 Hz, O=CCH2CH2CH2, O=CCH2), 
2.04-1.98 (1H, m, C(CH3)CH2), 1.92 (1H, ddd, J = 13.0, 12.8, 3.3 Hz, C(CH3)CH2), 1.72-
1.43 (6H, m, BCH, O=CCH2CH2, BCHCH2, O=CCH2CH2CH2), 1.22 (3H, s, C(CH3)CH2), 
1.11 (6H, s, C(CH3)2), 1.03 (6H, s, C(CH3)2); 13C NMR (125.8 MHz, CDCl3) δ 213.8 (C), 
207.1 (C), 139.5 (C), 135.0 (CH), 132.6 (CH), 131.9 (CH), 126.7 (CH), 120.6 (C), 83.5 (2 × 
C), 75.8 (C), 55.1 (C), 51.7 (CH), 36.3 (CH2), 31.9 (CH2), 29.8 (CH2), 24.7 (2 × CH3), 24.5 
(2 × CH3), 23.3 (CH2), 22.9 (CH3), 18.7 (CH2), tertiary carbon (CH) next to boron not 
observed due to quadrupolar coupling effects of 11B; HRMS (ESI) Exact mass calcd for 
C24H33O510B79Br [M+H]+: 490.1635, found: 490.1631; Enantiomeric excess was determined 
by HPLC with a CHIRALPAK IA-3 column (50:50 hexane:EtOH, 1.2 mL/min, 254 nm, 25 
°C); tr (major) = 6.7 min, tr (minor) = 12.7 min; 83% ee. 
 
(3aS,4S,5R,7aS)-4-Benzoyl-3a-hydroxy-7a-ethyl-5-(tetramethyl-1,3,2-
dioxaborolan-2-yl)-octahydro-1H-inden-1-one (389). The title 
compound was prepared according to a slight modification of the 
Representative Procedure from enone 343 (85 mg, 0.30 mmol) and t-
BuOH (10 M in THF, 60 µL, 0.60 mmol) in place of i-PrOH. Purification by column 
chromatography (9:1 → 4:1 hexane/EtOAc) gave a white solid (110 mg, 89%) as a >95:5 
ratio of diastereomers. Rf = 0.24 (4:1 hexane/EtOAc); m.p. 98-100 °C; [α]
20
D  +33.0 (c 2.30, 
CHCl3); IR 3416 (OH), 2974, 2928, 1734 (C=O), 1651 (C=O), 1369, 1325, 1225, 1140, 847 
cm-1; 1H NMR (500 MHz, CDCl3) δ 8.02-7.94 (2H, m, ArH), 7.61 (1H, t, J = 7.4 Hz, ArH), 
7.48 (2H, t, J = 7.8 Hz, ArH), 4.67 (1H, br s, OH), 3.39 (1H, d, J = 12.0 Hz, CHCOPh), 2.48 
(1H, ddd, 16.0, 8.8, 1.2 Hz, O=CCH2), 2.31-2.21 (1H, m, O=CCH2), 2.19-2.10 (2H, m, 
O=CCH2CH2, CH2CH2CHB), 1.79 (1H, dq, J = 15.2, 7.7 Hz, CH2CH3), 1.75-1.69 (1H, m, 
BCHCH2), 1.67-1.60 (2H, m, CH2CH3, BCH), 1.60-1.55 (1H, m, O=CCH2CH2), 1.35-1.20 
(2H, m, CH2CH2CHB, BCHCH2), 0.90 (6H, s, C(CH3)2), 0.84 (6H, s, C(CH3)2), 0.75 (3H, t, 
J = 7.6 Hz, CH2CH3); 13C NMR (125.8 MHz, CDCl3) δ 216.9 (C), 207.2 (C), 138.1 (C), 






34.8 (CH2), 30.8 (CH2), 24.9 (CH2), 24.4 (2 × CH2), 24.34 (2 × CH3), 24.27 (2 × CH3), 7.3 
(CH3), tertiary carbon (CH) next to boron not observed due to quadrupolar coupling effects 
of 11B; HRMS (ESI) Exact mass calcd for C24H34O510B [M+H]+: 412.2530, found: 412.2520; 
Enantiomeric excess was determined by HPLC with a CHIRALPAK IA-3 column (90:10 
hexane:i-PrOH, 1.5 mL/min, 254 nm, 25 °C); tr (major) = 7.3 min, tr (minor) = 12.7 min; 
96% ee. 
6.1.5. C-B Bond Transformations 
(4aS,5S,6R,8aS)-5-[(4-Chlorophenyl)carbonyl]-4a,6-dihydroxy-8a-
methyldecahydronaphthalen-1-one (395)  
 
To a stirred solution of 356 (127 mg, 0.30 mmol) in THF (1 mL) was added a suspension of 
NaBO3·H2O (149 mg, 1.50 mmol) in H2O (1 mL) in one portion and the resulting was 
mixture stirred vigorously at room temperature for 3 h open to air. The reaction mixture was 
then diluted with H2O (5 mL) and extracted with CH2Cl2 (3 × 5 mL). The combined organic 
phases were dried (Na2SO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (1:1 hexane/EtOAc) gave the title compound 395 as a white 
solid (87 mg, 86%). Rf = 0.40 (1:1 hexane/EtOAc); m.p. 180-185 °C; [α]
20
D  −1.7 (c 0.58, 
CHCl3); IR 3406 (OH), 2949, 2938, 1684 (C=O), 1651 (C=O), 1589, 1400, 1325, 1084, 
1026, 833 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.96 (2H, d, J = 8.6 Hz, ArH), 7.47 (2H, d, J 
= 8.6 Hz, ArH), 4.83 (1H, s, OH), 4.37-4.32 (1H, m, CHOH), 3.43 (1H, d, J =10.3 Hz, 
CHCHOH), 2.63-2.55 (1H, m, O=CCH2), 2.27 (1H, dd, J = 15.1, 5.3 Hz, O=CCH2), 2.18-
2.05 (2H, m, CH2CH2CH2, CH2CH2CHOH), 1.94-1.87 (1H, m, CH2CHOH), 1.77-1.67 (3H, 
m, CH2CH2CH2, CH2CH2CHOH), 1.43 (1H, d, J = 14.5 Hz, CH2CH2CH2), 1.39-1.29 (1H, 
m, CH2CH2CH2), 1.23 (3H, s, CH3); 13C NMR (125.8 MHz, CDCl3) δ 213.1 (C), 206.8 (C), 
140.7 (C), 137.0 (C), 130.1 (2 × CH), 129.2 (2 × CH), 78.1 (C), 71.5 (CH), 54.1 (C), 53.8 
(CH), 36.3 (CH2), 32.5 (CH2), 32.2 (CH2), 27.7 (CH2), 21.9 (CH3), 19.4 (CH2); HRMS (ESI) 





To a stirred suspension of 356 (133 mg, 0.30 mmol) in MeOH (1 mL) was added a solution 
of KHF2 (149 g, 1.50 mmol) in H2O (1 mL) in one portion and the resulting mixture was 
stirred vigorously at room temperature for 3 h. The solvent was evaporated in vacuo and the 
white solid obtained was washed with acetone (5 × 15 mL). The combined organic phases 
were dried (Na2SO4), filtered and concentrated in vacuo to give the title compound 396 as a 
white solid (104 mg, 82%). Rf = 0.60 (2:1 MeOH/CH2Cl2); m.p. 210-220 °C; [α]
20
D  +16.3 (c 
0.49, MeOH); IR 3443, 2936, 1703 (C=O), 1665 (C=O), 1587, 1400, 1092, 1031, 959 cm-1; 
1H NMR (500 MHz, CD3OD) δ 8.01 (2H, d, J = 9.3 Hz, ArH), 7.45 (2H, d, J = 9.3 Hz, 
ArH), 3.39 (1H, d, J = 12.0 Hz, CHCOAr), 2.63-2.56 (1H, m, O=CCH2), 2.16-2.06 (2H, m, 
O=CCH2, O=CCH2CH2CH2), 1.92 (1H, d, J = 12.9 Hz, CH2CHB), 1.58-1.48 (3H, m, 
CH2CH2CHB, CH2CH2CH2), 1.45-1.37 (2H, m, CH2CH2CHB, CH2CH2CH2), 1.26 (1H, d, J 
= 16.7 Hz, O=CCH2CH2CH2), 1.15 (s, 3H, CH3); 13C NMR (125.8 MHz, CD3OD) δ 216.5 
(C), 211.0 (C), 140.1 (C), 139.3 (C), 131.5 (2 × CH), 129.6 (2 × CH), 77.0 (C), 56.1 (C), 
50.3 (CH), 37.2 (CH2), 33.3 (CH2), 31.4 (CH2), 24.9 (CH2), 23.8 (CH3), 20.1 (CH2), tertiary 
carbon (CH) next to boron not observed due to quadrupolar coupling effects of 11B; 19F NMR 
(376 MHz, CD3OD) δ 143.5; HRMS (ESI) Exact mass calcd for C18H2010BClF3O3 [M-K+]-: 
386.1188, found: 386.1190. 
 
6.1.6 Stereochemical Determinations and X-ray Structures 
The relative and absolute stereochemistry of product 356o (enantiomerically pure material) 
was determined by X-ray crystallography: 
                                                      
o X-Ray data can be obtained free of charge from The Cambridge Crystallographic Data 






The absolute stereochemistry of all other products was assigned by analogy to 356. 
The relative stereochemistry of product 311ap (racemic material obtained using P(OEt)3 as 




The relative stereochemistries of products 292, 357, 358, 359, 360, 311b, 810a, 810b, 809a 
and 809b were assigned by analogy to the X-ray structures of 356 and 811a and by 
comparison of the 1H NMR spectra (see Figure 1).  
The relative stereochemistry of product 389q (racemic material obtained using P(OEt)3 as an 
achiral ligand) was determined by X-ray crystallography: 
                                                      
p I) X-Ray data can be obtained free of charge from The Cambridge Crystallographic Data 





The relative stereochemistry of the major diastereomers of products 387, 388, 390, 391 and 
392 was assigned by analogy to the X-ray crystal structures of 389 and on the similarity of 
their respective 1H NMR spectra. 
 
6.2. Iridium-Catalysed Arylative Cyclization of 
Alkynones by 1,4-Iridium Migration 
6.2.1. Substrate Precursor Synthesis 
2-Methyl-2-(prop-2-yn-1-yl)cyclopentane-1,3-dione (721) 
 
NaHCO3 (5.89 g, 56.1 mmol) was gradually added to a stirred suspension of 2-methyl-1,3-
cyclopentadione (5.72 g, 51.0 mmol) in H2O (250 mL). After the frothing had finished, 
                                                                                                                                                         
q I) X-Ray data can be obtained free of charge from The Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif150.  
 
propargyl bromide (6.25 mL, 56.1 mmol) was added and the resulting mixture was heated at 
80 °C for 16 h. The reaction was cooled to room temperature and the mixture was extracted 
with CH2Cl2 (3 x 100 mL). The combined organic phases were dried (Na2SO4), filtered, and 
concentrated in vacuo. Purification of the residue by column chromatography (1:1 
hexane:EtOAc) gave the title compound 721 as a white solid (7.1 g, 84%). Rf = 0.15 (40% 
EtOAc/hexane); 1H NMR (400 MHz, CDCl3) δ 2.88-2.80 (4H, m, CH2CH2), 2.49 (2H, d, J = 
2.8 Hz, CCH2C), 2.00 (1H, t, J = 2.8 Hz, C≡CH), 1.15 (3H, s, CH3). 




Propargyl bromide (12.3 mL, 110 mmol) was slowly added to a solution of 2-methyl-1,3-
cyclohexadione (12.6 g, 100 mmol), t-BuOK (12.3 g, 220 mmol) in DMSO (250 mL). The 
resulting mixture at 80 °C for 16 h. The reaction was cooled to room temperature, water (250 
mL) was added, and the mixture was extracted with CH2Cl2 (2 × 200 mL). The combined 
organic phases were washed with brine (3 × 50 mL), dried (Na2SO4), filtered, and 
concentrated in vacuo. Purification of the residue by column chromatography (1:1 
hexane:EtOAc) gave the title compound 724 as a white solid (17.1 g, 95%).  Rf = 0.17 (40% 
EtOAc/hexane); 1H NMR (400 MHz, CDCl3) δ 2.79-2.64 (6H, m, CH2CH2CH2 and CCH2C 
), 2.08-1.92 (3H, m, CH2CH2CH2 and C≡CH), 1.33 (3H, s, CH3). 
The data were in agreement with those in the literature.[132] 
 
Diethyl 2-methyl-2-(prop-2-yn-1-yl)malonate (760) 
 
 
To a suspension of NaH (0.92 g, 24 mmol) in THF (50 mL) was added dropwise diethyl 
methyl malonate (3.40 mL, 20.0 mmol) at 0 °C. The reaction was warmed to room 
temperature and stirred for 1 h. Propargyl bromide (2.45 mL, 22.0 mmol) was added 
dropwise and left stirring at room temperature for 16 h. The reaction mixture was cold down 
to 0 °C and quenched with 10% aqueous HCl (10 mL). Brine (50 mL) was added and the 
mixture was extracted with Et2O (2 × 25 mL). The combined organic phases were washed 
with brine (3 × 50 mL), dried (Na2SO4), filtered, and concentrated in vacuo. Purification of 
the residue by column chromatography (7:3 hexane:EtOAc) gave the title compound XX as a 
white solid (4.1 g, 78%).  Rf = 0.45 (30% EtOAc/hexane); 1H NMR (400 MHz, CDCl3) δ 
4.22-4.16 (4H, m, O=CCH2CH3), 2.76 (2H, d, J = 2.7 Hz, CH2C≡), 2.01 (1H, t, J = 2.7 Hz 
C≡CH), 1.53 (3H, s, CCH3), 1.24 (6H, t, J = 7.06 Hz, O=CCH2CH3). 
The data were in agreement with those in the literature.[133] 
 
Ethyl 2-acetyl-2-methylpent-4-ynoate (747) 
 
To a suspension of NaH (0.92 g, 24 mmol) in THF (50 mL) was added dropwise ethyl 2-
methylacetoacetate (3.76 mL, 20.0 mmol) at 0 °C. The reaction was warmed to room 
temperature and stirred for 1 h. Propargyl bromide (2.45 mL, 22.0 mmol) was added 
dropwise and left stirring at room temperature for 16 h. The reaction mixture was cold down 
to 0 °C and quenched with 10% aqueous HCl (10 mL). Brine (50 mL) was added and the 
mixture was extracted with Et2O (2 × 25 mL). The combined organic phases were washed 
with brine (3 × 50 mL), dried (Na2SO4), filtered, and concentrated in vacuo. Purification of 
the residue by column chromatography (6:4 hexane:EtOAc) gave the title compound XX as a 
white solid (3.7 g, 86%).  Rf = 0.33 (30% EtOAc/hexane); 1H NMR (400 MHz, CDCl3) δ 
4.26-4.19 (2H, m, O=CCH2CH3), 2.79-2.67 (2H, m, CH2C≡), 2.01 (1H, t, J = 2.7 Hz 
C≡CH), 2.19 (3H, s, O=CCH3), 2.02 (1H, t, J = 2.8 Hz), 1.49 (3H, s, CCH3), 1.27 (3H, t, J = 
7.13 Hz, O=CCH2CH3). 
The data were in agreement with those in the literature.[134] 
 
 
6.2.2. Substrate Synthesis 
2-Methyl-2-(3-phenylprop-2-yn-1-yl)cyclopentane-1,3-dione (711)  
 
2-Methyl-2-propargyl-1,3-cyclopentanedione (721) (1.50 g, 10.0 mmol) was added to a 
solution of Pd(PPh3)2Cl2 (140 mg, 0.199 mmol), CuI (106 mg, 0.557 mmol), and Et3N (2.4 
mL, 17.2 mmol) in anhydrous DMSO (20 mL). Bromobenzene (1.08 mL, 10.3 mmol) was 
added and the mixture was stirred at 90 °C for 2 h. The reaction was cooled to room 
temperature, water (50 mL) was added, and the mixture was extracted with Et2O (50 mL). 
The combined organic phases were washed with 10% aqueous HCl (3 × 20 mL), dried 
(Na2SO4), filtered, and concentrated in vacuo. Purification of the residue by column 
chromatography (10% EtOAc/hexane) gave the title compound 711 (1.90 g, 84%) as a pale 
yellow solid. Rf = 0.35 (30% EtOAc/hexane); m.p. 64-65 °C (Et2O/hexane); IR 2970, 1721 
(C=O), 1412, 1065, 760 cm-1; 1H NMR (400 MHz, CDCl3) δ 7.37-7.27 (5H, m, ArH), 2.90-
2.80 (4H, m, CH2CH2), 2.70 (2H, s, CH2C≡C), 1.19 (3H, s, CH3); 13C NMR (126 MHz, 
CDCl3) δ 215.6 (2 × C), 131.6 (2 × CH), 128.3 (CH), 128.3 (2 × CH), 122.5 (C), 83.9 (C), 
82.9 (C), 55.5 (C), 36.0 (2 × CH2), 25.9 (CH2), 18.9 (CH3); HRMS (ESI) Exact mass calcd 
for C15H18NO2 [M+NH4]+: 244.1338, found: 244.1332. 
 
2-[3-(4-Methoxyphenyl)prop-2-yn-1-yl]-2-methylcyclopentane-1,3-dione (732)  
 
2-Methyl-2-propargyl-1,3-cyclopentanedione (721) (1.50 g, 10.0 mmol) was added to a 
solution of Pd(PPh3)2Cl2 (140 mg, 0.199 mmol), CuI (106 mg, 0.557 mmol), and Et3N (2.4 
mL, 17.2 mmol) in anhydrous DMSO (20 mL). 4-Bromoanisole (1.72 mL, 13.7 mmol) was 
added and the mixture was stirred at 90 °C for 2 h. The reaction was cooled to room 
 
temperature, water (50 mL) was added, and the mixture was extracted with Et2O (50 mL). 
The organic layer was washed with 10% aqueous HCl (3 × 20 mL), dried (Na2SO4), filtered, 
and concentrated in vacuo. Purification of the residue by column chromatography (10% 
EtOAc/hexane) gave the title compound 732 (1.82 g, 71%) as a brown solid. Rf = 0.33 (30% 
EtOAc/hexane); m.p. 80-85 °C (hexane); IR 2965, 1722 (C=O), 1508, 1242, 1032, 833 cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.26 (2H, d, J = 8.9 Hz, ArH), 6.80 (2H, d, J = 8.9 Hz, ArH), 
3.80 (3H, s, OCH3), 2.89-2.78 (4H, m, CH2CH2), 2.68 (2H, s, CH2C≡C), 1.17 (3H, s, 
CCH3); 13C NMR (126 MHz, CDCl3) δ 215.8 (2 × C), 159.6 (C), 133.0 (2 × CH), 114.6 (C), 
113.9 (2 × CH), 82.7 (C), 82.4 (C), 55.5 (C), 55.3 (CH3), 36.0 (2 × CH2), 26.2 (CH2), 18.8 




2-Methyl-2-propargyl-1,3-cyclopentanedione (721) (1.50 g, 10.0 mmol) was added to a 
solution of Pd(OAc)2 (56 mg, 0.25 mmol), PPh3 (262 mg, 1.00 mmol), CuI (106 mg, 0.56 
mmol), and Et3N (2.4 mL, 17.2 mmol) in anh. DMSO (20 mL). A solution of 
1-Bromo-4-nitrobenzene (2.70 g, 11.0 mmol) in anh. DMSO (5 mL) was added and the 
mixture was stirred at 90 °C for 2 h. The reaction was cooled to room temperature, water (50 
mL) was added, and the mixture was extracted with Et2O (50 mL). The organic layer was 
washed with 10% aqueous HCl (3 × 20 mL), dried (Na2SO4), filtered, and concentrated in 
vacuo. Purification of the residue by column chromatography (10% EtOAc/hexane) gave the 
title compound 730 (1.82 g, 71%) as a pale orange solid. Rf = 0.29 (30% EtOAc/hexane); 
m.p. 124-126 °C (EtOAc/hexane); IR 1720 (C=O), 1338, 1076, 853, 745, 687 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 8.14 (2H, d, J = 8.9 Hz, ArH), 7.47 (2H, d, J = 8.9 Hz, ArH), 2.94-2.76 
(4H, m, CH2CH2), 2.74 (2H, s, CH2C≡C), 1.22 (3H, s, CCH3); 13C NMR (126 MHz, CDCl3) 
δ 214.6 (2 × C), 147.1 (C), 132.4 (2 × CH), 129.5 (C), 123.5 (2 × CH), 89.9 (C), 81.1 (C), 
55.3 (C), 35.6 (2 × CH2), 25.0 (CH2), 19.4 (CH3); HRMS (EI) Exact mass calcd for 






2-Methyl-2-(1-propyn-3-yl)cyclohexane-1,3-dione (724) (1.48 g, 9.01 mmol) was added to a 
solution of Pd(OAc)2 (40.4 mg, 0.180 mmol), PPh3 (189 mg, 0.721 mmol), CuI (68.6 mg, 
0.360 mmol), and Et3N (1.38 mL, 9.90 mmol) in anhydrous DMSO (20 mL). A solution of 
3-bromobenzene (1.41 mL, 13.5 mmol) in anhydrous DMSO (10 mL) was added and the 
mixture was stirred at 90 °C for 2 h. The reaction was cooled to room temperature, water (50 
mL) was added, and the mixture was extracted with Et2O (50 mL). The organic phase was 
washed with 10% aqueous HCl (3 × 20 mL), dried (Na2SO4), filtered, and concentrated in 
vacuo. Purification of the residue by column chromatography (10% EtOAc/hexane) gave the 
title compound 731 (1.63 g, 75%) as a pale yellow solid. Rf = 0.33 (30% EtOAc/hexane); 
m.p. 60-65 °C (hexane); IR 2967, 1694 (C=O), 1410, 1315, 1022, 766 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.35-7.33 (2H, m, ArH), 7.28-7.26 (3H, m, ArH), 2.87 (2H, s, CH2C≡C), 
2.73 (4H, td, J = 7.2, 2.1 Hz, CH2CH2CH2), 2.01 (2H, qd, J = 7.2, 2.1 Hz, CH2CH2CH2), 
1.36 (3H, s, CH3); 13C NMR (126 MHz, CDCl3) δ 209.3 (2 × C), 131.6 (2 × CH), 128.2 (2 × 
CH), 128.0 (CH), 123.1 (C), 85.6 (C), 83.0 (C), 64.0 (C), 38.5 (2 × CH2), 26.4 (CH2), 21.7 





2-Methyl-2-(1-propyn-3-yl)cyclohexane-1,3-dione (724) (1.64 g, 10.0 mmol) was added to a 
solution of Pd(OAc)2 (56 mg, 0.25 mmol), PPh3 (262 mg, 1.00 mmol), CuI (106 mg, 0.557 
mmol), and Et3N (2.4 mL, 17.2 mmol) in anhydrous DMSO (20 mL). A solution of 4-
bromoanisole (1.72 mL, 13.7 mmol) in anhydrous DMSO (10 mL) was added and the 
 
mixture was stirred at 90 °C for 2 h. The reaction was cooled to room temperature, water (50 
mL) was added, and the mixture was extracted with Et2O (50 mL). The organic phase was 
washed with 10% aqueous HCl (3 × 20 mL), dried (Na2SO4), filtered, and concentrated in 
vacuo. Purification of the residue by column chromatography (10% EtOAc/hexane) to give 
the tittle compound 732 (2.21 g, 82%) as a pale yellow solid. Rf = 0.28 (30% EtOAc/hexane); 
m.p. 70-75 °C (hexane); IR 2695, 1721 (C=O), 1508, 1244, 1032, 841 cm-1; 7.30-7.24 (2H, 
m, ArH), 6.82-6.76 (2H, m, ArH), 3.79 (3H, s, OCH3), 2.84 (2H, s, CH2C≡C), 2.73 (4H, t, J 
= 3.8 Hz, CH2CH2CH2), 2.08-1.92 (2H, m, CH2CH2CH2), 1.34 (3H, s, CCH3); 13C NMR 
(126 MHz, CDCl3) δ 209.4 (2 × C), 159.4 (C), 133.0 (2 × CH), 115.2 (C), 113.8 (2 × CH), 
83.9 (C), 82.9 (C), 64.0 (C), 55.3 (CH3), 38.6 (2 × CH2), 26.8 (CH2), 21.5 (CH3), 17.3 (CH2); 




Propargyl bromide (80% solution in toluene, 858 µL, 7.70 mmol) was added to a solution of 
1,3-dimethyl-1,2,3,4-tetrahydroquinoline-2,4-dione (349) (1.04 g, 5.50 mmol) and t-BuOK 
(678 mg, 6.04 mmol) in DMSO (50 mL). The mixture was stirred at room temperature for 16 
h, diluted with water (50 mL), and extracted with EtOAc (3 × 25 mL). The combined organic 
phases were dried (Na2SO4), filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (20% EtOAc/hexane) gave the title compound 762 (650 mg, 
52%) as a yellow oil. Rf = 0.33 (25% EtOAc/petroleum ether); IR 3272 (C≡C-H), 1698 
(C=O), 1656 (C=O), 1375, 1102, 758 cm-1; 1H NMR (500 MHz, CDCl3) δ 8.06-8.03 (1H, m, 
ArH), 7.68-7.63 (1H, m, ArH), 7.27-7.18 (2H, m, ArH), 3.51 (3H, s, NCH3), 2.90 (2H, d, J 
= 2.6 Hz, CH2), 1.84 (1H, t, J = 2.6 Hz, ≡CH), 1.47 (3H, s, CCH3); 13C NMR (126 MHz, 
CDCl3) δ 195.8 (C), 172.4 (C), 143.2 (CH), 136.2 (CH), 128.3 (CH), 123.2 (CH), 120.0 (C), 
114.8 (CH), 80.0 (C), 70.3 (CH), 56.8 (C), 29.9 (CH3), 26.2 (CH2), 24.4 (CH3); HRMS (ESI) 







Alkyne 762 (1.02 g, 4.49 mmol) was added to a solution of Pd(PPh3)2Cl2 (63.2 mg, 
0.0900 mmol), CuI (34.3 mg, 0.180 mmol), and Et3N (691 µL, 4.96 mmol) in anhydrous 
MeCN (15 mL) in a sealed tube. A solution of 4-chlorobromobenzene (1.29 g, 5.41 mmol) in 
anhydrous MeCN (5 mL) was added, the tube was sealed, and the mixture was stirred at 110 
°C for 16 h. The reaction was cooled to room temperature, water (50 mL) was added, and the 
mixture was extracted with EtOAc (50 mL). The organic phase was washed with aqueous 
10% HCl (3 × 20 mL), dried (Na2SO4), filtered, and concentrated in vacuo. Purification of 
the residue by column chromatography (10% EtOAc/hexane) gave the title compound 763 
(0.95 g, 63%) as a yellow solid. Rf = 0.46 (25% EtOAc/petroleum ether); m.p. 96-98 °C 
(MeOH/hexane); IR 2943, 1687 (C=O), 1651 (C=O), 1472, 1375, 1088, 758 cm-1; 1H NMR 
(500 MHz, CDCl3) δ 8.08 (1H, dd, J = 7.7, 1.5 Hz, ArH), 7.67-7.62 (1H, m, ArH), 7.23-7.18 
(2H, m, ArH), 7.16-7.12 (2H, m, ArH), 7.00-6.96 (2H, m, ArH), 3.50 (3H, s, NCH3), 3.08 
(1H, d, J = 16.2 Hz, CH2), 3.02 (1H, d, J = 16.2 Hz, CH2), 1.55 (3H, s, CCH3); 13C NMR 
(126 MHz, CDCl3) δ 196.1 (C), 172.6 (C), 143.4 (C), 136.2 (CH), 133.8 (C), 132.7 (2 × CH), 
128.3 (2 × CH), 128.2 (CH), 123.2 (CH), 121.5 (C), 120.4 (C), 114.8 (CH), 86.1 (C), 81.8 
(C), 56.6 (C), 29.9 (CH3), 29.0 (CH2), 23.3 (CH3); HRMS (ESI) Exact mass calcd for 
C20H1735ClNO2 [M+H]+: 338.0948, found: 338.0940. 
 
Ethyl 2-oxo-1-(3-phenyl-2-propynyl)cyclopentanecarboxylate (745) 
 
Et3N (40 mL) was added to a flask containing (MeCN)2PdCl2 (41.5 mg, 0.160 mmol), PPh3 
(83.9 mg, 0.320 mmol), and CuI (30.5 mg, 0.160 mmol). The mixture was stirred at room 
temperature for 5 min, ethyl 2-oxo-1-(2-propynyl)cyclopentanecarboxylate (744) (1.56 g, 
8.03 mmol) and iodobenzene (1.1 mL, 9.8 mmol) were added, and the mixture was stirred at 
 
60 °C for 8 h. The reaction was cooled to room temperature, water (50 mL) and saturated 
aqueous NH4Cl (25 ml) were added, and the mixture was extracted with EtOAc (3 × 50 mL). 
The combined organic phases were washed with brine (75 mL), dried (MgSO4), filtered, and 
concentrated in vacuo. Purification of the residue by column chromatography (20% 
EtOAc/hexane) gave the title compound 745 (1.74 g, 80%) as a yellow oil. Rf = 0.23 (10% 
EtOAc/petroleum ether); IR 2978, 1751 (C=O), 1726 (C=O), 1227, 1148, 1028 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 7.38-7.34 (2H, m, ArH), 7.31-7.27 (3H, m, ArH), 4.20 (2H, q, J 
= 7.1 Hz, OCH2), 3.00-2.91 (2H, m, CH2C≡C), 2.60-2.47 (2H, m, CH2C=O and 
CH2CH2CH2C=O), 2.43-2.28 (2H, m, CH2C=O and CH2CH2CH2C=O), 2.18-2.04 (2H, m, 
CH2CH2C=O), 1.27 (3H, t, J = 7.1 Hz, CH3); 13C NMR (126 MHz, CDCl3) δ 213.9 (C), 
170.5 (C), 131.6 (2 × CH), 128.2 (2 × CH), 128.0 (CH), 123.2 (C), 85.3 (C), 82.8 (C), 61.7 
(CH2), 59.1 (C), 38.4 (CH2), 32.8 (CH2), 24.2 (CH2), 19.9 (CH2), 14.1 (CH3); HRMS (ESI) 
Exact mass calcd for C17H19O3 [M+H]+: 271.1329, found: 271.1321. 
 
Diethyl 2-methyl-2-(3-phenylprop-2-yn-1-yl)malonate (761) 
 
Diethyl 2-methyl-2-(prop-2-yn-1-yl)malonate (2.65 g, 10.0 mmol) was added to a solution of 
Pd(OAc)2 (44 mg, 0.20 mmol), PPh3 (209 mg, 0.80 mmol), CuI (76.2 mg, 0.40 mmol), and 
Et3N (1.53 mL, 11.1 mmol) in anhydrous DMSO (20 mL). Bromobenzene (1.57 mL, 15 
mmol) was added and the mixture was stirred at 90 °C for 2 h. The reaction was cooled to 
room temperature, water (50 mL) was added, and the mixture was extracted with Et2O (50 
mL). The organic phase was washed with 10% aqueous HCl (3 × 20 mL), dried (Na2SO4), 
filtered, and concentrated in vacuo. Purification of the residue by column chromatography 
(10% EtOAc/hexane) gave the title compound 761 (2.33 g, 81%) as a colourless oil. Rf = 0.7 
(30% EtOAc/hexane); IR 3288, 2984, 1732 (C=O), 1599, 1450, 1294, 1022, 759 cm-1; 7.37-
7.34 (2H, m, ArH), 7.26-7.25 (3H, m, ArH), 4.25-4.17 (4H, m, O=CCH2CH3), 3.00 (2H, s, 
CH2C≡),  1.60 (3H, s, CCH3), 1.25 (3H, t, J = 4.5 Hz, O=CCH2CH3); 13C NMR (126 MHz, 
CDCl3) δ 171.5 (2 × C), 131.6 (2 × CH), 128.2 (2 × CH), 127.9 (CH), 123.3 (C), 84.7 (C), 
 
83.3 (C), 71.2 (C), 61.6 (2 × CH2) 26.7 (CH2), 19.9 (CH3), 14.0 (2 × CH3); HRMS (ESI) 
Exact mass calcd for C17H21O4 [M+H]+: 288.1362, found: 258.1324. 
 
Ethyl 2-acetyl-2-methyl-5-phenylpent-4-ynoate (747) 
 
Ethyl 2-acetyl-2-methylpent-4-ynoate (1.82 g, 10.0 mmol) was added to a solution of 
Pd(OAc)2 (44 mg, 0.20 mmol), PPh3 (209 mg, 0.80 mmol), CuI (76.2 mg, 0.40 mmol), and 
Et3N (1.53 mL, 11.1 mmol) in anhydrous DMSO (20 mL). Bromobenzene (1.57 mL, 15 
mmol) was added and the mixture was stirred at 90 °C for 2 h. The reaction was cooled to 
room temperature, water (50 mL) was added, and the mixture was extracted with Et2O (50 
mL). The organic phase was washed with 10% aqueous HCl (3 × 20 mL), dried (Na2SO4), 
filtered, and concentrated in vacuo. Purification of the residue by column chromatography 
(10% EtOAc/hexane) gave the title compound 747 (1.94 g, 75%) as a colourless oil. Rf = 0.6 
(30% EtOAc/hexane); IR 2984, 1720 (C=O), 1716 (C=O), 1598, 1491, 1105, 858 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 7.36-7.34 (2H, m, ArH), 7.28-7.25 (3H, m, ArH), 4.27-4.18 (2H, 
m, O=CCH2CH3), 3.00-2.89 (2H, m, CH2C≡), 2.22 (3H, s, O=CCH3), 1.54 (3H, s, CCH3), 
1.27 (3H, t, J = 7.0 Hz, O=CCH2CH3); 13C NMR (126 MHz, CDCl3) δ 203.9 (C), 171.5 (C), 
131.5 (2 × CH), 128.1 (2 × CH), 127.9 (CH), 123.1 (C), 84.8 (C), 83.4 (C), 61.7 (CH2), 59.3 
(C), 26.1 (CH3), 25.9 (CH2), 19.3 (CH3), 14.0 (CH3); HRMS (ESI) Exact mass calcd for 
C16H19O3 [M+H]+: 258.1256, found: 258.1206. 
 




methylcyclopentane-1,3-dione (5), and (±)-5-(diphenylmethylidene)-7-
methylcycloheptane-1,4-dione (6)  
 
 
Alkynone 711 (90.5 mg, 0.400 mmol), phenylboronic acid (73.2 mg, 0.600 mmol), 
[Rh(cod)Cl]2 (3.0 mg, 0.006 mmol), and KF (34.8 mg, 0.600 mmol) were added to an oven-
dried microwave vial. The vial was sealed with a septum-lined cap and purged with nitrogen 
for 1 h. Anhydrous toluene (4.0 mL) and t-BuOH (57 µL, 0.60 mmol) were added, and the 
mixture was stirred at 65 °C for 16 h. The reaction was cooled to room temperature, water (5 
mL) and saturated aqueous NH4Cl (5 mL) were added, and the mixture was extracted with 
EtOAc (3 × 10 mL). The combined organic phases were washed with brine (20 mL), dried 
(MgSO4), filtered, and concentrated in vacuo. The mixture was subjected to column 
chromatography (10% EtOAc/petroleum ether) leading to isolation of compound 712 
(49.5 mg, 41%) as a white solid, compound  719 (22.0 mg, 18%) as a pale yellow solid and 
compound 713 (20.5 mg, 17%) as a white solid. 
 
(±)-(3aR,9bR)-5-[(E)-Benzylidene)-9b-hydroxy-3a-methyl-1,2,3a,4,5,9b-
hexahydro-3H-cyclopenta[a]naphthalen-3-one (712). Rf = 0.42 (40% 
EtOAc/hexane); m.p. 144-145 °C (hexane); IR 3468 (OH), 2936, 1717 
(C=O), 1207, 1076, 758, 694 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.72 (1H, 
dd, J = 7.7, 1.2 Hz, ArH), 7.68 (1H, dd, J = 7.9, 1.2 Hz, ArH), 7.43-7.32 (4H, m, ArH), 
7.30-7.25 (3H, m, ArH), 7.24 (1H, d, J = 1.4 Hz, C=CH), 2.79 (1H, d, J = 14.1 Hz, 
CH2C=C), 2.68-2.58 (2H, m, CH2C=C and CH2C=O), 2.53-2.29 (3H, m, CH2C=O and 
CH2COH), 1.83 (1H, d, J = 1.6 Hz, OH), 1.01 (3H, s, CH3); 13C NMR (126 MHz, CDCl3) δ 
219.9 (C), 140.1 (C), 137.1 (C), 134.3 (C), 132.1 (C), 129.1 (2 × CH), 128.8 (CH), 128.4 (2 
× CH), 128.2 (CH), 127.9 (CH), 127.1 (CH), 126.5 (CH), 124.2 (CH), 80.1 (C), 54.1 (C), 
35.9 (CH2), 35.2 (CH2), 34.3 (CH2), 13.9 (CH3); HRMS (ESI) Exact mass calcd for C21H21O2 
[M+H]+: 305.1542, found: 305.1538. 
 
2-[(E)-2,3-Diphenylprop-2-en-1-yl]-2-methylcyclopentane-1,3-dione 
(719). Rf = 0.53 (40% EtOAc/hexane); m.p. 85-90 °C (CH2Cl2/hexane) IR 
 
1742 (C=O), 1210, 929, 730, 702 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.54-7.52 (2H, m, 
ArH), 7.47-7.43 (2H, m, ArH), 7.37-7.33 (3H, m, ArH), 7.32-7.27 (3H, m, ArH), 6.67 (1H, 
s, C=CH), 3.26 (2H, s, CH2C=C), 2.48-2.41 (2H, m, CH2CH2), 1.86-1.80 (2H, m, CH2CH2), 
1.10 (3H, s, CH3); 13C NMR (126 MHz, CDCl3) δ 216.7 (2 × C), 141.5 (C), 138.3 (C), 137.4 
(C), 132.5 (CH), 128.9 (2 × CH), 128.6 (2 × CH), 128.3 (CH), 128.2 (2 × CH), 128.0 (CH), 
127.0 (CH), 55.5 (C), 36.7 (CH2), 34.9 (2 × CH2), 22.1 (CH3); HRMS (ESI) Exact mass 
calcd for C21H20NaO2 [M+Na]+: 327.1356, found: 327.1354.  
 
(±)-5-(Diphenylmethylidene)-7-methylcycloheptane-1,4-dione (713). Rf = 
0.62 (40% EtOAc/hexane); m.p. 110-120 °C (CH2Cl2/hexane); IR 1708 (C=O), 
1215, 760, 702, 699 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.39-7.23 (6H, m, 
ArH), 7.20-7.17 (2H, m, ArH), 7.11-7.08 (2H, m, ArH), 2.85-2.64 (6H, m, 
CH2CH2 and CH2CH), 2.29-2.20 (1H, m, CHCH3), 0.99 (3H, d, J = 6.4 Hz, CHCH3); 13C 
NMR (126 MHz, CDCl3) δ 211.5 (C), 207.5 (C), 144.6 (C), 140.8 (C), 139.2 (C), 138.3 (C), 
128.9 (2 × CH), 128.6 (2 × CH), 128.5 (2 × CH), 128.3 (2 × CH), 127.8 (CH), 127.8 (CH), 
45.2 (CH), 38.9 (CH2), 37.6 (CH2), 34.4 (CH2), 15.6 (CH3); HRMS (ESI) Exact mass calcd 
for C21H21O2 [M+H]+: 305.1536, found: 305.1527 
 
6.2.4. Racemic Iridium Catalysed Arylative Cyclizations  
Representative procedure for the iridium-catalysed arylative cyclisation of alkynones 
(±)-(3aR,9bR)-5-[(E)-Benzylidene)-9b-hydroxy-3a-methyl-1,2,3a,4,5,9b-hexahydro-3H-




Alkynone 711 (90.5 mg, 0.400 mmol), phenylboronic acid (73.2 mg, 0.600 mmol), 
[Ir(cod)Cl]2 (4.0 mg, 0.0060 mmol), and KF (34.8 mg, 0.600 mmol) were added to an oven-
 
dried microwave vial. The vial was sealed with a septum-lined cap and purged with nitrogen 
for 1 h. Anhydrous toluene (4.0 mL) and t-BuOH (57 µL, 0.60 mmol) were added, and the 
mixture was stirred at 65 °C for 16 h. The reaction was cooled to room temperature, water (5 
mL) and saturated aqueous NH4Cl (5 mL) were added, and the mixture was extracted with 
EtOAc (3 × 10 mL). The combined organic phases were washed with brine (20 mL), dried 
(MgSO4), filtered, and concentrated in vacuo. The mixture was subjected to column 
chromatography (40% EtOAc/petroleum ether) leading to the isolation of compound 712 
(88.0 mg, 72%) as a white solid and compound 714 (28.4 mg, 27%) as a white solid. 
 
(±)-(3aR,9bR)-5-[(E)-Benzylidene)-9b-hydroxy-3a-methyl-1,2,3a,4,5,9b-







methylcyclopentane-1,3-dione (714). Rf = 0.13 (40% 
EtOAc/hexane); m.p. 206-208 °C (CH2Cl2/Et2O); IR 3438 (OH), 2926, 1736 (C=O), 1721 
(C=O), 1445, 1205, 1070 cm-1; 1H NMR (400 MHz, CDCl3) d 7.68 (1H, dd, J = 7.6, 1.3 Hz, 
ArH), 7.47 (1H, dd, J = 7.5, 1.4 Hz, ArH), 7.41 (1H, t, J = 7.6 Hz, ArH), 7.30-7.13 (7H, m, 
ArH), 6.94 (1H, s, C=CHPh), 6.78-6.84 (4H, m, ArH), 5.86 (1H, t, J = 7.5 Hz, 
CH2CH=CPh), 2.72-2.42 (7H, m, O=CCH2CH2C=O and CH2CH=C and CH2CH2COH), 
2.33-1.99 (5H, m, CH2CH2COH  and CH2COH and CH2C=CH), 1.82 (1H, d, J = 1.4 Hz, 
OH), 1.14 (3H, s, CH3C(C=O)2), 0.83 (3H, s, CH3CCOH); 13C NMR (101 MHz, CDCl3) d 
219.7 (C), 215.1 (2 × C), 147.8 (C), 142.4 (C), 142.1 (C), 139.4 (C), 136.9 (C), 134.8 (C), 
133.9 (CH), 132.3 (CH), 132.1 (C), 129.7 (2 × CH), 129.1 (2 × CH), 128.1 (2 × CH), 127.8 
(CH), 127.6 (2 × CH), 127.0 (CH), 126.9 (CH), 125.2 (CH), 123.1 (CH), 80.7 (C), 57.1 (C), 
54.6 (C), 35.8 (CH2), 35.1 (CH2), 34.9 (CH2), 34.8 (CH2), 34.73 (CH2), 34.69 (CH2), 16.7 
(CH3), 15.1 (CH3); HRMS (ESI) Exact mass calcd for C36H34NaO4 [M+Na]+: 554.2349, 





The title compound was prepared according to the Representative 
Procedure from alkynone 728 (96.0 mg, 0.400 mmol) and 
phenylboronic acid (73.2 mg, 0.600 mmol). Purification by column 
chromatography (10% EtOAc/hexane) gave 769 (91.1 mg, 72%) as a white solid. Rf = 0.29 
(30% EtOAc/hexane); m.p. 110-120 °C (i-PrOH); IR 3468 (OH), 2953, 1717 (C=O), 1450, 
1076, 959, 694 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.74 (1H, d, J = 1.5 Hz, ArH), 7.69 (1H, 
dd, J = 7.9, 1.2 Hz, ArH), 7.41 (1H, ddd, J = 7.7, 7.4, 1.3 Hz, ArH), 7.36 (1H, ddd, J = 7.9, 
7.4, 1.5 Hz, ArH), 7.29-7.24 (1H, m, ArH), 7.22 (1H, d, J = 1.4 Hz, C=CH), 7.13-7.07 (3H, 
m, ArH), 2.81 (1H, d, J = 14.1 Hz, CH2C=C), 2.69-2.59 (2H, m, CH2C=C and CH2C=O), 
2.51 (1H, ddd, J = 19.0, 9.0, 2.4 Hz, CH2C=O), 2.43 (1H, ddd, J = 13.6, 9.2, 2.4 Hz, 
CH2COH), 2.40-2.26 (1H, m, CH2COH), 2.37 (3H, s, ArCH3), 1.86 (1H, s, OH), 1.03 (3H, 
s, CCH3);  13C NMR (126 MHz, CDCl3) δ 220.0 (C), 140.1 (C), 137.9 (C), 137.0 (C), 134.3 
(C), 131.9 (C), 129.8 (CH), 128.7 (CH), 128.3 (CH), 128.1 (CH), 128.1 (CH), 127.9 (CH), 
126.5 (CH), 126.2 (CH), 124.1 (CH), 80.1 (C), 54.2 (C), 35.9 (CH2), 35.2 (CH2), 34.4 (CH2), 
21.5 (CH3), 13.8 (CH3); HRMS (ESI) Exact mass calcd for C22H26NO2 [M+NH4]+: 336.1964, 
found: 336.1958.  
 
(±)-(4aR,10aR)-9-[(E)-Benzylidene]-4a-hydroxy-10a-methyl-
3,4,4a,9,10,10a-hexahydrophenanthren-1(2H)-one (794). The title 
compound was prepared according to the Representative Procedure from 
alkynone 731 (96.0 mg, 0.400 mmol) and phenylboronic acid (73.2 mg, 
0.600 mmol). Purification by column chromatography (10% EtOAc/hexane) gave 794 (90.4 
mg, 71%) as a white solid. Rf = 0.29 (30% EtOAc/hexane); m.p. 170-171 °C (MeOH); IR 
3503 (OH), 2934, 1686 (C=O), 1167, 982, 754, 696 cm-1; 1H NMR (500 MHz, CDCl3) δ 
7.74 (1H, dd, J = 7.7, 1.5 Hz, ArH), 7.64 (1H, dd, J = 7.6, 1.5 Hz, ArH), 7.40-7.25 (6H, m, 
ArH), 7.24 (1H, d, J = 1.4 Hz, C=CH), 3.20 (1H, dd, J = 15.0, 2.0 Hz, CH2C=C), 2.81 (1H, 
dd, J = 15.0, 0.9 Hz, CH2C=C), 2.70 (1H, ddd, J = 14.9, 13.0, 6.6 Hz, CH2C=O), 2.46-2.37 
(1H, m, CH2C=O), 2.34-2.13 (2H, m, CH2COH), 2.02-1.94 (2H, m, CH2CH2COH and OH), 
1.93-1.85 (1H, m, CH2CH2COH), 1.02 (3H, s, CH3); 13C NMR (126 MHz, CDCl3) δ 213.7 
(C), 142.1 (C), 137.2 (C), 133.9 (C), 132.0 (C), 129.2 (2 × CH), 128.5 (CH), 128.4 (2 × CH), 
127.8 (CH), 127.08 (CH), 127.06 (CH), 125.3 (CH), 123.7 (CH), 78.4 (C), 53.3 (C), 36.9 
 
(CH2), 36.8 (CH2), 36.7 (CH2), 20.9 (CH2), 15.9 (CH3); HRMS (ESI) Exact mass calcd for 
C22H23O2 [M+H]+: 319.1698, found: 319.1696. 
 
(±)-(4aR,10aR)-4a-Hydroxy-9-[(E)-4-methoxybenzylidene]-10a-
methyl-3,4,4a,9,10,10a-hexahydrophenanthren-1(2H)-one (795). The 
title compound was prepared according to the Representative Procedure 
from alkynone 732 (108 mg, 0.400 mmol) and phenylboronic acid (73.2 
mg, 0.600 mmol). Purification by column chromatography (10% 
EtOAc/hexane) gave 795 (80.7 mg, 58%) as a white solid. Rf = 0.25 (30% 
EtOAc/hexane); m.p. 133-134 °C (Et2O/hexane); IR 3466 (OH), 2936, 1717 (C=O), 1452, 
1238, 1034, 758, 694 cm-1; 1H NMR (400 MHz, CDCl3) d 7.73-7.70 (1H, m, ArH), 7.64-
7.61 (1H, m, ArH), 7.36-7.29 (2H, m, ArH), 7.29-7.24 (2H, m, ArH), 7.17 (1H, d, J = 1.3 
Hz, C=CH), 6.93-6.88 (2H, m, ArH), 3.84 (3H, s, OCH3), 3.19 (1H, dd, J = 15.1, 1.9 Hz, 
CH2C=C), 2.80 (1H, dd, J = 15.1, 1.2 Hz, CH2C=C), 2.76-2.66 (1H, m, CH2C=O), 2.46-2.40 
(1H, m, CH2C=O), 2.33-2.14 (2H, m, CH2COH), 1.99-1.86 (3H, m, CH2CH2CH2 and OH), 
1.01 (3H, s, CCH3); 13C NMR (126 MHz, CDCl3) δ 213.8 (C), 158.6 (C), 141.9 (C), 134.3 
(C), 130.6 (2 × CH), 130.5 (C), 129.8 (C), 128.2 (CH), 127.7 (CH), 126.8 (CH), 125.1 (CH), 
123.6 (CH), 113.9 (2 × CH), 78.4 (C), 55.3 (CH3), 53.3 (C), 36.9 (CH2), 36.8 (CH2), 36.6 
(CH2), 20.9 (CH2), 15.9 (CH3); HRMS (ESI) Exact mass calcd for C23H25O3 [M+H]+: 
366.2069, found: 366.2066. 
  
(±)-(4aR,10aR)-4a-Hydroxy-9-[(E)-4-chlorobenzylidene]-10a-methyl-
3,4,4a,9,10,10a-hexahydrophenanthren-1(2H)-one (796). The title 
compound was prepared according to the Representative Procedure from 
alkynone 733 (110 mg, 0.400 mmol) and phenylboronic acid (73.2 mg, 
0.600 mmol). Purification by column chromatography (10% 
EtOAc/cyclohexane) gave 796 (112.6 mg, 80%) as a white solid. Rf = 0.36 
(30% EtOAc/hexane); m.p. 166-167 °C (MeOH); IR 3497 (OH), 2953, 1682 (C=O), 1489, 
1190, 870, 756 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.72 (1H, dd, J = 7.8, 1.3 Hz, ArH), 7.64 
(1H, dd, J = 7.7, 1.4 Hz, ArH), 7.39-7.30 (4H, m, ArH), 7.26-7.20 (2H, m, ArH), 7.17 (1H, 
s, C=CH), 3.17 (1H, dd, J = 15.0, 2.0 Hz, CH2C=C), 2.73 (1H, dd, J = 15.0, 0.8 Hz, 
CH2C=C), 2.67 (1H, ddd, J = 15.0, 12.7, 6.6 Hz, CH2C=O), 2.46-2.40 (1H, m, CH2C=O), 
2.32-2.14 (2H, m, CH2COH), 2.02-1.96 (1H, m, CH2CH2CH2), 1.94 (1H, d, J = 2.0 Hz, OH), 
 
1.92-1.84 (1H, m, CH2CH2CH2), 1.02 (3H, s, CH3);13C NMR (126 MHz, CDCl3) δ 213.4 
(C), 142.1 (C), 142.1 (C), 135.7 (C), 133.7 (C), 132.9 (C), 130.5 (2 × CH), 128.7 (CH), 
128.6 (2 × CH), 127.9 (CH), 125.7 (CH), 125.4 (CH), 123.8 (CH), 78.3 (C), 53.4 (C), 36.9 
(CH2), 36.7 (CH2), 36.6 (CH2), 20.8 (CH2), 16.1 (CH3); HRMS (ES) Exact mass calcd for 





(801). The title compound was prepared according to the 
Representative Procedure from alkynone 763 (135 mg, 0.400 mmol) 
and phenylboronic acid (73.2 mg, 0.600 mmol). Purification by 
column chromatography (10% EtOAc/hexane) gave 801 (120 mg, 
72%) as a white solid. Rf = 0.38 (30% EtOAc/petroleum ether); m.p. 174-176 °C 
(MeOH/hexane); IR 3293 (OH), 2936, 1638 (C=O), 1377, 1018, 752 cm-1; 1H NMR (400 
MHz, D6-DMSO, 85 °C) δ 7.88-7.84 (1H, m, ArH), 7.57-7.47 (3H, br m, ArH), 7.46-7.42 
(2H, m, ArH), 7.36 (1H, ddd, J = 8.1, 7.5, 1.6 Hz, ArH), 7.32-7.26 (1H, m, ArH), 7.20-7.13 
(3H, m, ArH and C=CH), 7.08 (1H, dd, J = 8.1, 1.0 Hz, ArH), 7.00 (1H, br s, ArH), 5.71 
(1H, s, OH), 3.22 (1H, br d, J = 16.1 Hz, CH2), 3.09 (3H, s, NCH3), 2.82 (1H, dd, J = 16.1, 
2.4 Hz, CH2), 1.00 (3H, s, CCH3); 13C NMR (101 MHz, D6-DMSO, 85 °C) δ 171.7 (C), 
138.3 (C), 137.5 (C), 136.2 (C), 134.5 (C), 133.6 (C), 130.8 (C), 130.5 (2 × CH), 130.4 (C), 
128.0 (CH), 127.8 (2 × CH), 127.5 (CH), 126.9 (CH), 126.8 (CH), 126.5 (CH), 123.3 (CH), 
123.1 (CH), 121.9 (CH), 113.9 (CH), 72.2 (C), 45.8 (C), 32.3 (CH2), 28.9 (CH3), 18.0 (CH3); 






Alkynone 743 (108 mg, 0.400 mmol), phenylboronic acid (146 mg, 1.21 mmol), [Ir(cod)Cl]2 
(6.7 mg, 0.010 mmol), and KF (69.7 mg, 1.20 mmol) were added to an oven-dried 
microwave vial. The vial was sealed with a septum-lined cap and purged with nitrogen for 1 
h. Anhydrous toluene (4.0 mL) and t-BuOH (126 µL, 1.32 mmol) were added and the 
mixture was stirred at 65 °C for 4 h. A solution of [Ir(cod)Cl]2 (6.7 mg, 0.010 mmol) in 
anhydrous toluene (1.0 mL) was added, and the mixture was stirred at 65 °C for 14 h. The 
reaction was cooled to room temperature, water (5 mL) and saturated aqueous NH4Cl (5 mL) 
were added, and the mixture was extracted with EtOAc (3 × 10 mL). The combined organic 
phases were washed with brine (20 mL), dried (MgSO4), filtered, and concentrated in vacuo. 
Purification of the residue by column chromatography (10% hexane/toluene) to give 
compound 802 (100 mg, 72%) as a white solid. Rf = 0.30 (10% EtOAc/hexane); m.p. 100-
105 °C (CH2Cl2/hexane); IR 3482 (OH), 2969, 1693 (C=O), 1313, 1201, 1020 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 7.72 (1H, dd, J = 7.7, 1.2 Hz, ArH), 7.56 (1H, dd, J = 7.9, 1.3 
Hz, ArH), 7.40-7.23 (6H, m, ArH), 7.07 (1H, d, J = 1.7 Hz, C=CH), 4.38 (1H, d, J = 2.2 Hz, 
OH), 3.93 (1H, dq, J = 10.7, 7.1 Hz, CH2CH3), 3.79 (1H, dq, J = 10.7, 7.1 Hz, CH2CH3), 
3.50 (1H, d, J = 14.2 Hz, CH2C=C), 2.71 (1H, dd, J = 14.2, 1.7 Hz, CH2C=C), 2.44-2.36 
(1H, m, CH2COH), 2.20-2.01 (3H, m, CH2CH2CH2COH), 1.93-1.81 (2H, m, 
CH2CH2CH2COH and CH2COH), 0.85 (3H, t, J = 7.1 Hz, CH3); 13C NMR (126 MHz, 
CDCl3) δ 176.2 (C), 141.8 (C), 137.5 (C), 134.3 (C), 134.1 (C), 129.1 (2 × CH), 128.4 (CH), 
128.3 (2 × CH), 127.2 (CH), 127.0 (CH), 126.8 (CH), 126.2 (CH), 123.7 (CH), 81.9 (C), 
60.7 (CH2), 57.7 (C), 41.2 (CH2), 36.1 (CH2), 34.5 (CH2), 20.7 (CH2), 13.5 (CH3); HRMS 












6.2.5 X-Ray Structures  
The relative stereochemistries of all products were assigned by analogy to the X-ray 





                                                      
r,r and s I) X-Ray data can be obtained free of charge from The Cambridge Crystallographic 
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